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Abstract
It is now well established that electrical, metabolic and mechanical properties 
vary across the wall of the mammalian ventricle. In this thesis, protein expression, 
intracellular [Ca^‘^ ], and myocyte shortening are examined in myocardium from 
endocardial and epicardial regions of normal rabbit hearts. These properties were 
compared with those in equivalent regions of hearts with significant left ventricular 
dysfunction (LVD) resulting from a ventricular apical infarct.
Resting myocyte length was significantly longer in myocytes isolated from 
LVD hearts but no regional differences in resting myocyte length in sham or LVD 
myocytes was observed. Fractional shortening was not significantly different between 
endocardial and epicardial myocytes from both sham and LVD hearts. LVD 
endocardial myocytes shortened less than myocytes from the comparable region in 
the sham group. No difference in fractional shortening was observed when 
comparing epicardial myocytes from sham and LVD hearts. Contraction kinetics 
were slower in both LVD endocardial and epicardial myocytes. The rest decay effect 
was more pronounced in endocardial compared with epicardial myocytes in both 
sham and LVD groups but minimal differences were observed when comparing 
experimental groups.
Peak systolic [Ca^’^ Ji was similar in endocardial myocytes from both 
experimental groups but was significantly lower in the LVD epicardial group than 
sham. Peak systolic [Ca^‘*‘]i was similar between endocardial and epicardial myocytes 
in the sham group but LVD epicardial peak systolic [Ca^’*']i was lower than 
endocardial. These results suggest various changes in [Ca^^]i transient amplitude and 
myocyte shortening in LVD that may be explained by changes in myofilament Ca^ "^  
sensitivity.
Transmural protein expression of Calsequestrin, SR Ca '^*'-ATPase (SERCA) 
and Na /^Ca '^*' exchanger was similar in sham and LVD myocytes. Calsequestrin and 
Na'^/Ca^'*'exchanger protein expression was significantly increased, and SERCA 
protein expression was significantly decreased, in LVD myocytes. The link between 
altered protein expression and altered intracellular [Ca^ "*"] transients in LVD is 
discussed.
Comparison of the amount of protein retrieved from sham and LVD 
ventricular homogenate samples showed that protein retrieval was similar throughout 
a range of ventricular tissue wet weights (60 to lOOOmg) and in sham and LVD 
myocardial samples. In contrast, protein retrieved from crude SR preparations (250 -  
lOOOmg) was significantly greater in LVD preparations than sham samples. In 
addition, crude SR vesicles derived from ventricular samples weighting less than 
250mg proved unsuitable for experimental use because of the variable protein 
retrieval when using such small sample weights.
Sources of experimental variation within the Western Blotting technique were 
also investigated. It was concluded that the major sources of variation were 
attributable to the electroblotting and the antibody binding steps.
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Chapter 1 
Introduction
Cardiac myocytes generate the contraction required for the pumping action of 
the heart. Under normal physiological conditions cardiac myocytes of the atria and 
ventricles function as a syncitium, where electrical and mechanical links between 
cells ensures that every cell contracts at each beat. The synchrony of cellular 
contraction is critically important for adequate cardiac function. As with most 
physiological systems there is no one simple process or mechanism governing 
cardiac function, rather there is a multitude of distinct complex mechanisms, all 
functioning together for the common goal; efficient cardiac function.
Clearly, pathophysiological conditions, such as congestive cardiac failure, 
which disrupt myocyte function and connective tissue structure and function can give 
rise to severe contractile dysfunction and hereafter potential systemic dysfunction.
It is appropriate at this point to discuss our cun*ent understanding of myocyte 
structure and function, and how myocyte contraction is mediated within mammalian 
cardiac muscle.
1.1. Ultrastructure of cardiac myocytes
Mammalian cardiac myocyte dimensions are similai" between species, for 
example; human myocytes measure, 19 ± 1.7|im by 141 ± 9 [xm (width/length) 
(Gerdes et a l 1992); rabbit; 27.3 ± 1.0p.m by 134.8 ± 2.7 |xm (sub-epicardium); 29.5 
± l.l|uim by 140.4 ± 2.6 (im (sub-endocardium) (McIntosh et a l 2000) and rat 22.1 ± 
0.8|uim by 149.4 ± 3.9 p,m (Gerdes et a l 1996). Mammalian myocytes contain either a 
single or double nucleus and are physically, electrically, and biochemically attached 
to adjacent myocytes by intercalated discs. The sarcomere is the functional unit of 
contraction within myocytes, and measures approximately 2|am in length. Sarcomeres 
are aligned side by side across the cell with their individual boundaries defined by Z 
lines. The A and I bands of the sarcomere give cardiac (and skeletal) myocytes their
characteristic striated appearance. In ventricular myocytes invaginations of the 
sarcolemma occur opposite Z lines forming transverse tubules (T-tubules). T-tubules 
transmit electrical stimuli rapidly into the myocyte interior and thus help activate 
multiple myofilaments simultaneously (Levick, 1995). Sarcomeres contain 2 main 
types of contractile proteins, thick (myosin) and thin (actin) filaments, plus additional 
modulatory proteins, namely tropomyosin, and troponin. Actin filaments project 
approximately l|xm from the Z lines and appear to be anchored to the latter by 
intermediate filaments. Myosin filaments are ~1.6|Ltm long and are connected to 
neighbouring myosin filaments by crosslinks.
The thick filament is composed largely of the protein myosin. The complete 
myosin molecule consists of 2 heavy chains and 4 light chains. Each of the two heavy 
chains consist of a long a-helical tail (~ 120nm) and a globular head. The 2 tails are 
intertwined and form a double-headed structure. The heavy chain itself is further 
divide into light meromyosin (most of the tail) and heavy meromyosin. Heavy 
meromyosin consists of subfragments 1 (SI, globular head and enzymatic activity) 
and 2 (S2) which are composed of the remainder of the tail section and the light 
chains. The globular heads contain the adenosine triphosphatase (ATPase) (site of 
ATP hydrolysis; ATP -high energy molecule,) and the actin (thin filament) binding 
site (See later for details of crossbridge cycling /sliding filament theory). It is the 
heavy meromyosin that forms the crossbridge which projects from the thick filament 
and interacts with the thin filament (actin).
The major component of the thin filament is the actin monomer (G-actin). 
Under physiological concentrations of ATP and Mg^ "^ , G-actin assembles into a 
helical double stranded F-actin polymer (the backbone of the thin filament). In 
addition the thin filament contains regulatory proteins; the double stranded protein 
Tropomyosin and Troponin, a complex of 3 functionally distinct proteins. Troponin 
consists of Troponin T which is the Tropomyosin binding subunit. Troponin I the 
inhibitory subunit, and Troponin C the Ca^'^-binding subunit. Troponin C possesses 1 
Ca^’*'-specific binding site and 2 Ca^ '*'-Mg^ '^  sites. (Solaro, 1995).
1.2. Calcium activated contraction
During diastole, when [Ca^‘^ ]i is -lOOnM, Ca^'^-binding sites on Troponin C 
are unoccupied. This status permits the interaction between Troponin I and Troponin 
C which appears to enhance the inhibitory effect of Troponin I, strengthening the 
interaction between Troponin I and actin. Such Troponin I/actin contact shifts the 
Troponin-Tropomyosin complex out of the actin groove and physically prevents the 
myosin heads (crossbridges) binding to actin (termed steric hindrance), and 
consequentially prevents crossbridge cycling. During systole, when [Ca '^^ ]i rises to 
~ljiM, Ca^ '*' binds to Troponin C (at Ca^^ specific sites). This binding alters the 
interaction of Troponin I and Troponin C and subsequently causes a configurational 
change between Troponin I and actin. This shifts the Troponin-Tropomyosin 
complex into the actin groove, removing the steric hindrance. In this state, the 
crossbridges can attach to actin and cross-bridge cycling and consequently 
contraction (shortening) can occur. Huxley first suggested this steric hindrance model 
in 1973, using x-ray diffraction studies.
During systole, in the presence of ATP and high [Ca '^ ]^i, attachment of the 
crossbridges to actin occurs. The ATP molecule bound to the myosin head Is 
hydrolysed (into adenosine di-phosphate; ADP, inorganic phosphate, Pi and H"^ ) and 
an energy source is released. This energy is used by the crossbridges to produce a 
power stroke which causes parallel sliding of the attached actin filament relative to 
the myosin filament. This sliding mechanism was first proposed in 1954 by two 
separate groups, H.E.Huxley and A.F. Huxley plus colleagues and was termed the 
sliding filament theory.
It is clear that both Ca^ "^  and ATP are essential metabolic requirements for 
cardiac contraction. As the active myocyte requires a constant supply of ATP, it 
comes as no surprise that myocytes possess an exceptionally high density of 
mitochondria; 35% of cell volume. Mitochondria produce ATP by oxidative 
phosphorylation for which oxygen is obligatory, hence the reason why cardiac 
performance is directly dependent on oxygen supply and hence coronary blood flow 
(Bers, 1993).
1.2.1. Calcium sensitivity of the myofilaments
Briefly, myofilament sensitivity to Ca^ '*' is affected by several factors 
including; temperature, (Harrison & Bers, 1989), pHi, (Fabiato & Fabiato, 1978; 
Kentish & Orchard, 1990; Hajjar et a l 2000), sarcomere length (Kentish et al. 1986; 
Schwinger et al. 1994), intracellular [Mg^ "^ ], (Best et al. 1977) and intracellular [Pi] 
(Kentish, 1986).
1.3. Calcium induced calcium release (CICR)
Initiation of electrical conduction begins within pacemaker cells found in the 
Sinoatrial node in the atria. Activation then spreads via the atrioventricular node 
through the specialised conduction system (Purkinje fibres), to the ventricles. 
Specialised sarcolemmal protein channels called gap junctions found within 
intercalated discs provide low resistance pathways, which allow electrical and 
biochemical coupling between adjacent myocytes (Bruzzone et al. 1996). These 
pathways are believed to be responsible for the rapid propagation of electrical 
excitation that allows the heart to contract as an electrical syncytium.
Electrical excitation of the myocyte surface membrane (sarcolemma) initiates 
an action potential (electrical signal) which propagates as a wave of depolarisation 
along the sarcolemma and down into the T-tubules. T-tubules penetrate deep into the 
myocyte, forming close contact with the junctional region of the sarcoplasmic 
reticulum (SR). Myocyte depolarisation by the action potential produces a rise in 
intracellular [Ca^ *^ ] ([Ca^’^ ji) via the Ca^^ cunent ( I c a )  and possibly a small influx via 
the sarcolemmal Na' /^Ca '^*' exchanger (NCX). This rise in [Ca^^ji triggers an 
additional and much magnified release of SR Ca^ "^  via Ca^^ release channels 
(Ryanodine receptors). This mechanism is termed Ca^ '*' induced Ca^^ release (CICR). 
These release channels are thought to be closely apposed to the sarcolemmal Ca^ "^  
channels (dihydropyridine receptor) (Block et al. 1988; Sun et al. 1995). This close 
spatial relationship is necessary for efficient excitation-contraction coupling (E-C 
coupling). SR Ca^ '*' release is generally accepted to be the dominant source of 
myofilament activator Ca^^ with small contributions from Ica and NCX. The 
localised increase in [Ca^^j; activates the nearby myofilaments in a [Ca^'*']-dependent
manner, and manifests as myocyte contraction/shortening. The CICR mechanism 
implies a positive feedback system, i.e. the greater the amount of Ca^  ^released, the 
greater is the amount of “trigger” Ca^ '*' available to induce further release. If this were 
the case all of the SR Ca^  ^ content would be released during depolarisation. 
However, this has been shown not to occur and in fact the magnitude of CICR is 
graded by the amount of trigger Ca^ "*", and also the rate of change of [Ca^ '^ 'ji 
surrounding the SR (Fabiato, 1983). Such a graded response suggests some degree of 
regulation within this system. To date, the CICR theory appears to be the most 
generally accepted, even though the exact nature of the release mechanism remains 
somewhat controversial. A schematic diagram of the intracellular Ca^ "^  transport 
mechanism within cardiac myocytes is shown in figure 1.1.
1.4. Intracellular calcium homeostasis
As Ca^ '*' is one of the most crucial participants in E-C coupling it is important 
to be aware of the different cellular regulatory mechanisms involved in and affecting 
its homeostasis. As discussed earlier, Ca^  ^enters the cell during the action potential 
either via the sarcolemmal Ca^  ^ channels (L-type) or via the NaVCa^^ exchanger 
working in reverse mode. After contraction (systole) cardiac muscle must relax, in 
order for this to occur it is essential that [Ca^’^Jj is reduced back to diastolic levels 
(lOOnM), such that Ca^  ^ will dissociate from Troponin C and the inhibition of 
Troponin I is removed.
There are 4 main mechanisms which contribute to this process:
1) SR Ca^ + ATPase pump (SERCA 2A)
2) Sarcolemmal NaVCa^  ^exchanger (NCX)
3) Sarcolemmal Ca^  ^ATPase
4) Mitochondrial calcium uniporter
1.4.1. SR -ATPase pump (SERCA 2A)
A Ca^ /^Mg '^*' dependent ATPase, a 997 amino acid transmembrane protein, 
pumps Ca^ "^  into the SR during diastole. Three Ca '^*'-ATPase genes exist, SERCA 1,2 
& 3, encoding the lOOkDa SR/ER (endoplasmic reticulum) calcium pumps within 
intracellular membranes. This family of enzymes is well conserved throughout many 
tissues performing identical functions. The SERCA 2 isozyme is found in cardiac 
muscle (as well as in slow skeletal, smooth and some non-muscle cells). Variants of 
SERCA 2; SERCA 2A, and SERCA 2B are found in cardiac and smooth muscle 
respectively. SERCA 2A transports 2 Ca^^ into the SR during one cycle and uses 1 
ATP molecule, calcium binding is sequential and cooperative (Colyer, 1993; 
Simmerman & Jones, 1998). SERCA 2A is a high affinity pump with a Km = 0.1-0.5 
pM, and a VMax of 20-30 nmol Ca^Vmg protein/s at 25®C (Where Km is [Ca^^] at 
which the pump is 50% activated, the lower the concentration the fewer Ca^  ^ are 
required for pump activation, therefore the greater the pump Ca^ "^  sensitivity). VMax is 
the maximum Ca^^ transport rate across the SR (Cai’afoli, 1985).
The principal regulator of SERCA 2A in cai’diac SR is the SR protein 
phospholamban (PLB). PLB is a pentamer of 5 identical subunits each containing 52 
amino acids (MW~25kDa). This protein can be divided into 2 almost equal parts; a 
cytoplasmic domain containing the phosphorylation sites (residues 1-30) and the 
transmembrane domain (31-52). PLB regulation of SERCA 2A depends on the 
phosphorylation state of PLB; dephosphorylated PLB inhibits SERCA 2A and 
phosphorylated PLB enhances pump activity. The exact mechanism of this inhibition 
remains controversial, but may reflect a physical inhibition of the pump by PLB. In 
vitro studies have identified Serine-16 and Threonine-17 as the residues 
phosphorylated by cAMP/cGMP-dependent protein kinases, and 
calcium/calmodulin-dependent protein kinases, respectively (Koss & Kranias, 1996). 
There is also some speculation that phosphorylation can occur on Serine-10 although 
this remains controversial. In total, there are 10 potential phosphorylation sites on 
PLB, five each on Serine-16 and Threonine-17 (Simmerman & Jones, 1998). PLB is 
one of the few proteins which is phosphorylated in SR by both by cAMP/cGMP- 
dependent protein kinases, and Ca^Vcalmodulin-dependent protein kinases.
Phosphorylation of these residues reduces the inhibitory affect of PLB on SERCA 
2A, and enhances the rate of calcium uptake into the SR (Koss & Kranias, 1996). 
PLB phosphorylation appears to increase the affinity of SERCA 2A for calcium, as 
even at low [Ca^^ji when the calcium pump is only marginally active, subsequent 
PLB phosphorylation causes a substantial increase in calcium transport. The rate of 
PLB phosphorylation parallels the activity of SERCA 2A and the rate of calcium 
transport into the SR. All of these processes occur additively (Simmerman & Jones, 
1998). PLB is also an important mediator in the regulation of cardiac function during 
p-adrenergic stimulation, via the cAMP cascade (Koss & Kianias, 1996; Simmerman 
& Jones, 1998). SERCA 2A is highly dependent on [ATP] and [Ca^ "^ ], its activity is 
also modulated by changes in intracellular pH (Fabiato, 1985). For reasons of brevity 
SERCA 2A shall subsequently be refen*ed to as SERCA.
1.4.2. Sarcolemmal NaVCa^^ exchanger (NCX)
The cardiac NaVCa^ "*" exchanger consists of 970 amino acids (MW~110kDa) 
including 12 transmembrane domains and 1 large cytoplasmic domain. The NaVCa^ "*" 
exchanger functions bidirectionally depending on the cell’s membrane potential and 
the extracellular and intracellular [Na’^ j and [Ca^ "^ ]. The Na' /^Ca '^  ^ exchanger is the 
main competitor with SERCA for cytoplasmic calcium during cardiac relaxation, 
with the latter normally dominant (28:70, Bassani, Bassani & Bers, 1994). The most 
widely accepted stoichiometry of NaVCa^ "*" exchanger is 3Na’^ :lCa '^^ (Reeves & Hale, 
1984), making the pump electrogenic (powered noimally by Na'  ^gradient, created by 
NaVK"  ^exchanger). The NaVCa '^*' exchanger is a low affinity pump with a Km (Ca^^) 
2-20\xM and a VMax of 15-30 nmole Ca^Vmg protein/s at 25°C (Carafoli, 1985). 
Again, there are many intracellular factors which can affect the activity of the 
NaVCa^ "*" exchanger. The NaVCa^"  ^exchanger transports [Na"*"] and [Ca^ "^ ] and is also 
regulated by these ions (Philipson & Nicoll, 2000). NaVCa^"  ^activity is modulated by 
intracellular pH, phosphorylation (Philipson et a l 1982) and [ATP] (Hilgemann, 
1990). For reasons of brevity Na’^ '/Ca^ '*' exchanger shall subsequently be refened to as 
NCX.
1.4.3. Sarcolemmal Ca^ ***ATPase
The sai'colemmal Ca '^^-Mg^  ^ dependent ATPase (sarcolemmal Ca^'^-ATPase) 
as its name suggests is a Ca^’*', Mg '^ ,^ ATP dependent calcium pump (MW-138kDa). 
The sarcolemmal Ca^^-ATPase pumps 1 Ca^”*" out of the cell per ATP molecule 
hydrolysed. Although, the pump has a relatively high affinity for [Ca^^]i (Km 0.5|rM) 
its transport rate is believed to be too slow (VMax 0.5 nmole Ca^Vmg protein/s at 
25^C) to make any substantial contribution to calcium fluxes during the cardiac 
cycle, however it may be influential for longer term cellular calcium extrusion 
(Carafoli, 1985).
1.4.4. Mitochondrial calcium uniporter
Under physiological conditions the mitochondrial role in regulating 
cytoplasmic [Ca^ '*’] appears to be minimal as Ca^ '*' uptake into the mitochondria is 
thought only to occur once cytoplasmic [Ca^^] reaches approximately 1pm. Calcium 
enters the mitochondria via a uniporter system down a laige electrochemical gradient 
set up by the extrusion of protons (H^). Calcium entry exhibits a sigmoidal 
dependence on [Ca]i. The uniporter has a Km of lOpM and a Vmux of 10 nmole 
Ca '^^/mg protein/s at 25®C (Carafoli, 1985). The uniporter is blocked by physiological 
ions such as [Mg^^] and by pharmacological agents such as ruthenium red.
Studies have concluded that SERCA and NCX are the 2 dominant 
mechanisms responsible for reducing cytoplasmic calcium during relaxation, (the 
former being more so). SERCA is thought to be responsible for removing 70% of the 
cytoplasmic Ca^ "^ , NCX removes about 28% and the remaining 2% is removed via 
the Ca^”^ -ATPase pump and the mitochondrial uniporter (Bassani et al. 1994). Bers et 
al. (1993), make an interesting point in that if ~25% of cytoplasmic Ca^ "*" is removed 
by the exchanger, then in order to maintain steady state contractions it is likely that 
25% of the Ca^^ needed to activate the myofilaments must come from outside the cell 
(via the Ica, or NCX, working in influx mode (outward)). In the absence of SERCA 
and NCX relaxation still occurs, albeit slowly, via the sarcolemmal Ca^^-ATPase and 
the mitochondrial calcium uniporter (Bersefa/. 1993).
1.5. Ultrastructure and function of Sarcoplasmic reticulum (SR)
The sarcoplasmic reticulum (SR) is an entirely intracellular, membrane bound 
organelle, separate from the sarcolemma. The SR is the main calcium store within 
cardiac myocytes. The SR consists of three distinct regions longitudinal, corbular and 
junctional SR. Ca^ "^  uptake by SERCA is thought to occur throughout the SR whereas 
Ca^^ release occurs predominantly within the junctional SR. Recent studies suggest 
that SR Ca^ "^  release channels or Ryanodine receptors (RyR) and calsequestrin are 
localised within the junctional SR (Allen & Katz, 2000).
1.5.1. Longitudinal SR
In 1965, Winegrad using autoradiograph studies proposed the theory that Ca^^ 
is sequestered into the longitudinal SR, and is then transported through the SR to 
release sites (RyR) at the junctional SR. To date these results have not been 
reproduced.
1.5.2. Junctional SR
Invaginating T-tubules within the sarcolemma form close contacts with the 
junctional SR (terminal cistemae), and it is at these areas that large proteins tenned 
“feet” span the gap. These feet proteins are thought to be the RyR, responsible for 
Ca^ "*" release during CICR. Numerous proteins are associated with the RyR providing 
structural and regulatory support. Several key proteins; RyR, triadin, junctin and 
calsequestrin have been reported to form a stable complex localised at the junctional 
SR and are believed to be required for normal SR Ca^ "^  release (Zhang et a l 1997). 
Furthermore, phosphorylation state (Marx et a l 2000) and the physical association of 
FK 506 binding proteins (FKBP12.6) with RyRs is important for stabilising RyR 
channel function (Brillantes et a l 1994) and facilitates coupled gating between 
neighbouring RyR channels (Marx et a l 2001). The RyR within mammalian cardiac 
muscle is activated by micromolar [Ca^^j, millimolar [ATP], inhibited by millimolar 
[Mg^ "^ ], micromolar [calmodulin] and is modified (activated/inhibited in a 
[dependent] manner) by the binding of ryanodine, a plant alkaloid (Meissner, 1994). 
The SR Ca^ "^  binding protein calsequestrin is increasingly believed to have a
modulatory affect on RyR activity (Ikemoto et a t 1989; Szegedi et al. 1999). Free 
SR calcium content has been estimated at approximately ImM, with additional Ca^ '*' 
bound to intracellular organelles and membranes (Szegedi et al. 1999). In addition to 
the known SR Ca^^ release channel (RyR), it is believed that a non-specific RyR 
insensitive Ca^ "^  leak also exists in the SR (Pessah et al. 1997).
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Figure 1.1. Schematic representation of Ca^^ transport systems within 
cardiac myocytes. Including sarcolemmal L-type Ca^^ channels, Ca^VNa^ 
exchanger, Ca^^ ATPase pump and NaVK^ ATPase. Intracellular transport 
systems include the Sarcoplasmic reticulum (SR) Ca^^ ATPase pump, SR 
Ca^^ release channel, a non specific Ca^^ leak and Mitochondrial Ca^^ 
transporters. Mito-mitochondrion, MF-myofilaments and SL-sarcolemma. 
(taken from Bers, 1993)
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1.6. Heterogeneity of cellular properties within mammalian 
myocardium
It is now well established that there are regional (transmural) differences in 
electrical, structural, metabolic and mechanical properties within mammalian 
myocardium. The myocardium can be subdivided into three regions; an inner sub­
endocardium region, a mid-myocardium and an outer sub-epicardium region. For 
brevity, in future sub-endocardial and sub-epicardial myocytes shall be simply 
referred to as endocardial and epicai'dial myocytes.
Transmural gradients in myocardial blood flow (Hoffman, 1995), 
intramyocardial pressure, capillary distribution and cell cross sectional area have 
been reported (Gerdes et a l 1979). Capillary density is lower in endocardial than the 
epicardial region, and a reduced blood flow during systole (due to higher intracardiac 
pressure) implies that endocardium peifusion is more likely to be compromised than 
that of the epicardium. This, coupled with a larger sub-endocardial cell size, 
(Hoffman, 1995), workload and a greater oxygen consumption rate (Robitaille et a l 
1990) make endocardial myocytes more susceptible to insufficient oxygen supplies 
(anoxia) during ischaemic insults and or in the normal heart during increased 
workloads. This is consistent with the finding that endocardial myocytes suffer most 
ischaemic damage post myocardial infarction (Hoffman, 1995).
Transmural differences in myocyte length have been reported by Campbell 
and Gerdes (1988) and McIntosh et a l (2000), who observed that endocardial 
myocytes were longer than epicardial myocytes. In contrast, other groups report no 
significant transmural length differences (Bishop et a l 1979; Smith et a l 1988; 
Chamunorwa & O’Neill 1995; Bryant et a l 1997). Such discrepancies may arise due 
to species variation. Additional structural differences, such as longer sarcomere 
lengths (Spotnitz et a l 1966) and larger cross-sectional areas have been reported in 
endocardial cells (Gerdes et a l 1979). Bishop et a l (1979) reported no transmural 
differences in myocyte volume.
Differences in action potential characteristics are the most commonly 
observed transmural electrophysiological feature. Several groups have reported
11
longer action potential durations in endocardial in comparison to epicardial myocytes 
(Antzelevitch et aL 1991; Cook et al. 1997; Bryant et al. 1997; McIntosh et al. 
2000). Analogous differences in action potential duration have been reported 
between apical and basal regions of guinea-pig (Bryant et a/. 1997) and rat left 
ventricle (Shipsey et al. 1997). However, other apical and basal physiological 
properties have not been extensively studied. L-type calcium cunent density ( I c a ) ,  
was found to be similar between endocardial and epicardial myocytes (Bryant et al.
1997) or slightly higher in endocardial myocytes (McIntosh et al. 2000). McIntosh et 
al. (2000) also observed longer calcium transients in endocardial in comparison to 
epicardial myocytes in rabbit ventricular myocytes, whereas Chamunorwa & O’Neill 
(1995) observed no such differences. Transmural differences in intracellular [Ca^ "^ ] 
have also been observed, ranging from higher diastolic and systolic [Ca^ '^ Ji in 
endocardial in comparison to epicardial myocytes (Figueredo et al. 1993), to similar 
transmural diastolic [Ca^‘*‘]i, and a higher epicardial systolic [Ca '^ j^i (McIntosh et al. 
2000). In addition, Cook et al. (1997) observed that intracellular [Na^]i differed 
across the rabbit ventricle with [Na‘*']i being significantly higher in epicardial in 
comparison to endocardial myocytes, at rest and during steady state stimulation.
Transmural metabolic studies by Robitaille et al. (1990) reported lower 
creatine phosphate (CrP) concentrations and a lower CrP/ATP ratio in endocardial in 
comparison to epicardial myocytes. Furthermore, Humphrey et al. (1988) reported 
that the capacity of ATP resynthesis is lost more rapidly in endocardial in comparison 
to epicardial myocytes. In contrast. Van der Vusse et al. (1990) investigated 
differences in energy requirements and metabolism but failed to reveal any 
substantial transmural differences.
Transmural differences in myosin isoforms are also believed to exist, which 
may have an influence on ATP metabolism and contraction (Eisenberg et al. 1985).
Evidently, from the above discussion some aspects of transmural 
heterogeneity remain controversial. However, it suffices to say that such transmural 
characteristics serve to co-ordinate myocardial function according to the varying 
transmural metabolic, mechanical and functional requirements of the ventricle.
12
1.7. Normal physiological features
1.7.1. The Force-frequency relationship
In normal myocardium an increase in stimulation frequency is accompanied 
by an increase in myocardial contractile force, termed a positive force-frequency 
relationship or treppe. Positive force-frequency relationships are observed in human 
(Davies et al. 1995; Pieske et al. 1999) and rabbit myocardium (Shattock & Bers, 
1989, Maier et al. 2000) whereas a negative force-frequency is observed in rat 
(Orchard & Lakatta, 1985; Maier et al. 2000) and mouse myocardium (Wolska & 
Solaro, 1996).
Essentially, increasing stimulation frequency leads to an increase in diastolic 
[Ca^"^]i and subsequent increase in SR Ca^’^ content via increased I c a  (Ca^"^ influx), 
plus less time between stimulation leads to decreased Ca^ '*' extrusion by NCX (Bers, 
2000). Additionally, higher stimulation frequencies increase [Na^]i (increased influx 
during action potential) which reduces the effectiveness of NCX in extruding Ca^ "^  
and subsequently [Ca^ '*']i increases. Increased diastolic [Ca^’*‘]i in turn stimulates the 
activity of SERCA to pump more Ca^ *^  into the SR, raising SR Ca^^ content. A high 
SR Ca^^ content allows for greater SR Ca^ "^  release, increasing the amount of Ca^ "^  
available for binding to Troponin C, and subsequent myofilament activation and 
force generation.
A negative force-frequency relationship produces a decrease in the force of 
contraction as stimulation frequency increases. This phenomenon is thought to reflect 
the shorter action potential duration and higher [Na' j^i found in rat hearts (Shattock & 
Bers, 1989; Maier et al. 2000).
1.7.2. Rest Decay
Following long periods of rest (>1 min) (no stimulation), the first contraction 
of ventricular muscle is reduced in amplitude, a phenomenon known as rest decay. 
This process is thought to reflect a time-dependent decrease in SR Ca^ "^  content via 
SR Ca^^ leak (Allen et al. 1976; Bers, 1985; Macleod & Bers, 1987; Bers, 1989;
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Hi’yshko et a l 1989; O’Neill 1993; Chamunorwa & O’Neill, 1995). Evidence for rest 
decay comes from experiments using rapid cooling contractures (RCC). RCC elicit 
Ca^ '*' release directly from the SR and is a relative indicator of SR Ca^ '*’ content 
(Bridge, 1986; Bers, 1989; Hryshko et a l 1989). For example, Hryshko et a l (1989) 
showed that the amplitude of the RCC declined as a function of the rest duration, 
parallel to the amplitude of the muscle contraction. As RCC amplitude depends 
directly on SR Ca^^ content, they concluded that rest decay reflects a decrease in SR 
Ca^ "^  content.
It has been proposed that during rest, both SR and cytosolic [Ca^^] must fall 
in order for rest decay to occur. If, for example, SERCA was the only means of 
reducing cytosolic Ca^ "^  then, Ca^ "*" released from the SR would be resequestered back 
into the SR, SR Ca^ "*" content (intraluminal [Ca^ '*']) would remain constant and rest 
decay would not occur. As rest decay does occur, this suggests that the Ca^ "^  leaking 
from the SR is removed completely from the cell by other mechanisms. The most 
likely candidates for this are the sarcolemmal Ca^ "^  pump and NCX, which normally 
regulate [Ca^ "^ ];, along with smaller contributions from the sarcolemmal Ca^^- 
ATPase pump and mitochondrion. Inhibition of NCX, by removing extracellular 
[Na"^ ] and/or [Ca^ '*'] abolishes rest decay confirming the critical link between 
cytosolic [Ca^ "*"] regulation and NCX (Hryshko et a l 1989; Bers et a l 1993, Bassani 
& Bers 1994) (See intracellular calcium homeostasis above). It has been concluded 
that during rest, [Na]j falls, due to a combination of the cessation of Na"^  influx 
during the action potential, and the continuous activity of the NaVK"  ^exchanger. Low 
[Na"^ ]i and increasing [Ca^ "^ ]i leaking from the SR enhances NCX activity and 
promotes Ca^ "^  extrusion from the cell. Subsequently, extracellular [Ca '^^ ] increases, 
[Ca^ "*"], decreases, SR [Ca^ "*"] content decreases and rest decay aiises (MacLeod & 
Bers, 1987; Shattock & Bers, 1989). Rest decay is observed in several mammalian 
species, with the exception of rat, ferret, dog ventricle (Bers et a l 1993) and rabbit 
atria (Bers, 1985).
Post rest potentiation is an increase in the amplitude of the first contraction 
following short rest periods. Post rest potentiation has been observed in mouse 
(Tenacciano et a l 1998) rat, femet and dog ventricle (up to 2 min of rest, beyond 
which time rest decay ensues) (Bers et a l 1993). Post rest potentiation is thought to
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reflect an increase in intracellular (and subsequent SR) suggesting that these
myocytes gain Ca^^ during rest and electrical stimulation actually reduces 
intracellular and SR [Ca '^^ ] (Bers, 1989; Hryshko et al. 1989; Shattock & Bers, 
1989). Rat myocardium has an intrinsically high [Na^],, which during rest reduces the 
reversal potential for NCX and favours Ca^ '*' influx hereby increasing [Ca^^ii, SR 
Ca^ "^  content and produces rest potentiation. However, post rest potentiation observed 
in ferret ventricle was not paralleled by a raised SR Ca^ "^  content, but was believed to 
reflect an initial increased fractional release of SR Ca^^ in response to electrical 
stimulation (Bers et al. 1993).
A recent study by Pieske et al. (1999) observed for the first time that in non­
failing human ventricular muscle strips, an increase in rest interval produced a 
parallel increase in post rest twitch force. This increased twitch force was associated 
with progressive SR Ca^ "^  loading during rest and increased fractional SR Ca^  ^release 
upon restimulation.
Experimentally rest decay is used as a tool to indicate the calcium load of the 
myocyte, which then can be related to the efficiency of the intracellular Ca^’*’ 
transporters/pumps and therefore the physiological condition of the myocyte.
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1.8. Pathophysiology of failing/hypertrophied cardiac myocytes
Structural and functional remodelling of cardiac myocytes occurs in both 
compensated and failing mammalian myocardium. Hypertrophy is an enlargement of 
myocyte size, via a combination of increased cell length and/or width. Hypertrophy 
within the context of this work refers to myocyte enlargement caused by a 
pathophysiological disease. However, hypertrophy does not always have deleterious 
effects on cardiac function, an example being the enlarged heart of the athlete 
(physiological hypertrophy).
The extent, site and form of myocyte remodelling appears to be dependent on 
the aetiology and severity of the underlying disease. The initial cellular adaptations 
associated with the early stages of cardiac hypertrophy (compensatory reactive 
hypertrophy) are activated as a compensatory mechanisms in an attempt to enable the 
heart to maintain an adequate cardiac output despite adverse haemodynamic 
conditions. This is sometimes referred to as the adaptive phase (compensated 
hypertrophy). If these adaptations are insufficient to maintain adequate cardiac output 
the adaptive phase can deteriorate into decompensated ventricular hypertrophy or 
heart failure. Progressive changes in myocyte form/function, ventricular cavity 
volume/pressure, and extracellular matrix structure occur, producing an enlarged, 
poorly contracting myocardium. Such characteristics are often associated with the 
syndrome of heart failure. Heart failure can be defined as “a syndrome which 
develops as a consequence of cardiac disease, and is recognised clinically by a 
constellation of symptoms and signs produced by complex circulatory and 
neurohormonal responses to cardiac dysfunction” (Cowie et al. 1997).
There is a vast literature concerning heart failure and its pathophysiological 
consequences, the following is only an overview of some cellular characteristics, 
which are altered during hypertrophy and heart failure.
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1.8.1. Origin of contractile dysfunction in failing/hypertrophic cardiac 
ventricular myocytes
1.8.1.1. Morphological changes associated with failing/hypertrophied cardiac 
myocytes
The exact origin of contractile dysfunction in failing myocardium remains 
controversial, but is thought to reflect many detrimental alterations to cellular form 
and function. Myocytes isolated from failing myocardium show abnormal structural 
changes, the nature of which, depends on the cause and severity of the hypertrophy. 
In general, ventricular pressure overload, induced, for example by hypertension, 
produces an increase in ventricular wall thickness, which is reflected at cellular level 
by increased myocyte cross sectional area (diameter) with little change in ventricular 
chamber diameter. Such remodelling is termed concentric. In comparison, ventricular 
volume overload, which is commonly associated with myocardial ischaemia, 
produces eccentric remodelling. Generally a proportional increase in chamber 
diameter and wall thickness occurs due to a proportional increase in myocyte length 
and diameter (Gerdes et al. 1996). It must be noted that a combination of these 
length/width changes are possible within any one form of overload.
Numerous studies have observed morphological changes in failing or 
hypertrophied cardiac myocytes. Increased cell length in myocytes isolated from both 
hypertrophied and failing myocardium in guinea-pigs, (Bryant et al. 1997), rabbits 
(McIntosh et al. 2000), rats (Liu et al. 1991 ;1&2; Smith et al. 1988; Bishop et al. 
1979; Gerdes et al. 1996) and humans (Beltrami et al. 1994; Gerdes et al. 1992; 
Gerdes et al. 1995) have commonly been observed. Del monte et al. (1995) in 
contrast, reported no significant changes in failing ventricular human myocytes. 
Changes in either myocyte length or width can produce alterations in myocyte 
length/width ratio. For example, increased length/width ratio has been observed in 
human (Gerdes et al. 1992 & 1995) and rat myocytes (Gerdes, 1996). Increased cell 
volume (Bishop et al. 1979; Smith et al. 1988; Lui et al. 1991,1&2; Gerdes et al. 
1992; Olivetti et al. 1994) and cross sectional area (Smith et al. 1988; Gerdes, 1992 
& 1996, Olivetti et al. 1994; and del Monte, 1995) have also been described. Such
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cellular adaptations increase the normal ventricular wall/lumen diameter ratio which 
subsequently decrease ventricular wall stress thus acting as a compensatory 
mechanism. Myocyte loss and subsequent replacement fibrosis has been reported in 
hypertrophied human hearts (Schaper & Schaper 1986; Olivetti et al. 1994). Further, 
no change (Gerdes et al. 1992 & 1996; Del monte et al. (1995), or an increase in 
sarcomere length (Harding et al. 1989) have been reported.
1.8.1.2. Abnormal intracellular calcium homeostasis
Diastolic [Ca^'^li - Studies have reported that failing human myocardium is 
unable to restore low [Ca^ '^ Ji during diastole (Gwathmey et a/. 1987; Morgan et al. 
1990; Beuckelmann et al. 1992; Arai et al. 1993) and diastolic [Ca^ '*']i is 
subsequently raised. Beuckelmann et al. (1992) observed that diastolic [Ca^ "^ ]i decay 
was prolonged in failing myocardium and concluded that a decreased Ca^ "*" uptake 
into the SR and prolongation of the action potential were responsible. McIntosh et al. 
(2000) observed in the same rabbit model of hypertrophy used in this study, increased 
and unchanged diastolic [Ca^ '*']i in endocardial and epicardial failing myocytes 
respectively, suggesting transmural heterogeneity in [Ca^ '^ Ji regulation.
Systolic [Ca^^li - Reduced peak systolic [Ca^ '*']i has been reported in failing 
myocardium reflecting a decreased SR Ca^’*' content, secondary to a reduced Ca^ '*' 
uptake into the SR (Beuckelmann et al. 1992; Schmidt et al. 1998; Lindner et al.
1998). Unchanged peak systolic [Ca^^]i (Gwathmey et al. 1990) has also been 
observed. Siri et al. (1991) observed a decreased peak systolic [Ca^^ii and unchanged 
diastolic [Ca^’^ Ji in a guinea-pig model of heart failure.
Transmural differences in peak systolic [Ca^ "^ ]i were reported in this rabbit 
coronary ligation model, with an increased endocardial and a reduced epicardial peak 
systolic [Ca^‘^ ]i (McIntosh et al. 2000).
Gwathmey et al. (1987) showed prolongation of Ca^’*' transient duration in 
failing human heart muscle and observed that these preparations showed two distinct 
components. They concluded that the second additional component reflected 
dysfunction of both sarcolemma and SR Ca^  ^ transport, producing a prolongation of 
the Ca^ "*" transient. These results were further confirmed by later studies (Morgan et
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al. 1990; Gwathmey et al. 1991). McIntosh et al. (2000) reported transmural 
differences in Ca^ "^  transient and action potential duration in failing rabbit myocytes, 
were duration of both parameters was decreased in endocardial and increased in 
epicardial myocytes. This data agrees with transmural action potential differences 
observed in rat hypertrophy (Shipsey et al. 1997). Bryant et al. (1997) also observed 
a prolonged action potential in hypertrophic epicardial myocytes but unchanged 
duration in endocardial myocytes. Prolongation of action potential duration is the 
most consistently observed electrophysiological abnoimality observed in cardiac 
hypertrophy (Gwathmey et al. 1991, Hart, 1994, Milnes & MacLeod, 2001).
There is conflicting evidence regarding changes in Ca^ "*" current density ( I c a )  
(via L-type sarcolemmal channels) in hypertrophic and failing myocardium. 
Increased Ca^ '*' cuiTent in rat hypertrophic myocardium (Keung et «71989), decreased 
cuiTcnt in guinea-pig myocardium (Ming et al. 1994) and cardiomyopathic hamsters 
(Hatem et al. 1994) and unchanged Ca^ "^  current in failing rabbit myocardium have 
all been observed (Pogwizd et al. 1999). McIntosh et al. (1999) reported transmural 
differences in Ica in failing hearts, (epicardial higher than endocardial) and Ica had a 
tendency to be higher in endocardial failing myocytes in comparison to control 
myocytes. No differences in Ica between control and failing epicardial myocytes was 
observed. Assessment of Ca^ '*' cunent density in failing human myocardium remains 
controversial with Beuckelmann et al. (1992) observing no reduction whereas 
Ouadid et al. (1995) found a reduction in patients undergoing cardiac transplantation 
(severe failure).
1.8.1.3. Alterations in intracellular gene and protein expression
Intracellular Ca^ '*' homeostasis within myocytes is precisely regulated by both 
sarcolemmal and SR Ca^ "^  handling proteins. Therefore, alterations in gene and 
protein expression may have serious effects on intracellular Ca^ "^  homeostasis.
Human studies
SERCA protein expression in human studies remains controversial as several 
studies have reported reduced SERCA protein expression in failing human 
myocardium (Hasenfuss et al. 1994; Meyer et al. 1995; Hasenfuss, 1998 (review);
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Ravens, 2000 (review) as well as no change (Movesian et al. 1994; Hasenfuss, 1998; 
Ravens, 2000 (review). Decreased SERCA mRNA expression has been reported by 
Mercadier et al. (1990) and Arai et al. 1993. Several groups have observed reduced 
SERCA and phospholamban activity and mRNA levels without accompanying 
alterations in protein expression (Schwinger et al. 1995; Linck et al. 1996 and Flesch 
et al. 1996). Flesch et al. (1996) concluded that these proteins were either subjected 
to posttranscriptional or posttranslational regulation.
Levels of NCX protein expression in human failing myocardium were found 
to be either unchanged (Schwinger et al. 1999, Prestle et al. 1999) or increased 
(Reinecke et al. 1996; Hasenfuss et al. 1999). Hasenfuss et al. (1999) subdivided 
their failing human heart results (which included preparations from dilated 
cardiomyopathy and ischaemic cardiomyopathy) into two groups according to 
diastolic function. The phenotype with disturbed diastolic function expressed a 
decreased SERCA and unchanged NCX expression, and the other group with 
preserved diastolic function expressed increased levels and activity of NCX and 
unchanged SERCA expression. They concluded that increased NCX expression was 
activated as a compensatory mechanism to preserve diastolic function. This is in 
agreement with previous work by Studer et al. (1994) on dilated cardiomyopathy and 
ischaemic heart failure in humans.
It is generally accepted that calsequestrin protein expression is unchanged in 
failing human myocardium in comparison to control myocardium (Takahashi et al. 
1992 (mRNA), Movesian et al. 1994; Meyer et al. 1995; Schwinger et al. 1999; 
Prestle et al. 1999). As calsequestrin protein levels appear to be unchanged in human 
hypertrophy and heart failure it is often used as a protein standard with which to 
compare alterations in other intracellular protein expression levels.
Reduced SR Ca^ "^  release channel or Ryanodine receptor protein (RyR) 
mRNA levels were found in end stage human heart failure (Takahashi et al. 1992; 
Arai et al. 1993; Go et al. 1995;). Brilliantes et al. (1992) reported decreased RyR 
mRNA expression in myocardium taken from patients with ischaemic 
cardiomyopathy, but observed a small increase in RyR mRNA taken from patients
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with dilated cardiomyopathy. In contrast, Meyer et al. (1995) reported unchanged 
protein expression in human dilated cardiomyopathy.
Animal studies
The literature regaining SERCA expression in animal studies is fairly clear 
with most studies reporting reductions in SERCA protein (Hasenfuss 1998 [review]; 
O’Rourke et al. 1999; Ravens & Dobrev 2000, [review]) and mRNA expression 
(Hasenfuss 1998,[review]; Pogwizd et al. 1999; Ravens & Dobrev 2000,[review]). 
CuiTie & Smith, (1999), using the same rabbit model described in this study (volume 
overload model), and Kiss et al. (1995) (pressure overloaded guinea -pig model) 
reported reductions in SERCA expression with concomitant decreases in 
phospholamban expression (PLB). Cuii'ie & Smith (1999) also observed increased 
PLB phosphorylation. Arai et al. (1996) reported increased SERCA mRNA 
expression in mild hypertrophy with a subsequent reduction in severe hypertrophy.
Increased NCX protein (O’Rourke et al. 1999; Pogwizd et al. 1999) and 
mRNA expression (Pogwizd et al. 1999) have been reported in failing hearts. 
Increased NCX activity was reported by Hatem et al. 1994; Pogwizd et al. 1999, 
whereas, Dixon et al. (1992) and Naqvi & Macleod, (1994) observed decreased NCX 
activity in a coronary ligated rat model and a guinea pig (volume overloaded) model 
of heart failure respectively. In a rat hypertrophy model (volume overloaded) CSQ 
mRNA expression was unaltered over a range of hypertrophic severity (Arai et al. 
1996). Matsui et al. (1995) observed a decrease in mRNA calsequestrin expression 
whereas, in contrast, a recent study by Naqvi et al. (2001) observed a significant 
increase in calsequestrin protein expression (65%) in a rabbit model of cardiac 
hypertrophy.
Increased RyR protein levels have been observed in a mild rat hypertrophy 
model (volume overloaded) but levels subsequently diminished in severe hypertrophy 
(Arai et al. 1996). In contrast, Hisamatsu et al. (1997) reported a reduction in RyR 
numbers during early changes in a volume overloaded rat model of heart failure. 
Milnes & MacLeod (2001) recently reported a 34% reduction in RyR density in a 
rabbit model of left ventricular dysfunction.
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Clearly, there is conflicting evidence regaiding protein/gene expression of 
NCX and SR Ca^ '*' transporting proteins in both hypertrophied and failing 
myocardium. These differences may reflect species differences and/or the mode and 
severity of the failure. In addition, mRNA and protein expression levels do not 
always follow the same trend in expression, such differences may represent post -  
translational or post-transcriptional regulation.
In summary, it has been established that a conelation between intracellular 
Ca^ "^  handling mechanisms and contractile dysfunction exists in both human and 
animal models of heart failure. Experimental evidence suggests that mRNA and /or 
protein expression encoding SR Ca^’^ transporting proteins is altered in cardiac 
hypertrophy and heart failure both in humans and in experimental animal models. 
These changes may be partly responsible for the altered contractile function observed 
in failing and hypertrophic myocytes. Furthermore, changes in electrophysiological 
parameters and myofilament Ca^  ^ sensitivity in failing and hypertrophic myocytes 
may also contribute to contractile dysfunction.
1.8.1 A. Changes in physiological features
In general, the force-frequency relationship observed in failing or 
hypertrophied myocytes is depressed or reversed. This phenomenon has been 
observed in human papillary muscles (Schwinger et al. 1993; Schmidt et al. 1994); 
ventricular muscle strips (Muliere et al. 1992); ventricular trabeculae (Morgan et al. 
1990; Pieske et al. 1999) and studies on whole rabbit hearts (Ezzaher et al. 1992). 
Studies suggest that the most likely cause for this depressed force-frequency 
relationship is a disruption of intracellular Ca^ '*’ handling, producing abnormal 
diastolic and systolic [Ca^ '^ Ji (Morgan et al. 1990; Gwathmey et al. 1991).
Minimal work has been earned out on the effect of rest decay in 
failing/hypertrophic cardiac myocytes. A recent study by Pieske et al. (1999) using 
failing human muscle strips showed signs of rest decay as rest interval duration was 
increased. This was the opposite of the behaviour displayed by non-failing myocytes. 
Pieske et al. (1999) concluded that a combination of reduced SERCA and increased
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NCX activity in failing preparations would bias Ca^ """ extrusion from the cytosol 
rather than its reuptake into the SR and subsequently rest decay would ensue.
It is possible to conelate the kinetics of contraction with the kinetics of the 
Ca^ "^  transients and subsequent mechanical dysfunction. Similar to prolongation of 
the Ca^’*' transient duration, both the contraction and relaxation velocity of myocytes 
are slowed in failure preparations, thus confirming their association (Gwathmey et al. 
1987; Morgan et al. 1990; Gwathmey et al. 1991, Beuckelmann et al. 1992). 
Prolonged contraction kinetics have also been attributed to reduced peak systolic 
[Ca^ '*'] {Siri et al. 1991) a variety of intracellular abnormalities (del Monte et al. 
1995) and defective SR Ca^ *^  release (Milnes & MacLeod, 2001). Contractile 
dysfunction may also by affected by decreased myofilament Ca^ "^  sensitivity, 
although this theory remains controversial (Gwathmey et al. 1990; Perez et al. 1999).
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1.9. Thesis Aims
As discussed in the Introduction, minimal experimental work has been 
performed investigating transmural physiological properties in isolated cardiac 
myocytes. In order to properly understand the functions of mammalian myocardium 
it is essential to be aware of any differences in transmural physiological properties. 
The purpose of the work reported here was to study transmural properties in normal 
rabbit hearts and hearts with left ventricular dysfunction, induced by coronary artery 
ligation (LVD). Contractile function, intracellular [Ca^^] and protein expression of 
cardiac Ca^ "*" handling proteins were assessed in endocardial and epicardial myocytes 
in sham operated hearts and hearts with LVD. Experimental results from sham 
operated and LVD hearts were then compared.
Chapter 2 outlines the general methods used in the experimental work 
described in this thesis. These include:
a) The coronary artery ligation procedure involved in producing the coronary 
ligation model of left ventricular dysfunction.
b) Assessment of left ventricular function using Echocardiography
c) Physiological solutions
d) Isolation procedure of single cardiac myocytes
e) Biochemical tissue preparation
D Western blotting technique
Chapter 3 of this thesis describes measurements of isolated myocyte 
contractile function and contraction kinetics. All measurements were made from 
myocytes isolated from sub-endocardial (Endo) and sub-epicardial (Epi) regions of 
sham operated and hearts with left ventricular dysfunction. These experiments were 
undertaken to explore possible differences in transmural and sham/LVD contractile 
function.
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Chapter 4 describes measurements of intracellular [Ca^ '*'] in the above 
mentioned experimental groups (Sham - Endo/Epi; LVD - Endo/Epi). Transmural 
and Sham/LVD comparisons were made. These experiments were performed to 
investigate whether changes in intracellular [Ca^^] were responsible for possible 
changes in contractile function.
Chapter 5 aims to assess and compare protein retrieval in homogen ate and SR 
vesicle preparations isolated from sham operated and hearts with LVD. This part of 
the study also assessed the suitability of a range of sample sizes for use in 
experimental protocols, the criterion of which depended on protein retrieval 
efficiency.
Chapter 6 explains the sources of experimental variation observed in the 
standard Western Blotting technique. Potential experimental and technical 
improvements to minimise variation were assessed and implemented in the 
experiments performed in chapter 7.
Chapter 7 describes the quantification of specific cardiac Ca^^ handling 
protein expression. Protein expression was assessed in the fore mentioned 
experimental groups (Sham - Endo/Epi; LVD - Endo/Epi). Conelation between 
protein expression and intracellular [Ca^’*'] was subsequently investigated.
Finally, chapter 8 summarises the experimental results and attempts to 
correlate changes in contractile function with changes in intracellular [Ca^ "^ ]. 
Further, attempts to relate changes in intracellular [Ca^ ***] to changes in Ca^ "^  handling 
protein expression were also investigated. The results are also related to our current 
understanding of the pathophysiology of heart failure or left ventricular dysfunction.
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Chapter 2 
General Methods
2.1. Animal Model
The model of left ventricular dysfunction used in this study was a rabbit 
coronary artery ligation model described by Pye et al. (Pye et al. 1996).
New Zealand male white rabbits (2.5-3.5kg) were anaesthetised using 
Midazolam (1-2 mg kg"^) via a marginal ear vein, and were intubated and ventilated 
throughout the surgical procedure using an 0%, NO & Halothane mixture (1:1:1). A 
left thoracotomy was perfoimed, and the ventricular branch of the left coronary 
artery was ligated mid way between the artery’s origin and the cardiac apex. This 
procedure produced a significant apical infarct. Sham operated animals underwent 
the same surgical procedure except that no coronary artery was tied off. Post­
operative analgesics and antibiotics were administered and the animals were allowed 
to recover. Left ventricular size and function were assessed by echocardiographic 
and haemodynamic examination 8 weeks post-operatively, prior to sacrifice for 
invitro experimentation. Echocardiographic assessment was performed under light 
sedation using a Toshiba SSH160 A echocardiograph. Left ventricular (LV) size (LV 
end diastolic internal diameter) and area ejection fraction (EF-%) (end-diastolic area 
-  end-systolic area / end-diastolic area) were measured (Pye et a l 1996).
2.1.1. Assessment of In vivo left ventricular function
The degree of left ventricular dysfunction (LVD) induced by this coronary 
artery ligation model was quantified by analysing ejection fraction (%) and left 
ventricular end-diastolic dimension (LVEDD) (mm) using In vivo echocardiography 
(table 2.1). Table 2.1 below shows the mean ejection fraction (%) and LVEDD 
obtained for all sham operated and LVD animals used throughout this study. 
Significant haemodynamic dysfunction is observed in the LVD animals in terms of 
decreased ejection fraction (p<0.001) and increased LVEDD (p<0.001) in 
comparison to the sham data.
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Experimental
group
Mean ejection 
Fraction (%)
Mean LVEDD 
(mm)
Sham (n=60) 73.4 ± 0.7 17.2 + 0.2
LVD (n=69) 45.3 ± 0.8 * 21.0 ±0.3*
Table 2.1. Mean echocardiographic parameters in sham and LVD animal 
groups. Data are mean ± SEM. n= number of animals. * significant difference 
between sham and LVD animals at the level of p<0.001.
Previously published data using this model of LVD also observed significant 
decreases in left ventricular ejection fraction and significant increases in LVEDD and 
left atrial dimension (Ng et a l 1998; McIntosh et a l 2000) in comparison to sham 
operated animals. Furthermore, significant increases in heart, lung and liver wet 
weights where also observed in this model (Ng et a l 1998; McIntosh et a l 2000 
(liver & lung only).
This coronary ligation procedure produces a volume overload condition due 
to a dysfunctional left ventricle with clinical signs of liver and lung congestion and 
heart and liver enlargement. This condition is similar to that observed in human 
subjects with valvular regurgitation or post myocardial infarction. Eccentric 
remodelling occurs in this model of LVD with increases in myocyte length and width 
(McIntosh et a l 2000). In addition, a degree of left ventricular wall thinning occurs 
(Burton, McPhaden, & Cobbe, 2000).
In this study coronary ligated animals were categorised according to their 
ejection fractions into moderate (> 45%) or severe (< 45%) LVD. Animals were 
subdivided and refeired to as either sham operated (sham), moderate left ventricular 
dysfunction (Moderate LVD) and severe left ventricular dysfunction (severe LVD), 
(chapter 5) unless stated otherwise. Where no significant differences in the results 
between moderate LVD and severe LVD where observed, these two groups where 
combined and classed together as the LVD group (chapter 3,4,7).
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2.2. Physiological studies
2.2.1. Physiological saline solutions
Accurate electrolyte concentrations within physiological solutions are vital 
during any scientific experiments using animals. Optimum electrolyte concentrations 
vary between species, therefore it is critically important to use as near as possible a 
species specific physiological saline solution during experimentation. With this in 
mind, arterial blood samples were taken from both sham operated and coronary 
ligated rabbits (LVD) to verify normal rabbit arterial electrolyte concentrations. 
Electrolyte analysis was performed using standard clinical methods by the 
Department of clinical Biochemistry, Glasgow Royal Infirmary. These blood results 
combined with cunent literature solution values enabled suitable physiological 
solutions to be calculated, and hereafter used experimentally. The electrolyte levels 
for sham and LVD animals were indistinguishable from each other and were 
therefore combined (table 2, this study). Blood electrolyte concentrations from three 
rabbit studies are shown in table 2.2. Note that ionised Ca^ "^  is approximately 1/3 of 
total Ca^ "^  concentrations, suggesting that the other 2/3 are bound to plasma proteins, 
such as albumin. Table 2.3 shows physiological solutions used by a variety of 
researchers using various animal species. The original superfusate solution used in 
this study (Solution A) was modified to solution B after the blood data was collected.
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2.2.2. Single cardiac myocyte isolation
In this study both sham (control) and rabbits with left ventricular dysfunction 
(LVD) were used. All rabbits were terminally anaesthetised with pentobarbitone 
sodium (200mg) mixed with heparin (5000 units) via the marginal ear vein. Animals 
were deemed terminally anaesthetised when both stretch and comeal reflex were 
absent. All procedures were undertaken in accordance with the United Kingdom 
Animals (Scientific Procedures) Act 1986. The following procedure was used to 
isolate cardiac myocytes for use in both contraction (chapter 3) and fluorescent 
experiments (chapter 4).
Hearts were quickly excised and mounted onto a Langendorff perfusion 
apparatus. The heart was perfused retrogradely at 37°C via the aorta with a Ca^^ free 
Krebs solution (in mM: 140 NaCl, 20 Hepes, 5.4 KCl, 0.52 NaH2p 0 4 , 3.5 MgCb, 20 
Taurine, 10 Creatine, and 11.1 Glucose, pH 7.25 at 37°C). The heart was perfused 
with approximately 350mls of Krebs to clear blood from the coronary circulation (10 
nun). The heart was then digested (approximately 10 min) with 75 ml of an enzyme 
solution containing Collagenase 1.5mg ml'* (typel, Worthington Chemicals) and 
Protease 25mg ml'* (type XIV, Sigma). Enzyme perfusion was earned out until the 
ventricular tissue became soft to touch, indicating digestion of the heart’s connective 
tissue. The right ventricle and atria were dissected from the heart and discarded. The 
left ventricle was removed from the Langendorff apparatus and placed in a petri dish 
containing 1% bovine serum albumin solution (BSA) in Krebs with O.lmM CaClz. 
Layers of tissue from basal endocardial and epicardial surfaces of the left ventricular 
free wall were then dissected out. This tissue was finely chopped, shaken to enhance 
individual cell separation and filtered through a nylon mesh (250jim) into O.lmM 
CaCri Krebs/BSA. This cellular suspension was then gently spun in a hand operated 
centrifuge (30 - 60 s) until a pellet of cells lay at the bottom of the tube. The 
supernatant was discarded and the cells were resuspended in 0.5mM CaCE 
Krebs/BSA. The cells were allowed to settle (15 min), the supernatant was removed 
and the pellet was resuspended in ImM CaClj Krebs/BSA. The cells were stored in 
this ImM CaCli Krebs/BSA solution at room temperature until use.
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Amendments to the above myocyte isolation protocol were implemented 
between the time that the contraction experiments and the fluorescent experiments 
were carried out. These amendments greatly improved the yield of viable myocytes. 
The amended protocol is as follows. Briefly, hearts were isolated as previously 
described and perfused with 150ml of Krebs instead of 350ml. Enzyme 
concentrations and digestion times were as before, except that 0.05mM CaClz was 
added to the recirculated enzyme. In addition, 100ml of BSA was perfused through 
the heart prior to its removal from the apparatus. Sub-endocardial and sub-epicardial 
chunks were dissected as before but were placed into a flask and shaken in a water 
bath (37**C) for 60min to allow gentle separation of single myocytes. The supernatant 
was removed and hand centrifuged until a pellet of cells was formed. The 
supernatant was discarded and the pellet was resuspended in Krebs/BSA containing 
0.125mM CaClz. This suspension was allowed to settle (approx. 15 min), the 
supernatant was removed and the pellet resuspended in Krebs/BSA (1%) containing 
0.25mM CaClz. This resuspending procedure was repeated for 0.5 and ImM CaClz 
Krebs/BSA solutions. The cells were stored in the final Krebs/BSA (ImM CaCl2) 
solution until use.
2.2.2. L Statistical Analysis
All data are expressed as mean (± SEM). Students t tests or paired t test were 
used to compare two groups and ordinary ANOVA analysis (parametric) was used to 
compare multiple groups (followed by Tukey post test when appropriate). Value of p 
<0,05 was considered statistically significant.
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2.3. Biochemical studies
2.3.1. General tissue preparation
In this study both control (sham operated) and rabbits with left ventricular 
dysfunction (LVD) were used. All rabbits were terminally anaesthetised with 
Pentobarbitone sodium (200mg, mixed in heparin lOOOunits) via the marginal ear 
vein. Hearts were quickly excised, rinsed in ice cold Ringer solution to clear them of 
blood (in mM: 150 NaCl, 5 Hepes, 5 KCl, 1 MgCla, 2 CaCl, pH 7.4 at 37°C) and 
kept on ice until use.
Tissue samples were dissected from endocardial and epicardial regions of the 
left ventricle and immediately placed in cold homogenisation buffer (in mM: -  300 
Sucrose, 20 Histidine, 10 Imidazole, 1 Dithiothreithol (DTT; reducing agent), 
Protease inhibitors Leupeptin 5mg/ml, Aprotinin lOmg/ml at pH 7.2). Care was 
taken when dissecting tissue from LVD hearts that fibrotic, adipose and infarcted 
tissue was not removed, thus ensuring that only viable muscle tissue was used in 
these samples. The above procedure was used to prepare tissue samples for 
experiments detailed in chapters 5,6 and 7.
2.3.2. Homogenate tissue samples for Western blot analysis
Initially, samples for Western blot analysis were prepared as described in the
2.3.1 and stored in ice cold Ringer solution until use, A vertical incision was made 
from apex to base up the left side of the septum, allowing exposure of the left 
ventricular free wall (LV). The LV was pinned down onto a petri dish with the LV 
free wall endocardium facing upwards, and covered in ice cold Ringer solution. 
Approximately 1mm thick strips of basal endocardium tissue were dissected, the 
heart was turned over and similar sized epicardial samples were dissected. Papillary 
muscles were not used in any samples. These endocardial and epicardial tissue 
samples were weighed (blotted to remove excess Ringer solution) and resuspended in 
5 volumes of homogenisation buffer (taken as 1ml = Img).
Prior to Western blot analysis of proteins, experiments were performed on 
transmural homogenate samples to assess homogenate and SR protein retrieval (see 
chapter 5). Based on the amount of variation observed within intracardiac samples
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during the protein retrieval experiments it was considered essential to prepare every 
future tissue sample, irrespective of use, in exactly the same way to avoid any 
unnecessary variation in protein content. Therefore, all samples underwent equal 
homogenisation times at the same temperature and were resuspended in equal 
volumes of homogenisation buffer. All endocardial and epicardial tissue samples 
were finely chopped with scissors and then homogenised using an ultra-turrax Tg 
(IKA Labortechnik) for two 30s periods on ice. Samples were removed for protein 
assay (2.3.3.) and the remainder was frozen at -80^ C until use.
2.3.3. Protein assay
The assaying of total protein content (mg ml'*) for all tissue samples 
(homogenate, SR vesicles, endocardial, epicardial sham and LVD samples) was 
peiformed in the following way.
Protein content (mg ml'*) was determined using the Coomassie Plus protein 
reagent (Pierce) and Bovine serum albumin (BSA) 0.1-Img ml * as standard 
(Bradford method). Figure 2.1. below shows a typical sigmoidal calibration curve 
produced by the BSA standards. Protein samples were assayed on a 96 well plate 
(triplicate samples) and protein content was determined by measuring the optical 
density of the samples at a wavelength of 595nm (Reader program, Dynatech 
Laboratories.
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Figure 2.1. BSA standard calibration curve. Standard concentrations (0.1- 
Img mg.ml'^ (abscissa) vs optical density (ordinate). Dashed line
indicates optimum area for accurate protein measurements.
Filters within the spectrophotometer are set (595nm) to allow specific 
measurements of absorption at that wavelength. The amount of absorption measured 
at that wavelength is standardised using the calibration curve and converted into a 
protein concentration. To improve the accuracy of this assay, sample values were 
taken on the straight line of the curve (indicated by the dashed line in figure 2.1). 
This avoids the upper and lower optical density readings where the resolution of 
protein concentrations is the least accurate.
2.3.3. L Statistical Analysis
All data ar*e expressed as Mean (± SFM) unless stated otherwise. ANOVA 
multi variant analysis (parametric) was used to compare multiple groups. A value of 
p<0.05 was considered statistically significant.
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2.3.4. Western blot technique
After tissue isolation and preparation (see 2.3.1 & 2) homogenate samples 
were prepared for electrophoresis according to manufacture’s instructions. Briefly, 
samples were diluted with deionised water and sample buffer (Invitrogen) to desired 
concentration. All samples were reduced (Dithioreithol (DTT)- 0.5M) and heated at 
70**C for 10 min prior to loading into the gel. In order to maximise the number of 
comparisons that could be made within one gel both sham and LVD endocardial and 
epicardial homogenate samples were loaded into a 15 well gel. For each sample three 
different total protein amounts 0.5, 1, and 2|ig were loaded.
Such a gel set-up allowed comparisons of protein expression between:
Sham -  Fndo: Fpi
LVD -  Fndo: Fpi
FNDO -Sham: LVD
FPI - Sham: LVD
The 12 individual samples were loaded into 15 well polyacrylamide gels 
(Bis-Tris 4-12%) Rainbow Marker (Amersham, Life sciences) or See Blue Plus 2 
(Invitrogen) were used as molecular weight standards. SDS-polyacrylamide gel 
electrophoresis (PAGF) was then performed as described by Laemmli (1970) with 
antioxidants included in the buffers. Electrophoresis running times were optimised at 
200 volts for 90 min (Biorad power/pac 1000). Proteins were transferred to 
nitrocellulose membranes using the X cell II Blot module. The “Gel sandwich” was 
made up according to manufacturer’s instructions (Invitrogen). Protein transfer times 
were optimised at 30 volts for 75 min. After protein transfer, nitrocellulose 
membranes were cut horizontally at the 66 kDa marker to allow parallel but separate 
antibody incubations for proteins with different molecular weights. Non specific 
protein binding sites on the membranes were blocked using Blocking buffer for 
various time periods depending on the protein of interest. Blocking times, antibody 
concentrations and incubation times varied and were optimised for each protein of 
interest (see table 2.4). Nitrocellulose membranes were incubated with primary 
antibodies (in incubation buffer) washed in low/high/low salt buffers (3xl0min),
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incubated in secondary antibody (in incubation buffer) and the washes were repeated. 
All secondary antibodies were conjugated with Horseradish peroxidase (HRP) which 
when mixed with the chemoluminescence assay ECL reagent mix catalyses a 
chemical reaction which emits light (chemiluminescence). This emitted light is 
detected on the autoradiograph film (Hyperfilm, Amersham). Nitrocellulose 
membranes were incubated in ECL reagent mix (Amersham) for 60s placed in a film 
cassette and exposed to autoradiograph film. Exposure time varied according to the 
intensity desired, and was optimised for each protein of interest. Films were 
developed using the Kodak X-OMAT processor (MF-3).
After film development, the nitrocellulose membranes probed with the NCX primary 
antibody (antiserum) were stripped of this antibody using Restore western blot 
stripping buffer (Pierce) for 30 min at 37°C (gentle mixing). To test the efficiency of 
the stripping buffer, FCL reagent was reapplied to the membranes and reexposed to 
autoradiographic films. No residual antibody was detected on the films.
Nitrocellulose membranes were then washed (3xlOmin) and the antibody incubation 
procedure was repeated for the detection of the SFRCA 2 protein.
2.3.4.1. Coomassie stained gels
Staining gels directly after electrophoresis enables a good visual indication of 
the size and abundance of proteins present in any one sample. Samples and 
molecular weight markers were loaded into 14% Tris -glycine gels and were 
subjected to electrophoresis at a constant cun'ent of 25mA for 2.5 hr. Gels were 
stained for 3hrs using Colloidal Blue stain (Invitrogen), and destained overnight in 
distilled water. Gels were then dried at 80°C for 2hrs on a gel dryer (Biorad). See 
image (figure 5.2).
An additional staining method to assess protein transfer involved running and 
transfemng gels (Bis-Tris 4-12%) as described above in 2.3.4. Gels were stained 
after transfer in 0.125% Coomassie Brilliant blue (R-250, Biorad) for 60 min to 
verify transfer efficiency. Gels were then destained in Destain I for 2hr and Destain 
II overnight and stored in Destain II until use. Coomassie stained gels were also used 
to detei-mine total protein values within individual bands and lanes. Consistently a 
200 IcDa protein remained largely untransfeiTed under the above conditions. The
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suitability of total lane protein and this 200kDa protein as normalisation standards 
was subsequently assessed (see chapter 6).
Target protein Blocking time Primary
antibody
Secondary
antibody
SERCA Overnight 1:20,000-45min 
(monoclonal, 
Affinity)
1:2,000 - 45min
(Goat anti-mouse
Ig G: HRP) 
(Transduction 
Laboratories, (TL))
Sodium-calcium
exchanger
(NCX)
60 min
l:5,000-ovemight 
(antiserum,Swant)
l:5,000-120min 
(Goat anti-rabbit
Ig G: HRP) (TL)
Calsequestrin
(CSQ)
Overnight
1:80,000 - 30 min 
(anti serum,Swant)
1:20,000 -30min 
(Goat anti-rabbit 
Ig G: HRP) (TL)
Table 2.4. Details of optimised blocking times, antibody dilutions and 
incubation times for the specific proteins investigated; SERCA , NCX and 
CSQ.
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2.3.4.2. Biochemical solutions:
All solutions were made up in ultra pure (deionised) water (using either Maxima, 
Elga or Milli-Q, Millipore water systems).
Running bujfer contained: NuPage 20 X MOPS SDS running buffer (Invitrogen) 
diluted with deionised water. Antioxidant (500|il in 200ml) of IX running buffer 
(inner chamber).
Transfer buffer contained: NuPage 20 X transfer buffer, diluted with deionised water 
and 10% Methanol, SDS (O.lg, denatures proteins) and antioxidant (500pl in 500ml)
Incubation Buffer contained: 100 mM MgCh, 0.5% Tween 20, 1% Triton X-100, 
100 mM Tris HCl, pH’d to 7.5, then BSA 5%, Foetal calf serum (PCS) 5% and 
Thimerosal 0.01% were added.
Blocking buffer contained:3% BSA added to incubation buffer
Low salt buffer contained in mM 150 NaCl, 1 EDTA, 0.1% TritonX-100, 10 Tris- 
HCl, 0.05% Tween 20, at pH 7.5.
High salt buffer contained in mM: 600 NaCl, 1 EDTA, 0.1% TritonX-100, 10 Tris- 
Base, 0.05% Tween 20, at pH 7.5.
Coomassie stain contained: 1% stock made up in distilled water, then diluted to
0.125% in Destain I.
Destain I  contained: 50% Methanol, 10% Acetic acid, 40% deionised water.
Destain //contained: 5% Methanol, 7% Acetic acid, 88% deionised water.
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2.3.5. Quantification of Immunoreactive Bands
Auotoradiographs were scanned using an AGFA imaging densitometer 
(ARCUS II). The densitometer was internally calibrated for optical density using a 
step tablet standard. Prior to scanning every film additional calibrations were 
performed. Imaging parameters were adjusted according to the image to be scanned 
(film or gel). Films were scanned using maximum resolution in transmissive mode 
and files were saved using the software package Quantity One (4.2.1, Biorad).
Mean band intensity was calculated using the following basic steps.
1) Initial images were filtered (5x5 median filter).
2) Lanes were created and inserted through each protein band profile.
3) Background signal was deducted from the protein band profile on a lane to lane 
basis (example figure 2.2).
4) Brackets were inserted, adjusted in size and numbered around each protein band 
(in figure 2.2).
5) Intensity profiles (optical density) were calculated for each protein band and data 
was exported directly into Excel 97 (Microsoft).
Average optical density readings for Sham and LVD endocardial and 
epicardial samples were calculated. Protein optical density readings were normalised 
to the nominal protein loads of 0.5, 1 and 2 p,g. The slopes of the linear regression 
lines fitted to the data at 0.5, 1 and 2 jag determined the relative protein expression 
within each sample. Coomassie stained gels were scanned and analysed in the same 
way as the developed films using Quantity One software program.
In order to maximise the accuracy of the Western blotting technique (minimise 
variation) the protein gradient results were expressed relative to another sample type
i.e. endocardiahepicardial; sham:LVD within the same gel. Alternatively, protein 
expression can be expressed relative to another protein developed from the same 
nitrocellulose membrane.
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Figure 2.2. Typical trace from Quantity One showing the Intensity reading of 
an individual band and the background signal (brown solid line, inset) to be 
deducted. In addition, individual lane profiles and bands can be seen.
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RESULTS 
Chapter 3
Cardiac myocyte contractility measurements
3.1. Background
This chapter describes work aimed at assessing cardiomyocyte contractility in 
endocardial and epicardial myocytes in sham and LVD groups. Alterations from 
normal contractile function at the myocyte level are thought to be the basis of 
ventricular dysfunction in the whole heart. Cellular contractile function can be 
affected by many intracellular mechanisms such as changes in protein expression and 
activity or concentration of intracellular ions including those that affect intracellular 
pH regulation and myofilament Ca^ '*' sensitivity.
Much experimental evidence is available in the literature regarding changes in 
contractile parameters in hypertrophied and failing cardiac myocytes yet, to date, 
little experimental work has been peiformed to assess contractile parameters in the 
endocardial and epicardial regions of the ventricular wall.
Contractile function can be measured by assessing contractile features such as 
the fore e-frequency relationship and contraction kinetics. Additionally, the rest decay 
phenomenon can be used to assess Ca^ "^  handling processes within cardiac myocytes. 
More details of the above contractile features are described in chapter 1 
(Introduction). Therefore, only a brief resume is mentioned here.
In most mammalian species (Orchard & Lakatta 1985; Davies et al. 1995; 
Pieske et al. 1999) a positive force-frequency relationship is observed, i.e. increasing 
stimulation frequency results in an increase in the force of contraction (increased 
myocyte shortening). In general, the force-frequency relationship observed in 
hypertrophied or failing preparations is depressed or reversed. This phenomenon has 
been observed in many human and animal models of failure (Muliere et al. 1992; 
Schwinger et al. 1993; Schmidt et al. 1994, plus see Introduction).
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In healthy cardiac myocytes, contraction kinetic velocity (contraction and 
relaxation) increases as stimulation frequency increases (Davies et al. 1995; Perez et 
al. 1999). In general, studies have observed a slowing of contraction kinetics in 
hypertrophied or failing preparations in human (Gwathmey et al. 1987; del Monte et 
al. 1995; Perez et al 1999) and animal models (Naqvi & MacLeod, 1994; Bryant, 
Shipsey & Hart 1997; plus see Introduction). Transmural differences in contraction 
kinetics were investigated in control and hypertrophied guinea-pig myocytes by 
Bryant et al. (1997) but no significant differences were observed. A study by Perez et 
al. (1999) investigated the effect of changing extracellular [Ca^ '*'] and observed an 
increase in time to 50% decay (relaxation) in the heart failure group in comparison to 
control as extracellular [Ca^^] was increased. Increasing extracellular [Ca^ "^ ] has a 
similar experimental affect to increasing stimulation frequency, i.e. both produce a 
subsequent rise in [Ca^^]i, and an increase in contraction amplitude and Idnetics.
Following prolonged periods of rest (no electrical stimulation) the force of 
contraction of cardiac muscle is reduced, a phenomenon known as rest decay. Rest 
decay is thought to reflect a time dependent decrease in SR Ca^ "*" content via SR Ca^* 
leak (see introduction for references and more details on rest decay). Transmural 
differences in rest decay have been investigated by O’Neill (1993) who observed that 
the amplitude of the first twitch after rest (3min) was 77.5% and 52.3% of control in 
epicardial and endocardial myocytes respectively. They suggested that the SR of 
endocardial myocytes was less able to retain its SR Ca^ '*’ store than epicardial 
myocytes. An extension of this study (Chamunorwa & O’Neill, 1995) observed that 
the rest decay of cell shortening was faster and the recovery from the rested state 
slower in endocardial in comparison to epicardial rabbit myocytes. They concluded 
that changes in factors that affect myofilament calcium sensitivity produced the 
regional differences observed in rest decay. An alternative explanation could be that 
transmural differences in SR function exist which affect rest decay.
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3.2. Methods
Isolation of single cardiac myocytes was performed as described in the 
general methods chapter (2.2.2). Cardiac myocytes were loaded into a small 
perfusion bath (SOOpl) mounted on an inverted Nikon Diaphot 200 microscope. The 
bath was perfused at 1ml min'* with Krebs supeifusate between 35.5- 37.5**C 
(solution A in mM: 144 NaCl, 5 Hepes, 5.4 KCl, 0.3 NaHPo4 , 1.0 MgCl2 , 11.1 
Glucose, 1.8 CaCl2 , pH 7,3 at 37°C). Single cells were stimulated using a silver- 
silver chloride electrode system, with electrodes placed either side of the bath, 
allowing cuiTent to pass between them. Stimulation pulse rate was controlled via the 
dT-Max computer programme Version 1.1 (F.L.Burton, 1992) and was delivered to 
the electrodes by a Digitimer DS2 stimulator at 80-100V for durations of 2-4 ms. 
Cell length was recorded as a voltage (V) every 5ms via a Photodiode array system 
(Cairn Research Limited). Enhancement of cell edge contrast was achieved by 
minimising a window around each single cell. Single cell length measurements were 
recorded on video, paper trace and computer and digitised using the software 
program WCP (John Dempster (1993-4).
Stimulation protocols were performed as follows; 0.3, 0.5, 1, 2, and 3Hz for 
the force-frequency protocol and IHz only interspersed with periods of 30, 60, and 
180s rest for the rest decay protocol.
3.2.1. Data analysis
Steady state contraction records throughout the frequency range were 
averaged using WCP and converted to microns (pm) using conversion factors and 
data from the calibration curve (figure 3.1). Resting myocyte length was measured at 
the end of a 3min rest interval during the rest decay protocol.
Electrical stimulus was applied 20ms after the beginning of the sweep and diastolic 
myocyte length was taken as the length recorded between 10 -20 ms from the 
beginning of the sweep. Systolic lengths were recorded at their peak contraction 
values (minimum length). Diastolic and systolic lengths were measured to assess 
changes in myocyte length and to calculate fractional shortening throughout a range 
of stimulation frequencies. Diastolic and systolic length changes were expressed 
relative to diastolic length at 0.3Hz.
43
Fractional shortening was calculated by the following formula:
(Diastolic length - Systolic length)/ Diastolic length x 100 
= % fractional shortening
Only myocytes that responded to the complete stimulus frequency range (0.3 to 3Hz) 
were included in the data. WCP recordings were started only after steady state 
contraction had been achieved for each stimulation frequency.
Averages of diastolic, systolic, fractional shortening and rest decay values were 
calculated for each experiment (1-8 myocytes, average 2), each experimental average 
(n = number of hearts) was then used to calculate group results. Data comparisons 
were subsequently made between the following experimental groups:
• Sham - endo: epi
• LVD - endo: epi
• Endo - Sham: LVD
• Epi - Sham: LVD
Kinetic measurements were calculated from averaged shortening records at all 5 
stimulation frequencies (figure 3.2). Contraction values for peak amplitude (PA), 
time to reach peak amplitude i.e. 100% (TTP), time to reach 50% peak amplitude 
(TTP50) were measured. Relaxation values for time to 50% and 90% 
decay/relaxation, (TD50, TD90) and duration at 50% contraction (D50) were also 
calculated. Calculations of TD90 proved to be less reliable and consistent than TD50, 
therefore only TD50 measurements were included in the final analysis.
A schematic diagram of the experimental apparatus used in the contraction 
experiments is shown in figure 3.3.
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inîercept -4.7 +/- 0.05 (se) 
Slope =0.06+/-0.001 
R =0.99 +/-0.1(sd)
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Figure 3.1. Length/voltage calibration curve. Linear regression analysis 
produced an r value of 0.99 and a slope of 0.06.
3.2.L I , Statistical analysis
All data are expressed as mean ± SEM. Either t tests (one sided) or ordinary 
ANOVA (parametric) analysis was used to compare single or multiple groups 
respectively. A value of p <0.05 was considered statistically significant.
3.2.1.2. In vivo left ventricular echocardiographic parameters
Mean ejection fractions (EF) were 74.7 ±1.1 and 44.4 ± 1.9% and LVEDD 
values were 16.9 ± 0.3 and 21.0 ± 0.3mm for sham (n=28) and LVD (n=16) 
respectively. The above values were not statistically different from the mean EF and 
LVEDD values calculated for this whole study (table 2.1).
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Stimulus
TD90
TP50
i L
D50
Length PA
TD50
TTP
Time
Figure 3.2. Schematic showing Kinetic parameters measured to show 
contraction characteristics of single cardiac myocytes isolated from rabbit 
myocardium. TTP, Time to peak contraction; PA, peak amplitude; TP50, time 
to 50% peak amplitude; D50, duration of contraction at 50%; TD50, time to 
50% contraction decay; TD90, time to 90% contraction decay. Stimulus line 
represents point at which stimulus begins.
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3.3. Single myocyte contraction measurements
Normally as stimulation frequency is increased a concomitant increase in 
fractional shortening is observed (positive force-frequency relationship). This 
relationship is observed in figure 3.4. Decreases in both diastolic and systolic length 
occur as stimulation frequency is increased. Furthermore, an increase in contraction 
amplitude is observed (change in myocyte length). Figure 3.5 shows individual 
contraction traces enlarged and superimposed upon one another. This diagram clearly 
shows that with increasing stimulation frequency, diastolic length (D) decreases and 
contraction amplitudes increases.
116-,
115-
Posi t ive force - f requency  relat ionship
0.3 0.5
O) c
CD 1 1 4 -
>>
Ü
o>. 113-
1 1 2 -J
3Hz
2 5 s
Figure 3.4. Example trace of posltive-force frequency relationship showing 
the change in myocyte length associated with increasing stimulation 
frequency (0.3, 0.5,1,2 & 3Hz). NB -The fractional shortening for this example 
was lower than the average fractional shortening.
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D10 microns
,0.3
0.5
D - diastolic length 
S - systolic length
2 0 0  in s
Figure 3.5. Enlarged individual contraction traces produced at various 
stimulation frequencies (0.3, 0.5,1,2 & 3Hz) and superimposed upon one 
another. Time and length (jam) scales are represented by solid lines.
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3.3.1. Resting myocyte length
Resting myocyte length was measured at the end of a 3min rest interval 
during the rest decay protocol (see 3.2). No transmural difference in resting length 
existed in both the sham (endocardial 126.2 ± 6.45 pm & epicardial 124.1 ± 3,1pm, 
n=14 &15 respectively) and the LVD (endocardial 149.7 ± 3.2 pm & epicardial 
149.8 ± 7.8pm, n=14 &10 respectively) data sets. However, a significant increase in 
resting length was observed when sham and LVD endocardial (p<0.002) and 
epicardial (p<0.002) myocytes were compared (figure 3.6). The endocardial and 
epicardial LVD myocyte lengths were approximately 20% greater than the 
coiTesponding values in sham hearts.
I
160 r-
150
140O)
130o
&
100
Resting myocyte length -- Sham vs LVD 
P=0.002 P=0.002
Sham endo 
(n=14)
LVD endo 
(n=15)
Sham epi 
(n=14)
LVD epi 
(n=10)
Figure 3.6. Comparisons between sham and LVD resting myocyte lengths 
(microns), n indicates number of hearts. p<0.05 are considered statisticaiiy 
significance. Data are Mean ± SEM.
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3.3.2. Changes in diastolic length
3.3.2.1. Transmural diastolic length dijferences
Diastolic length decreased as stimulation frequency increased in both sham 
and LVD myocytes. No significant difference in relative diastolic length change was 
observed between endocardial and epicardial myocytes in both sham and LVD 
groups (table 3.1). Transmural relative diastolic length changes ranged from 1 to 0.97 
at 0.3 and 3Hz respectively in both sham endocardial and epicardial myocytes. A 
similar range was observed in LVD myocytes with relative length changes ranging 
from 1 to 0.97 and 1 to 0.96 in endocardial and epicardial myocytes respectively 
(table 3.1).
3.3.2.2. Comparisons between sham and LVD diastolic length
Comparisons of relative diastolic length changes between sham and LVD revealed 
minimal differences in both endocardial and epicardial myocytes. LVD endocardial 
and epicardial length changes had a tendency to be smaller in comparison to sham 
myocytes. None of the above data showed any statistical differences when analysed 
using ANOVA.
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Relative changes in Diastolic length
Cell Type
0.3Hz 0.5Hz 1Hz 2Hz 3Hz
Sham
endo
Mean
(n=22)
1.0 0.997 0.996 0.978 0.966
SEM 0 0.001 0.005 0.002 0.002
Sham
epi Mean
(n=19)
1.0 0.996 0.991 0.978 0.971
SEM 0 0.002 0.003 0.002 0.003
LVD
endo Mean
(n=15)
1.0 0.999 0.993 0.985 0.969
SEM 0 0.001 0.001 0.004 0.005
LVD epi
Mean
(n=10,*9) 1.0 0.999 0.995 0.984 0.963*
SEM 0 0.001 0.001 0.003 0.012
Table 3.1. Mean relative changes in diastolic length for Sham and LVD 
endocardial and epicardial myocytes associated with increasing stimulation 
frequency (0.3 to 3Hz). Data are Mean ± SEM and expressed relative to 
diastolic length at 0.3 Hz. n indicates number of hearts.
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3.3.3. Changes in systolic length
3.3.3.1. Transmural systolic length dijferences
A  small transmural difference in relative systolic length changes was 
observed in the sham data. A trend towards greater relative systolic length changes 
were observed in sham endocardial myocytes in comparison to epicardial myocytes, 
although this did not reach statistical significance. Endocardial changes ranged from 
0.92 ± 0.01 to 0.86 ± 0.01 (0.3 to 3Hz) whereas epicardial changes ranged from 0.93 
± 0.01 to 0.88 ± 0.01(0.3 to 3Hz) (figure 3.7, A). In contrast, changes in LVD 
endocardial relative systolic length were smaller than epicardial length changes. 
Endocardial changes ranged from 0.93 ± 0.01 to 0.87 ± 0.01 (0.3 to 3Hz) whereas 
epicardial changes ranged from 0.92 ± 0.01 to 0.85 ± 0.014 (0.3 to 3Hz). (figure 3.7, 
B). These data suggest that the small transmural differences in relative systolic length 
changes that exist in the sham data are not maintained in LVD although the 
differences were not statistically significant (ANOVA).
3.3.3.2. Comparisons between sham and LVD systolic length
Compai'isons in systolic length changes between sham and LVD endocardial 
myocytes showed that frequency-dependent systolic length changes were slightly 
greater in sham than LVD endocardial myocytes although not significantly (figure
3.8, A). The opposite trend occurred in epicardial myocytes where systolic length 
changes were slightly greater in LVD in comparison to sham myocytes (figure
3.8,B).
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Figure 3.7. Transmural change in relative systolic length in sham (A) and 
LVD (B) myocytes associated with increasing stimulation frequency (0.3 to 
3Hz). n is same as diastolic length (table 3.1). No statistical differences were 
observed within the data sets.
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Figure 3.8. Comparisons between sham and LVD endocardial (A) and 
epicardial (B) relative systolic length changes associated with increasing 
stimulation frequency (0.3 to 3Hz). No statistical differences were observed 
within the data sets.
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3.3.4. Fractional shortening
3.3.4.1. Transmural fractional shortening
Endocardial and epicardial myocytes from both sham and LVD hearts 
displayed a positive force-frequency relationship up to 2Hz with a levelling off of 
fractional shortening occurring at 3Hz, close to physiological resting rate. The reason 
for the plateauing of the relationship at 3Hz is unknown. In vivo, myocytes shorten 
with both isometric and isotonic phases, furthermore there is significant autonomic 
influence even at rest. The absence of these conditions in vitro may explain the 
apparent maximal shortening at 2Hz.
A small transmural difference in fractional shortening was found to exist 
between sham endocardial and epicaidial data. Fractional shortening in endocardial 
myocytes was found to be greater especially at higher stimulation frequencies in 
comparison to epicardial myocytes although the differences were not significant 
(ANOVA, figure 3.9,A). Fractional shortening ranged from 7.16 ± 0.51 to 10.87 ± 
0.55% (0.3 to 3Hz) and from 6.94 ± 0.77 to 9.74 ± 0.6% (0.3 to 3Hz) in endocardial 
and epicardial myocytes respectively.
Endocai'dial and epicardial fractional shortening in LVD was almost identical 
(figure 3.9,B). Although a small trend is present indicating greater fractional 
shortening in endocardial myocytes. LVD fractional shortening in endocardial 
myocytes ranged from 7.18 ± 0.64 to 9.5 ± 0.6% and from 5.83 ± 0.66 to 9.9 ± 0.8% 
in epicardial myocytes. None of the above data were significantly different when 
analysed using ANOVA.
3.3.4.2. Comparisons between sham and LVD fractional shortening
Comparisons in fractional shortening between sham and LVD endocardial 
myocytes showed that sham endocardial myocytes shorten more than LVD myocytes 
(not statistically different) at all except the lowest stimulation frequency (figure 3.10, 
A). In contrast, minimal differences in fractional shortening appear to exist between 
sham and LVD epicardial myocytes (figure 3.10,B), although sham epicardial 
myocytes have a tendency to shorten more than LVD epicardial myocytes.
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Figure 3.9. Effect of increasing stimulation frequency (0.3 to 3Hz) on 
transmural (endocardial/epicardial) fractional shortening (%) in sham (A) and 
LVD (B) myocytes. Data are mean ± SEM. n = number of hearts.
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Figure 3.10. Comparisons between sham and LVD endocardial (A) and 
epicardial (B) fractional shortening as stimulation frequency is increased (0.3 
to 3Hz). Data are mean ± SEM. n = number of hearts.
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3.4. Single myocyte kinetic measurements
3.4.1. Transmural and Sham vs LVD kinetic measurements
Details of all contraction kinetic measurements are shown in figure 3.2. 
Increasing stimulation frequency (0.3 to 3Hz) resulted in an increase in peak 
amplitude in all myocytes types (endocardial and epicardial) from both sham and 
LVD groups (table 3.2). Transmural comparisons in peak amplitude revealed 
increased peak amplitude in endocardial myocytes in both sham and LVD groups in 
comparison to epicardial myocytes. These differences were not statistically different 
(ANOVA). Peak amplitudes of both endocardial and epicardial LVD myocytes were 
slightly higher than sham myocytes although LVD epicardial peak amplitude was 
less than shams at the two lowest stimulation frequencies (0.3 & 0.5Hz).
Increasing stimulation frequency produced an overall decrease in time to 
peak amplitude (table 3.2). Time to peak amplitude had a tendency to be slower in 
both sham and LVD endocardial myocytes in comparison to epicardial, although 
these differences were not statistically significant (ANOVA). Time to peak 
amplitude in LVD endocardial and epicardial myocytes were slower at all 
stimulation frequencies when compared to sham (not significantly different).
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Myocyte type Peak amplitude (jum)
0.3Hz 0.5Hz IHz 2Hz 3Hz
Sham endo (n=18) 8.9 ±
0.8
9.8 ±
0.8
12.3 ±
0.7
13.7±
0.7
12.4±
0.7
Sham epi (n=17) 8.8 ±
1.1
10.0 ±
1.2
11.1 ±
0.9
12.2 ±
0.8
11.2±
0.7
LVD endo (n=15) 10.0 ±
1.0
10.9 ±
1.0
13.3 ±
1.0
14.5 ±
1.0
13.4 ±
1.0
LVD epi (n=10) 8.3 ±
1.0
9.1 ±
1.1
11.9±
1.1
13.3 +
1.2
13.2 ±
1.2
Time to peak amplitude (ms)
Sham endo (n=18) 145.5 ±
5.5
142.1 ±
6.3
142.8 ±
5.6
129.9 ±
5.8
117.8 ±
4.2
Sham epi (n=18) 129.0 ±
6.2
123.6±
6.1
127.1 ±
5.6
114.8 ±
4.0
105.7 ±
3.3
LVD endo (n=15) 148.4 ±
7.1
149.5 ±
6.4
145.8 ±
6.5
135.9 ±
5.0
126.4 ±
4.3
LVD epi (n=10) 136.5 ±
7.0
133.1 ±
6.6
135.7 ±
6.5
119.3 ±
6.2
112.6 ±
6.5
Table 3.2. Effect of increasing stimulation rate (0.3 to 3Hz) on peak amplitude 
(pm) and Time to peak amplitude (ms) in sham and LVD endocardial and 
epicardial myocytes. All data are mean ± SEM. n indicates number of hearts.
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Similar prolongation of contraction kinetics was observed in the LVD data set 
when measuring time to 50% peak amplitude (table 3.3). In all myocyte types and 
experimental groups time to 50% peak amplitude decreased as stimulation frequency 
increased. Time to 50% peak amplitude had a tendency to be slower in both sham 
and LVD endocardial myocytes in comparison to epicardial. Comparisons between 
sham and LVD endocardial and epicardial myocytes showed that generally both 
LVD myocyte types were slower in comparison to sham, although epicardial values 
were similar at 2 and 3Hz. These differences were not significant.
The general trend in duration at 50% contraction showed a decrease in all cell 
types and groups as stimulation frequency increased (table 3.3). At all frequencies 
endocardial sham and LVD myocyte durations were longer than the corresponding 
epicardial values. Sham and LVD comparisons showed that endocardial durations 
were almost identical to one another. LVD epicardial duration at 50% was longer 
than sham especially at higher stimulation frequencies (1,2 & 3Hz), although this 
was not significant (ANOVA).
As stimulation frequency increased, time to 50% decay decreased in all cell 
types and groups (table 3.3). Sham endocardial decay was longer in comparison to 
epicardial myocytes at all frequencies, whereas in LVD endocardial myocytes decay 
was longer than epicardial at lower 0.3, 0.5 & IHz, and was the same at higher 
frequencies. None of these differences were statistically significantly. LVD 
endocardial decay at 50% contraction was slightly faster than sham at all stimulation 
frequencies except 0.3Hz. LVD epicardial decay was faster at 0.3 and 0.5Hz and 
similar at higher frequencies. However, no statistical differences were observed 
(ANOVA).
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Myocyte type
Time to 50% peak amplitude (ms)
0.3Hz 0.5Hz IHz 2Hz 3Hz
Sham endo (n=18) 55.7 +
3.2
52.8 +
2.7
43.7 +
2.7
36.9 ±
2.9
35.9 ±
2.3
Sham epi (n=18) 44.7 +
4.2
42.7 ±
4.3
42.1 +
3.8
34.7 ±
2.8
34.8 ±
3.8
LVD endo (n=15) 54.1 ±
2.7
54.5 +
3.5
47.6 ±
2.2
41.5 ±
2.2
39.7 +
2.3
LVD epi (n=10) 49.7 ±
8.1
48.7 ±
6.4
43.9 ±
4.6
33.9 ±
2.9
32.0 ±
3.2
Duration at 50% contraction (ms)
Sham endo (n=18) 139.9 ±
6.1
144.7 ±
6.1
144.6 ±
5.5
139.9 ±
4.9
127.0 ±
4.7
Sham epi (n=18) 133.0 ±
5.7
132.9 ±
6.3
128.4 ±
6.2
122.3 ±
5.5
113.5 ±
5.6
LVD endo (n=15) 142.9 ±
7.5
144.9 ±
7.2
143.4 ±
7.9
136.5 +
6.1
126.7 +
5.1
LVD epi (n=10) 125.7 ±
8.0
127.6 ±
8.7
136.1 ±
6.4
133.1 ±
7.6
120.9 ±
6.9
Time to 50% decay (ms)
Sham endo (n=18) 53.6 ±
2.9
55.2 ±
2.9
52.7 ±
2.7
50.0 ±
1.5
47.8 +
1.9
Sham epi (n=18) 53.3 ±
2.5
52.2 ±
2.2
47.4 ±
2.5
45.5 ±
2.9
44.9 ±
2.7
LVD endo (n=15) 55.5 ±
3.4
53.6 ±
2.5
51.2 +
3.0
49.6 ±
2.9
46.3 +
2.8
LVD epi (n=10) 50.0 ±
4.5
47.8 ±
3.3
49.8 +
3.1
49.6 +
3.0
45.7 + 
3.0
Table 3.3. Effect of increasing stimulation rate (0.3 to 3Hz) on Time to 50% 
peak amplitude (ms), Duration at 50% contraction (ms) and Time to 50% 
Decay (ms) in sham and LVD endocardial and epicardial myocytes. All data 
are mean ± SEM. n indicates number of hearts.
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3.5. Single myocyte Rest decay measurements
3.5.1. Transmural rest decay measurements
A typical example of the rest decay phenomenon is shown in figure 3.11. Post 
rest potentiation is observed in the first contraction after 10s rest (panel A) and rest 
decay (smaller contraction amplitude) is observed as the rest interval is increased to 
30 (B) and 180s (C). The fractional shortening data described here are normalised 
relative to the average steady state contraction prior to beginning the rest intervals. 
Steady state values quoted in table 3.4 and figures 3.12 - 3.14 are values measured 
approximately l-2min after recommencing stimulation depending on rest interval 
duration. These steady state values show that relative fractional shortening returned 
to normal after the various rest interval protocols.
Relative fractional shortening for the first contraction and the steady state values 
after rest intervals of 10, 30 and 180s are shown in table 3.4.
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Figure 3.11. Single myocyte contractions after 10 (A), 30 (B) and 180s (C) 
rest intervals. Electrical stimulation was 1Hz prior to rest interval. 2s time 
scale is indicated by solid line (left hand side). Solid bracketed bar indicates 
duration of rest.
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Rest Interval (s)
10s 30s 180s
Cell
type
ist
contraction SS contraction SS
1 "
contraction SS
Sham 0.92 ± 1.02 ± 0.86 ± 1.01 ± 0.81 ± 0.95 ±
endo 0.09 0.03 0.08 0.02 0.09* 0.02
Sham 1.14± 1.07 + 1.06 ± 0.97 + 0.87 ± 0.99 ±
epi 0.05* 0.04 0.08 0.02 0.09 0.03
LVD 0.98 ± 0.99 ± 0.84 ± 1.02 ± 0.67 + 0.99 ±
endo 0.02 0.01 0.04* 0.02 0.07* 0.03
LVD epi 1.04 ± 0.98 1.02 + 1.02 ± 0.76 ± 0.97 ±
0.05 ±0.02 0.08 0.03 0.12* 0.03
Table 3.4. Relative fractional shortening of first and steady state contractions 
after rest intervals of 10, 30 and 180s in sham and LVD endocardial and 
epicardial myocytes. SS values are contraction values measured 1-2 min 
after electrical stimulation was recommenced. All data are mean ± SEM. 
* denotes significantly different value from SS values (prior to cessation of 
electrical stimulation).
The amplitude of the first contraction after rest is the most important as it 
reflects SR Ca^ "^  content after rest. The subsequent results and discussion therefore 
focus only on the relative fractional shortening of the first contraction after rest. 
Transmural comparisons between sham and LVD show an almost identical trend in 
rest decay at all three rest intervals measured (10, 30 and 180s). Table 3.4 shows that 
post rest potentiation is present in the first contraction after 10s rest in both sham and 
LVD epicardial (p <0.05) but not in endocardial myocytes. After 30s rest, the first 
contraction in both sham and LVD epicardial myocytes shows similar relative 
fractional shortening to steady state values. In contrast, rest decay is observed in 
sham and LVD endocardial myocytes (p <0,001). After 180s rest, significant rest
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decay is observed in both endocardial and epicardial sham (endo; p <0.05) and LVD 
myocytes (endocardial; p < 0.001, epicardial, p < 0.05). Interestingly, epicardial 
relative fractional shortening is consistently higher than endocardial irrespective of 
rest interval duration. These results are more clearly shown in figure 3.12, which 
shows the relationship between relative fractional shortening of the first contraction 
and 10, 30 and 180s rest intervals. Both Sham and LVD epicardial first contractions 
tend to be larger than endocardial, with this trend being more defined in the sham 
data. Post rest potentiation is also more apparent in sham than LVD epicardial 
myocytes.
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Figure 3.12. Relationship between first contraction (reiative fractional 
shortening) and rest interval in sham (A) and LVD (B) endocardiai and 
epicardial myocytes. Data plotted are mean ± SEM. Data are expressed 
relative to steady state fractional shortening prior to rest intervals.
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3.5.2. Sham vs LVD endocardial rest decay measurements
Comparisons between sham and LVD endocardial rest decay measurements 
show no differences in relative fractional shortening of the first contraction after a 
10s rest interval. The first contraction in each experimental group is not significantly 
different to the steady state value prior to the rest interval (sham 0.92 ± 0.09 LVD; 
0.98 ± 0.02), suggesting that neither post rest potentiation or rest decay has occun'ed 
after 10s rest (figure 3.13,A). Prolongation of the rest interval to 30 and 180s 
produces a progressive post rest decay of the first contraction in both sham (30s; 0.86 
± 0.1 & 180s; 0.81 ± 0.1, p<0.05) and LVD endocardial myocytes (30s; 0.84 ± 0.04, 
p<0.001 & 180s; 0.67 ± 0.1, p<0.001) (see figures 3.14 & 3.15, panel A), p values 
indicate values that are significantly different from SS values prior to cessation of 
stimulation.
3.5.3. Sham vs LVD epicardial rest decay measurements
In contrast, both sham and LVD epicardial myocytes show post rest 
potentiation in the first contraction after a 10s rest interval (sham; 1.14 ± 0.05, p< 
0.05) and LVD; 1.04 ± 0.05; figure 3.13,B). No statistical differences were observed 
between the sham and LVD data sets. Increasing the rest interval to 30s reduced the 
relative fractional shortening of the first contraction to values similar to steady state 
(sham; 1.06 ± 0.1, & LVD 1.02 ± 0.1) and relative fractional shortening was reduced 
further still after 180s rest (sham; 0.87 ± 0.09 & LVD; 0.76 ± 0.12, p <0.05) (figures 
3.14 & 3.15, B).
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Figure 3.13. Effect of 10s rest interval on relative fractional shortening in 
sham and LVD endocardial (A) and epicardial (B) myocytes. SS value on 
graph indicates steady state contraction value after recommencing 
stimulation. Data are expressed relative to steady state fractional shortening 
prior to rest intervals. n= number of hearts. * indicates significant difference 
(p<0.05) from SS contraction before rest.
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Figure 3.14. Effect of 80s rest interval on relative fractional shortening in 
sham and LVD endocardial (A) and epicardial (B) myocytes. SS indicates 
steady state contraction value after recommencing stimulation. Data are 
expressed relative to steady state fractional shortening prior to rest intervals. 
n= number of hearts. ** indicates significant difference p<0.001.
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Figure 3.15. Effect of 180s rest interval on relative fractional shortening in 
sham and LVD endocardial (A) and epicardial (B) myocytes. SS indicates 
steady state contraction value after recommencing stimulation. Data are 
expressed relative to steady state fractional shortening prior to rest intervals. 
n= number of hearts. * indicates statistical significance p<0.05, ** Indicates 
statistical significance p <0.001.
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3.6. Discussion
3.6.1. Myocyte length
An increase in myocyte length has been observed in many volume overload 
models of hypertrophy or heart failure in both human and animal studies (see 
introduction for references). These cellular changes are thought to reflect an in vivo 
compensatory cellular hypertrophy initiated by the failing myocardium to maintain 
cardiac output. The results observed in this study are consistent with previously 
published data. A significant increase in myocyte length occuired to the same extent 
in both endocardial and epicardial LVD myocytes (figure 3.6). The increased 
myocyte length observed in failing myocardium is thought to be achieved by the 
addition, in series, of more sarcomeres rather than increasing sarcomere length as 
sarcomere length is reportedly unchanged (Gerdes et a t 1992 & 1996).
Decreases in relative diastolic length were observed in all myocyte types and 
experimental groups as stimulation frequency increased. As stimulation frequency 
increases, diastolic [Ca^’‘']i rises (chapter 4) and a subsequent decrease in diastolic 
length ensues. No transmural differences in sham and LVD diastolic length were 
observed and comparisons between sham and LVD endocardial and epicardial 
diastolic lengths suggested a trend towards a longer relative diastolic length in LVD, 
although these differences were not significant. The longer relative diastolic length 
may reflect either a lower diastolic [Ca^ '^ Ji or a reduced myofilament Ca^ ''" sensitivity 
in both endocardial and epicardial LVD myocytes (chapter 4, & general discussion).
Relative systolic length decreased as stimulation frequency increased. A 
small transmural difference in systolic length change was observed in the sham data 
set with epicardial systolic length changing less than endocardial (figure 3.7, A). The 
reverse trend was observed in LVD with endocardial systolic length changing less 
than epicardial myocytes. Endocardial and epicardial differences within the sham and 
LVD data sets revealed no significant differences. The reason for the reversal in 
systolic length changes in LVD may reflect differences in systolic [Ca^^Ji between 
sham and LVD myocytes (chapter 4). Systolic length changes were less evident in 
LVD endocardial and greater in epicardial in comparison to sham myocytes (figure 
3.8), although not statistically significant. The reason for greater change in systolic 
length in LVD epicardial myocytes is unknown, especially as diastolic length
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changes appear similar in both endocardial and epicardial myocytes. This difference 
may be due to lower [Ca^ *^ ]i in LVD epicardial myocytes in comparison to LVD 
endocardial (see chapter 4 & general discussion).
3.6.2. Fractional shortening
In line with normal force-frequency relations, greater fractional shortening 
was observed as stimulation frequency increased. In agreement with previous 
observations (Bryant et al. 1997), transmural fractional shortening was slightly 
greater in sham endocardial than epicardial myocytes (not significant). This trend 
was maintained in LVD at all frequencies except 3Hz, although the differences were 
not as distinct (figure 3.9). These fractional shortening differences may be due to 
transmural differences in systolic and/or myofilament Ca^ '*' sensitivity (see
chapter 4 & general discussion). There was no significant difference in fractional 
shortening between sham and LVD endocardial myocytes although there was a 
marked reduction in fractional shortening in LVD in comparison to sham myocytes. 
In contrast, fractional shortening was the same in sham and LVD epicardial 
myocytes. The reduced fractional shortening in LVD endocardial myocytes may 
reflect either lower systolic [Ca^^i, and/or alterations in myofilament Ca^  ^ sensitivity 
(chapter 4 & general discussion).
3.6.3. Contraction kinetics
As stimulation frequency was increased, peak amplitude increased in all cell 
types and groups. These results are in agreement with previously published data 
(Davies et at. 1995). Peak amplitude was slightly greater in both sham and LVD 
endocardial myocytes in comparison to epicardial and in general, LVD peak 
amplitude was greater than sham (endo -all frequencies; epi 1,2 & 3Hz) (table 3.2) 
although not significantly. Peak amplitude is an absolute measure of shortening 
(diastolic -systolic length) and is therefore directly related to cell length. As LVD 
myocytes are significantly longer than sham myocytes then a greater peak amplitude 
in LVD myocytes would be expected. However, as there are no apparent transmural 
differences in cell length within the two experimental groups (figure 3.6), this does 
not explain the slightly greater peak amplitude observed in endocardial sham and 
LVD myocytes in comparison to epicardial myocytes. This difference may reflect 
transmural differences in [Ca^ '*']i (chapter 4).
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Time to peak amplitude was longer in sham and LVD endocardial myocytes 
in comparison to epicardial myocytes and overall, time to peak amplitude was longer 
in LVD endocardial and epicardial myocytes in comparison to sham (table 3.2). An 
almost identical trend was observed in time to 50% peak amplitude (table 3.3).
It has previously been reported that increasing stimulation frequency causes 
an increase in contraction amplitude (positive force-frequency relationship), 
(Orchard & Lakatta 1985) and produces faster contraction kinetics (Davies et al. 
1995). The observed increase in contraction kinetic speed as stimulation frequency is 
increased is most likely due to an increased rate of intracellular Ca^ "^  cycling 
processes (Ca^^ uptake and release). Increased Ca^^ cycling rates are required to 
ensure that adequate [Ca '^ j^i is available for normal contractile function when 
stimulation frequency is increased. Furthermore, increased stimulation rate means 
less time for Ca^ "^  extrusion per unit time, leading to an increase in diastolic 
and hereafter increased SR Ca^ "^  uptake and subsequent release. This process is 
believed to be responsible for the increasing amplitude observed as stimulation 
frequency is increased. Even though peak amplitude increases as stimulation 
frequency increases the time to peak amplitude decreases (due to faster Ca^ '*' cycling 
rates). LVD peak amplitude was generally larger yet time to peak amplitude tended 
to be longer. One possible explanation for the slower time to peak in LVD myocytes 
is that the velocity of contraction kinetics is related to cell size, i.e. longer myocytes 
have slower contraction kinetics. This relationship was investigated by plotting time 
to peak verses myocyte length. The data in figure 3.16 represent endocardial data 
only, however the same trend was observed when epicardial sham and LVD 
myocytes were compared (data not shown). These data suggest that the velocity of 
contraction is unrelated to myocyte length in both sham and LVD myocytes (r = - 
0.048 & -0.28, p = 0.85 and 0.31, sham and LVD respectively). These results agree 
with previously published data (del Monte et al. 1995), Alternative reasons for the 
slower contraction kinetics observed in LVD myocytes may be either a slower and/or 
reduced Ca^ "^  transient amplitude or that the response to changes in [Ca '^ j^i in LVD 
myocytes is reduced (see chapter 4). In general, the slowing of LVD contraction 
kinetics presented here are in agreement with previously published data. Prolonged 
contraction times have been reported in human (Davies et a l 1995; del Monte et a l 
1995) rat myocytes (Perez et al. 1999) and rabbit myocytes (Milnes & McLeod 
2001).
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Alterations in transmural contraction kinetics were investigated by Bryant et 
al. (1997), who observed no change in hypertrophic endocardial myocyte time to 
peak amplitude but a marked prolongation in epicardial time to peak amplitude. 
Bryant et al. (1997) also observed a small prolongation in hypertrophied endocardial 
time to 10% relaxation and a more marked prolongation in hypertrophied epicardial 
myocytes.
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Figure 3.16. Relationship between time to peak amplitude (ms) and resting 
myocyte length (pm) in sham (solid squares) and LVD (open squares) 
endocardial myocytes. Solid and dotted lines represent the best fit to a linear 
correlation with gradient values of -0.040 and -0.28 for sham and LVD data 
respectively, r = -0.04 and -0.28 and p= 0.85 and 0.31 for sham and LVD 
respectively.
Duration at 50% contraction was increased in endocardial sham and LVD 
myocytes at all stimulation frequencies in comparison to epicardial myocytes (not 
significant). Comparisons between sham and LVD endocardial duration showed no 
differences and LVD epicardial duration was shorter at 0.3 and 0.5 Hz but longer at 
1, 2 and 3Hz (not significant). Electrophysiological studies using this model
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observed a slight decrease in LVD endocardial and an increase in epicardial action 
potential duration (McIntosh et a l 2000). These electrophysiological changes may 
explain the alterations in the contraction duration observed in this study, i.e. decrease 
in both action potential duration and contraction duration in LVD endocardial 
myocytes and an increase in both action potential duration and contraction duration 
in LVD epicardial myocytes.
In general, the results presented here observed slower contraction kinetics in 
LVD myocytes in comparison to sham and are in agreement with previous reports 
showing prolongation of cell decay/relaxation times in failing myocytes. 
Interestingly, time to 50% decay was faster in LVD endocardial in comparison to 
sham myocytes although not significantly. This finding was unusual and the reasons 
are unknown. Whether this finding is important remains to be determined, as the 
difference in decay rate was not significantly faster and all other LVD contraction 
kinetics were slower in comparison to sham. Additional experiments are required to 
confirm these results.
In summary, the slower contraction kinetics observed in endocardial 
myocytes (sham & LVD) and the LVD group may reflect either reduced peak 
systolic [Ca '^^ Ji, a slower rate of rise in [Ca^’^ Jj (slow SR Ca^ "^  release) and/or a 
decrease in myocyte myofilament responsiveness to [Ca '^ J^i (chapter 4). Expression 
and functional activity of Ca^ "*" handling proteins such as SERCA and NCX 
determine rate, amplitude of contraction and extent of relaxation of cardiac myocytes 
by affecting [Ca^^ji. Therefore alterations in protein expression may have significant 
affects on myocyte contractility (see chapter 7).
Although there was a trend towards less fractional shortening (endocardial 
myocytes) and prolonged contraction kinetics in LVD myocytes no statistically 
significant differences were observed. Even though these findings imply that a 
degree of dysfunction has occurred in these LVD myocytes the data do not suggest 
that major abnormalities exist. Previously published data investigating contractile 
function have observed significant contractile dysfunction in hypertrophic and/or 
failing myocytes (see 1.8.1.4). The question that now arises is; Why were no 
significant differences observed between sham and LVD myocytes in this study?
Was the left ventricular dysfunction severe enough to produce cellular dysfunction? 
The echocardiography results suggest that significant LVD was present as ejection 
fraction was significantly decreased and LVBDD values were significantly increased
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in the LVD animals used in this study. Such contractile abnormalities are not only 
observed in single myocytes as studies using the same animal model as this study 
observed contractile dysfunction in isolated working whole hearts (Pye et al. 1996; 
Ng et al. 1998). It is possible that during the myocyte isolation procedure the 
unhealthiest LVD myocytes do not survive leaving the healthiest LVD myocytes 
alive, which will subsequently be used for experiments. These healthy LVD 
myocytes may have only slight contractile dysfunction, making it difficult to 
distinguish significant contractile differences between sham and LVD myocytes.
Although some of the differences within the data sets are almost significant, 
for example, endocardial fractional shortening at 2 & 3Hz (figure 3.10, A). The high 
variation within the data sets indicates that a high n number would be required in 
order to reveal any significant differences (n ~ 40 -  50 hearts in each group).
3.6.4. Rest decay
In line with previously published data, the results in this study showed a 
progressive decrease in contraction amplitude of the first contraction as rest intervals 
increased (figure 3.12). At all three rest interval durations both sham and LVD 
epicardial relative fractional shortening was noticeably higher than endocardial 
although this difference was not significant. Similar results have been observed by 
O’Neill (1993) and Chamunora & O’Neill (1995) who investigated transmural 
differences in rest decay recovery in normal rabbit myocytes. The data presented 
here suggest that the SR of sham and LVD epicardial myocytes are either able to 
retain SR Ca^ "^  longer (lower SR Ca^  ^leak) or have a larger SR Ca^ "^  storage capacity 
in comparison to endocardial myocytes. Several factors such as rate/expression of SR 
Ca^ *^  pump (SERCA), rate of SR leak and rate of Ca^ "^  efflux from the cell (NCX) 
may influence SR Ca^ '*' content. Alternatively, higher [Na’^ Jj may be responsible for 
the greater relative fractional shortening observed in the first contraction after rest in 
sham and LVD epicardial myocytes. As discussed previously, (Introduction) higher 
[Na'^ Ji reduces the reversal potential for NCX favours Ca^ "** influx and increase 
[Ca^^li. Raised [Ca^^i reduces the rest decay affect. Transmural [Na"*"]; was assessed 
in rabbit left ventricular myocytes by Cook et al. (1997) who observed significantly 
increased [Na"^ ], in epicardial in comparison to endocardial myocytes. Higher [Na^]i 
may be responsible for the reduced rest decay observed in epicardial myocytes but
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assessment of endocardial and epicardial [Na' J^i would be required to verify this 
hypothesis in both sham and LVD myocytes.
No significant differences in relative fractional shortening of the first 
contraction after rest were observed between sham and LVD endocardial and 
epicardial myocytes (10, 30 and 180s rest intervals, figures 3.12). A trend to lower 
relative fractional shortening of the first contraction in LVD endocardial and 
epicardial myocytes after all rest intervals was observed, although the differences 
were not significant. These results may suggest that LVD endocardial and epicardial 
myocytes are either less able to retain (greater leak) and/or have a lower SR 
Ca^^storage capacity in comparison to sham myocytes during rest intervals. 
Additional SR functional measurements would have to be performed in order to 
assess transmural and sham LVD differences in SR Ca^ "^  content (see chapter 4). It is 
unlikely that lower [Na"*"]! is responsible for the slightly greater rest decay in LVD 
myocytes as studies have commonly observed increases in [Na' J^i rather than 
decreases in hypertrophied human and guinea-pig myocardium (Gray et al. 2001) 
and in isolated whole guinea-pig hearts with compensated hypertrophy (Jelicks and 
Siri, 1995). This suggests that alternative cellular mechanisms are affecting rest 
decay.
3.7. Summary
No transmural resting myocyte length differences were observed within either 
sham or LVD groups. LVD endocardial and epicardial resting myocyte lengths were 
significantly longer than sham myocytes. No significant transmural differences were 
observed in both sham and LVD diastolic myocyte length changes as stimulation 
frequency was increased. Comparisons in diastolic length changes between LVD and 
sham myocytes revealed no significant differences. Sham transmural systolic length 
changes revealed a smaller rate-dependent change in epicardial in comparison to 
endocardial myocyte length, the opposite difference was observed in LVD 
(endocardial length changed less than epicardial). Endocardial sham verses LVD 
comparisons showed that the change in LVD endocardial systolic length was less 
than sham, but epicardial LVD systolic length changes were greater than sham. 
However, none of the sham vs LVD differences were statistically significant.
Sham fractional shortening was slightly larger in endocardial in comparison 
to epicardial myocytes, however LVD fractional shortening appeared similar in both
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regions. Sham endocardial myocytes shortened more than LVD, but sham and LVD 
epicardial myocytes showed similar shortening, although sham myocytes had a 
tendency to shorten more at lower stimulation frequencies. No statistical differences 
were observed when transmural and sham vs LVD comparisons were made.
Peak amplitude was slightly larger in endocardial sham and LVD myocytes in 
comparison to epicardial, and peak amplitude in LVD myocytes was larger than 
sham, although not statistically significant. In general, contraction kinetics 
(contraction and relaxation) in sham and LVD endocardial myocytes were longer in 
comparison to epicardial myocytes (not significantly). Duration at 50% contraction 
was slightly longer in sham endocardial myocytes in comparison to epicardial, but 
minimal transmural differences were observed in LVD. Overall contraction kinetics 
were slower in LVD in comparison to Sham, although such differences never 
reached statistical significance. Duration at 50% contraction was similar in LVD 
endocardial and slower in epicardial myocytes. Time to 50% decay was faster in 
LVD endocardial (not significant) and slower at the higher frequencies (1, 2 & 3Hz) 
in epicardial myocytes in comparison to the corresponding sham values.
Sham and LVD transmural rest decay was similar and showed post rest 
potentiation after 10 and 30s rest and rest decay after 180s. Throughout the range of 
rest intervals, epicardial sham and LVD myocytes showed noticeably higher 
fractional shortening of the first contraction in comparison to endocardial myocytes. 
Relative fractional shortening in sham and LVD endocardial and epicardial myocytes 
were similar, with a trend to lower fractional shortening in LVD myocytes.
A cascade of intracellular factors are responsible for contractile function in 
cardiac myocytes. The expression of sarcolemmal and SR Ca^ "^  handling proteins 
directly affects SR Ca^^ content which subsequently influences [Ca^ "^ ]i. Hereafter, 
coupled with myofilament Ca^ "^  sensitivity, changes in [Ca^ "^ ]i are responsible for 
myocyte contraction. Some of these intracellular factors are addressed in subsequent 
chapters (chapter 4 & 7) and their influences on contractile function are discussed in 
the general discussion (chapter 8).
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Chapter 4 
Intracellular Calcium measurements
4.1. Background
Measurement of intracellular Ca^ '*' transients using fluorescent indicators like 
Fura-2 are used to assess intracellular Ca^ "^  homeostasis within isolated cardiac 
myocytes. Accurate measurements of end diastolic and peak systolic [Ca^^]i can 
subsequently be determined from intracellular calcium transients. The aim of this 
study was 2 fold; one, to assess transmural (endocardiakepicardial) [Ca^ "^ ]i in Sham 
and LVD myocytes and two; to compare [Ca^^]i between sham and LVD myocytes.
To date, minimal work has been published on transmural [Ca^’^ Jj differences 
in either normal or failing myocardium. A previous study using the same model of 
LVD described in this study investigated transmural differences in action potentials 
and intracellular calcium transients (McIntosh et a l 2000). They observed no 
significant transmural differences in either end diastolic or peak systolic [Ca '^ j^j in 
sham myocytes. However, there was a trend towards lower peak systolic [Ca '^ j^j in 
sham endocardial myocytes. Figuerdo et a l (1993) observed higher end diastolic and 
peak systolic [Ca^^ji in the endocardium in comparison to epicardium in their 
perfused whole rat heart study (control). McIntosh et a l concluded that the 
differences in results between the two studies was due to either the differences in 
action potential duration between rat and rabbit or that the mechanical stresses 
between endocardial and epicardial were different between single dissociated 
myocytes and those intact within the whole myocardium.
McIntosh compared sham and LVD end diastolic [Ca^ '^ Ji and observed higher 
endocardial end diastolic [Ca^ "^ ]i but minimal changes in LVD epicardial end 
diastolic [Ca^^i. In contrast, LVD endocardial end diastolic [Ca '^ I^i and peak systolic 
[Ca^^Ii was higher in comparison to the corresponding sham data. Figuerdo et a l 
(1993) observed that during ischaemia, endocardial diastolic [Ca '^^ Ji rose to a greater 
degree than epicardial levels.
In human heart failure, increased end diastolic [Ca^‘*“]i (Gwathmey et a l 1987; 
Beuckelmann et a l 1992; Arai et a l 1993,), decreased peak systolic [Ca^ '*']i 
(Beuckelmann et a l 1992) and unchanged peak systolic [Ca^^], (Gwathmey et a l
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1990) have been observed. In addition, prolongation of Ca^’^ transient duration has 
also been observed (Gwathmey et a l 1987 &1991, Beuckelmann et a l 1992).
Similar results have been observed in animal models of heart failure. Siri et 
a l  (1998) in their guinea pig model of heart failure observed a decrease in peak 
systolic [Ca^^i but observed no change in end diastolic [Ca^ '*']i. McIntosh et a l 
(2000) observed a reduced peak systolic and an unchanged end diastolic [Ca^’*']i in 
failing epicardial myocytes in comparison to sham epicardial myocytes. In contrast, 
failing endocardial myocytes showed an increased peak systolic and end diastolic 
[Ca^ "^ ]i. Ca^^ transient duration was also increased in epicardial but decreased in 
endocardial failing myocytes.
4.2. Methods
4.2.1. Fluorescent measurements
Changes in intracellular Calcium concentration ([Ca^^];) during electrical 
stimulation (termed Ca^^ transients) were recorded using the fluorescent Ca^ "^  
indicator Fura-2 AM (Molecular probes). Fluorescence excitation at 340 and 380nm 
was produced by a Xenon arc light source and a spinning wheel system at 60Hz 
(Cairn Research Systems). Fluorescence emissions above 500nm were collected 
using an interference filter (long pass 500nm) and passed through a dichroic mirror 
to the photomultiplier. Output (V) from the photomultiplier was measured by a 
spectrophotometer (Cairn Research Systems). The adjustable window surrounding 
each single cell was minimised to reduce external fluorescence and a red filter was 
introduced within the microscope to allow the cell image to be monitored. Changes 
in intracellular [Ca^ "*"] ([Ca^^ji) were calculated by the ratiometric measurement of the 
excited fluorescence signals at 340 and 380nm. These two wavelengths and the 
340:380 ratio value were recorded on a chart recorder (Gould Instruments Ltd), video 
and digitised onto a computer.
The bath and perfusion system used to measure intracellular fluorescence 
differed from that used in the cell length set-up. Firstly, a smaller bath, 200)11 volume 
was used thus enhancing the speed of solution changes. Secondly, the inflow tube 
was positioned by micromanipulators directly above the cell of interest. Such a 
system localises and optimises the effect of solution changes. All other apparatus and
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recording equipment was identical to that used in the cell length measurements 
(figure.3.3).
Myocytes were loaded by incubation with 5pM Fura-2 AM (Spl ml'^) for 10 
min at room temperature, subsequently diluted with Ki*ebs by a factor of 2, left for a 
further 10 min then used as required, up to a maximum of 60min. Myocytes were 
placed into the heated bath and perfused with Krebs (Sol" B, Ca^^ 1.8mM). 
Fluorescence ratios from individual myocytes were recorded during the following 
protocol. Myocytes were electrically stimulated at 0.5 Hz until steady state 
contraction was reached. Simultaneously, stimulation was ceased and perfusion was 
switched from Krebs to Krebs containing 20mM caffeine for 5s. Electrical 
stimulation was recommenced 15 s later for Imin followed by a second caffeine 
application. This protocol was repeated at 1 and 2Hz stimulation. Only myocytes that 
responded to the complete stimulus frequency range were included in the data set. 
Rapid caffeine application allows accurate quantification of SR [Ca^ '*']. Data from 
such experiments can be used to compare SR Ca^ "^  release produced by caffeine 
application (pharmacological) and that produced by electrical stimulation.
4.2.2. Calibration of Fura-2 fluorescence ratio
Ideally, calibration should be calculated on each and every individual cell, 
however, due to time and technical constraints this is not always practical. A 
relatively quick and simple method to obtain approximate individual myocyte Rmin 
(minimum fluorescence ratio) and R^ax (maximum fluorescence ratio) values was 
used in these experiments. Isolated myocytes that had been quiescent for 4-8 hours 
were placed in the perfusion bath and Fura-2 fluorescence ratio was measured prior 
to commencing electrical stimulation. This value was taken as Rmin, assuming that 
after periods of quiescence the [Ca^^]i within the myocyte had reduced to levels that 
cannot be distinguished from Rmin using EOT A (Ca^^ buffer). Additional Rmin values 
obtained by perfusing myocytes with a 10 EGTA solution ([Ca^ '*'] -O.InM) using 
either (3-escin permeabilisation or microelectrode impalement techniques were not 
significantly different from the calculated resting Rmin- Therefore, in this study 
resting fluorescence ratio could be confidently used as an accurate Rmin value. After 
each experimental protocol had been canied out a maximum fluorescence ratio 
(Rmax) was obtained by perfusing the cell with a high Ca^ "*" solution (in mM: 120 KCl,
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20 Hepes, 10 CaCL, 1 MgCli, 10 Caffeine at pH 7.4). This produced a large Ca^ "^  
influx resulting in instant hypercontraction of the myocyte i.e. without significant 
loss of any Fura-2 ratio signal via cell permeabilisation techniques. Intracellular 
calibration of Fura-2 was performed by another member of the laboratory on the set­
up used in this study. Using a Fura-2 calibration curve a value for Kd was determined 
using data from a group of myocytes. The best fit for the data calculated a Kd of 
1.64|LtM (1.64 ± 0.14 xlO"  ^fiM). Fluorescence ratios were converted to free [Ca '^ j^ 
according to equation [1] (Grynkiewicz et a l 1985) using individual Rmin and Rmax 
values and the mean Kd.
R “R mIN \  
— K d X I " -  I
V  R max - R /
[1]
It is unknown what [Ca^^]; individual myocytes adopt after 4-8 hrs of quiescence 
(after dissociation from heart). Based on the sensitivity of Fura-2 for Ca^ "*", cytosolic 
levels < 20nM would generate a Fura-2 fluorescence within 10% of Rmin- Previous 
measurements from Bassani et a l (1995) suggest that after 2hrs of quiescence, 
[Ca '^ l^i in rabbit myocytes is ~ 80nM, this would produce a Fura-2 ratio considerably 
above Rmin- Therefore, it would appear that the longer period of quiescence in this 
study resulted in a [Ca '^ j^i considerably less than 80nM.
A typical example of an experimental trace including Rmin and Rmax ratio values is 
seen in figure 4.1, panel A. Fura-2 fluorescence ratio values increase as stimulation 
frequency increases. Using the same experimental trace Fura -2  fluorescence ratio is 
converted into [Ca^’*']i (panel B) according to equation [1] (see Fura-2 calibration).
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Figure 4.1. Typical experimental trace of Fura-2 fluorescence ratio (A) 
produced during complete frequency protocol: including Fura-2 ratio at 0.5, 1 
& 2 Hz, Rmin and Rmax ratios. Changes in [Ca^^], associated with increasing 
stimulation frequency (B). Solid line represents 30s time scale. Gaps in trace 
B represent cessation of electrical stimulation during caffeine application (c). 
The amplitude and time-course of the steady state Ca^^ transients were 
analysed prior to caffeine application.
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4.2.3. Data analysis
Diastolic and systolic fluorescent Fura-2 ratios were recorded by the software 
Chart program. The data was converted to Ca^ '*' values using Rmi„ and Rmax values 
from the experimental record and the previously measured Kd value (see 4.2.2). 
Diastolic [Ca^^]i (resting) was measured at 0- 20ms post stimulation and peak 
systolic [Ca^ '*']i was measured at the peak of the calcium transient. To increase the 
accuracy of the data and to ensure that steady state fluorescence had in fact been 
attained, diastolic and systolic [Ca^^]i were averaged over two periods of stimulation 
(immediately prior to caffeine application). Two caffeine-induced peak systolic 
[Ca^ "^ ]! values were also measured for each stimulus rate and each cell (figure 4.1).
4.2.3.1. Statistical analysis
All data are expressed as mean ± SEM. Unpaired t tests were used to compare 
two groups and ordinary ANOVA analysis was used to compare multiple groups. A 
value of p <0.05 was considered statistically significant.
4.2.3.2. In vivo left ventricular echocardiographic parameters
Mean ejection fractions were 72.0 ±1.3 and 45.5 ± 1.9% and LVEDD values 
were 17.8 ± 0.4mm and 19.45 ± 1.81mm for sham (n=12) and LVD (n= ll) animals 
respectively. The above values were not statistically different from the mean EF and 
LVEDD values calculated for this whole study (table 2.1).
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Figure 4.2. Typical examples of calcium transients recorded from sham and 
LVD epicardial myocytes. Records were produced from a range of 
stimulation frequencies; A:0.5, B:1 & C: 2Hz. Solid lines represent 2s time 
scale.
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4.3. Transmural intracellular calcium measurements
Although previous intracellular [Ca^ "^ ] has been measured in this model of 
LVD (McIntosh et al. 2000), the experiments performed in this study were 
undertaken using different experimental conditions and protocols. Most importantly, 
the experiments undertaken in the McIntosh study were performed on cardiac 
myocytes impaled with a micro-electrode.
Typical examples of calcium transients obtained from sham and LVD 
myocytes during electrical stimulation at 0.5, 1 and 2Hz are shown diagrammatically 
in figure 4.2. Note the increase in both diastolic and systolic [Ca^‘^ ]i when stimulation 
frequency is increased.
4.3.1. Calcium measurements in Sham operated myocytes
End diastolic and peak systolic [Ca^^Ji were calculated from intracellular Ca^^ 
transients elicited by electrically induced stimulation at 0.5,1 & 2Hz.
Measurements of end diastolic [Ca^ '^ Ji for sham endocardial and epicardial myocytes 
are shown in table 4.1, A. Increasing stimulation frequency from 0.5 to 1 to 2Hz 
produced an increase in end diastolic [Ca^ '*']i in both sham endocardial and epicardial 
myocytes. At all stimulation frequencies sham endocardial end diastolic [Ca^ '*']i was 
smaller than in epicardial myocytes although these differences were not statistically 
significant (table 4.1,A; ANOVA analysis).
Similar to the trend observed in end diastolic [Ca^‘*']i, sham endocardial and 
epicardial myocytes showed a frequency related increase in peak systolic [Ca^’^Ji ( 
figure 4.3;A). Throughout the frequency range applied endocardial peak systolic 
[Ca^ '*']i was slightly lower than epicardial (endocardial range: 259.3 ± 24.2nM at 0.5 
Hz to 505.8 ± 37.5nM at 2Hz; epicardial range: 272.6 ± 25.9nM at 0.5 Hz to 608.1 ± 
83.9nM at 2Hz).
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A Sham endocardial Sham epicardial
Stimulation Mean diastolic Mean diastolic
frequency (Hz) Ca^ + (nM) SEM (n) Ca "^ (nM) SEM (n)
0.5 139.0 15.5 (33) 164.5 18.5 (23)
1 183.5 16.2 (29) 240.3 22.0 (22)
2 300.7 26.0 (23) 370.0 45.5 (21)
B LVD endocardial LVD epicardial
Stimulation Mean diastolic Mean diastolic
frequency (Hz) Ca'+ (nM) SEM (n) Ca "^ (nM) SEM (n)
0.5 98.8 14.0 (25) 85.2" 10.4 (29)
1 149.9 12.2 (20) 123.7 "" 14.4 (29)
2 235.0 19.1 (24) 205.4 * 17.3 (24)
Table 4.1. Mean end diastolic [Ca^^i produced by eiectrical stimulation (0.5, 
1 and 2Hz) for sham (A) and LVD (B) endocardial and epicardial myocytes 
Data shown are mean ± SEM. (n) indicates number of myocytes. Hearts 
used equals sham endo; 11, sham epi 10; LVD endo 9; LVD epi 10. "denotes 
statistical significance in comparison to sham data (* p<0.01, "*p<0.001).
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4.3.2. Calcium measurements in LVD myocytes
Similai* to the results observed in the sham data, increasing stimulation 
frequency from 0.5 to 2 Hz produced an increase in end diastolic and peak systolic 
[Ca '^ j^i in both endocardial and epicardial LVD myocytes. At all stimulation 
frequencies LVD endocardial end diastolic [Ca^^]i had a tendency to be higher than 
epicardial end diastolic [Ca^ "^ ]i (table 4.1,B) although this did not reach statistical 
significance. Peak systolic [Ca^ "^ ]i rose as stimulation frequency increased and the 
transmural difference remained, i.e. endocardial [Ca^ "^ ]! was higher than epicardial. 
Endocardial peak systolic [Ca^ '*’]i ranged from 233.2 ± 19.8 to 448 ± 36.7nM and 
epicardial peak systolic [Ca^^]; ranged from 188.8 ± 18.7 to 360 ± 30.1nM (figure 
4.3,B). None of these results were statistically different (ANOVA). In contrast to the 
sham data, LVD endocardial end diastolic and peak systolic [Ca^’*’]i were higher than 
epicai'dial. This suggests that the noimal transmural differences in end diastolic and 
peak systolic [Ca^ '*']i were reversed in LVD.
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Figure 4.3. Transmural (endocardlal/epicardial) changes in peak systolic 
[Ca^^i (nM) associated with increasing electrical stimulation frequency (0.5 to 
1 to 2Hz) in sham (A) and LVD (B) myocytes. Data are mean ± SEM.
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4.3.3. Comparisons between Sham and LVD [Ca^ '*']i
4.3.3.1. Endocardial comparisons
A marked difference between Sham and LVD endocardial end diastolic 
[Ca^ '*']i was present at all stimulation rates although this was not statistically 
significant (table 4.1; A, B). Comparisons between sham and LVD endocardial peak 
systolic [Ca^ '*’]t ai'e shown in figure 4.4 (A) where minimal differences were 
observed.
4.3.3.2. Epicardial comparisons
In marked contrast to the endocardial data, there was a significant difference 
between sham and LVD epicardial end diastolic and peak systolic [Ca^ '^ Ji. End 
diastolic [Ca^^]i was significantly lower in LVD epicardial myocytes in comparison 
to sham at all three stimulation frequencies (p<0.01, p<0.001, p<0.01 at 0.5, 1 and 2 
Hz respectively; see tables 4.1., A & B). Similarly, LVD epicardial peak systolic 
[Ca^^]i was significantly lower than sham at all stimulation frequencies (figure 4.4, 
ANOVA, p<0.05 at 0.5, IHz & 2Hz).
In general, end diastolic and peak systolic [Ca^’^ ji are lower in the LVD group 
(epicardial myocytes particularly) than sham myocytes.
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Figure 4.4. Comparisons between Sham and LVD endocardial (A) and 
epicardial (B) peak systolic [Ca^^j produced by electrical stimulation (0.5,1 & 
2Hz). * indicates statistical significance of p<0.05.
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4.4. Caffeine induced transients
4.4.1. Background
Caffeine binds to a specific site on the cytosolic side of the ryanodine 
receptor (RyR) and increases the open probability of the calcium-activated calcium 
release channel (RyR) without altering the duration of open events (Sitsapesan & 
Williams, 1990). Rapid caffeine exposure at millimolar concentrations is thought to 
induce complete release of SR Ca^^ and is often used to assay total SR Ca^ "^  content 
(Bers, 1987; Varro et a l 1993).
Briefly, in this study, steady state systolic [Ca '^ l^i was attained at the desired 
electrically stimulated frequency (0.5,1 & 2Hz). Electrical stimulation was ceased 
and 20mM caffeine (5s) was applied, 15s later electrical stimulation was 
recommenced for 1 min and a second caffeine pulse was applied. Typical examples 
of calcium transients produced by electrical stimulation (0.5, 1 & 2Hz) and those 
produced by the application of caffeine (20mM) after stopping stimulation are shown 
in figure 4.5. This figure also shows that the peak amplitude of the caffeine induced 
transient is comparable to transients produced by electrical stimulation. These results 
are in line with previously published caffeine experiments (Frampton et a l 1990). 
Prolonged duration of caffeine induced transients are observed in caffeine 
experiments. This phenomenon is thought to reflect the inability of SERCA to 
resequester Ca^ "^  into the SR due to the increased open probability of ryanodine 
receptors (Bers, 2000) and continuous release of SR Ca^^ during caffeine application. 
As the rate constant of NCX to remove Ca^^ from the cytosol is less than SERCA 
(Bassani et a l 1994), the Ca^’*' transient in caffeine is slower to decay.
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4.4.2. Transmural differences in caffeine induced calcium transients
Increasing stimulation frequency leads to an increase in SR [Ca^ '*‘] content, 
and consequently a larger peak systolic It follows that caffeine-induced Ca^ "^
transients associated with increasing stimulation frequencies would reflect this 
increase and would also produce a larger systolic [Ca^ "^ ]; (Frampton et al. 1991).
As caffeine application assesses SR Ca^^content, only peak systolic [Ca^’^ Jj results 
are detailed here. Similar to the trends observed in electrically elicited Ca^^ 
transients, a very similar frequency-dependent pattern in caffeine-induced transients 
was observed in both sham and LVD data sets.
Caffeine application produced peak systolic [Ca^ "*"], ranging from 270.9 ± 
30.0 at 0.5Hz to 464.6 ± 45.9 nM at 2Hz (sham; endocardial) and from 311.8 ± 35.3 
to 691.1 ± 121.3nM respectively in sham epicardial myocytes (figure 4.6,A). The 
normal sham transmural difference observed in electrically stimulated myocytes (i.e. 
higher epicardial peak systolic [Ca^ *^ ]i than endocardial) was maintained in caffeine 
induced transients. LVD endocardial peak systolic [Ca '^ j^i ranged from 253.5 ± 19.8 
(0.5Hz) to 452.5 ± 34.3nM (2Hz) and from 206.6 ± 21.2 (0.5Hz) to 361.5 ± 
31.9nM (2Hz) in the epicardial data (figure 4.6,B). Again, the nonual transmural 
difference observed in the sham data was not maintained in LVD as endocardial peak 
systolic [Ca^ "^ ]i was higher than epicardial (figure 4.6). These LVD caffeine results 
are similar to those produced by electrical stimulation of LVD myocytes (figure 4.3).
4.4.3. Comparisons between Sham and LVD caffeine induced [Ca ],
Caffeine induced peak systolic [Ca^ "^ ], in endocardial sham and LVD 
myocytes were almost identical (figure 4.7,A). In contrast, there was a significant 
difference between sham and LVD epicardial peak systolic [Ca^’^ ji at 0.5 (p<0.05), 1 
& 2Hz (p<0.01) (figure 4.7,B). These results follow the same trend as the sham:LVD 
peak systolic [Ca '^ ]^i comparisons observed during electrical stimulation (figure 4.4).
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Figure 4.6. Effect of caffeine (20mM) on transmurai peak systolic [Ca^^i (nM) 
following cessation of electrical stimulation at 0.5, 1 and 2Hz. Sham endo 
n=22,17, 15 and epi n=18,14,11. LVD endo n=27,26,21 and epi n=20,20,20 
for 0.5, 1 and 2 Hz respectively. n= number of myocytes.
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4.5. Discussion
4.5.1. Transmural differences in Cs?'^  transients
In all sham myocytes, end diastolic and peak systolic [Ca '^ ]^i increased as 
stimulation frequency increased and no significant transmural differences in either 
parameter were observed, although epicardial [Ca^^]; had a tendency to be higher 
than endocardial. Similar to sham myocytes, end diastolic and peak systolic [Ca^^]i in 
LVD myocytes increased as stimulation frequency increased. In contrast to the sham 
data, LVD endocardial end diastolic and peak systolic [Ca^ '*']i were higher than 
epicardial, although these differences were not significant. Therefore, the transmural 
difference in end diastolic and peak systolic [Ca '^ ]^i observed in sham was not 
maintained in LVD, These transmural differences may be due to either alterations in 
Ca^^ handling protein expression which subsequently affects SR Ca^^content (see 
chapter 7) or to differences in SR Ca^ "^  release mechanisms.
4.5.2. Comparisons between sham and LVD Ca^  ^transients
End diastolic and peak systolic [Ca^’^ ji were similar in both sham and LVD 
endocardial myocytes, although there was a tendency for sham values to be 
marginally higher than LVD (figure 4.4). These diastolic results are similar to those 
published by McIntosh et a l (2000), who observed similar end diastolic values 
between moderate (EF > 45%), severe failure (EF < 45%) and sham operated 
animals. In contrast, McIntosh et al. observed higher endocardial systolic [Ca^ '*']i in 
severely failing LVD myocytes in comparison to sham but no difference in systolic 
[Ca^^Ji was observed in the moderately failing myocytes. The reason for the 
differences in LVD endocardial systolic [Ca^’’']i between this and the McIntosh study 
may be due to differences between mean ejection fraction. A significant difference 
between EF values was observed between the severe LVD data (McIntosh et at. 
2000) and the mean EF observed in this study (p<0,05). FurtheiTnore, no significant 
difference in mean LVEDD values were observed between the two studies. No 
significant differences were observed in the echocardiographic data between the 
moderately failing myocytes (McIntosh study) and this study. This result suggests 
that the degree of change in systolic [Ca^ '^ Jj may be linked to the severity of the 
failure (as assessed by EF). LVD epicardial end diastolic and peak systolic [Ca^^Ji
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were significantly smaller than sham epicardial values. These data are in agreement 
with the McIntosh study, although the diastolic differences are less distinct.
LVD endocardial myocytes displayed a trend to smaller peak systolic [Ca^ '*']i 
in comparison to sham endocardial myocytes (not significant). LVD epicardial peak 
systolic [Ca^ "^ ]i was significantly smaller at all three stimulation frequencies ( 
p<0.05). These results are in line with previously published data on failing hearts 
(Siri et a l, 1991; Beuckelmann et a l, 1992;) and are consistent with reports of 
disruption of intracellular Ca^ "^  handling mechanisms in failing myocardium. Such 
disruption may be due to alterations in the expression of cardiac myocyte Ca '^  ^
handling proteins. It appears that alterations of intracellular Ca^^ handling 
mechanisms has occuiTed in both LVD endocardial and epicardial myocytes, leading 
to a reduced end diastolic and peak systolic [Ca^‘*‘]i. As LVD epicardial peak systolic 
[Ca '^ l^i is significantly reduced in comparison to endocardial this suggests that 
heterogeneous changes in Ca^ '*' handling mechanisms occurred across the left 
ventricle in LVD, i.e. greater changes in LVD epicardial Ca^ "^  handling mechanisms 
have occuiTed in comparison to endocardial. One possible factor that may be 
responsible for the transmural pattern of disruption of intracellular Ca^^ handling is 
that alterations in the expression and/or activity of intracellular Ca^’^ handling 
proteins are heterogeneous in LVD myocytes (see chapter 7 and general discussion).
4.5.3. Transmiiral caffeine induced Ca^  ^transients
Caffeine-induced Ca^ '*’ transients demonstrate an almost identical trend in 
changes to peak systolic as Ca^^ transients elicited by electrical stimulation,
i.e. increasing peak systolic [Ca^‘*‘]i as stimulation frequency increases. In normal 
sham myocytes epicardial peak systolic [Ca^^i had a tendency to be higher than 
endocardial, although this did not reach statistical significance. In contrast, LVD 
endocardial peak systolic [Ca^^Ji was higher than epicardial. Therefore, the normal 
transmural difference in caffeine induced peak systolic [Ca^ "^ ]i was not maintained in 
LVD (figure 4.6). Larger peak systolic [Ca^^i are normally associated with a larger 
SR Ca^^ store suggesting that sham Epi and LVD endocardial myocytes have either 
a larger SR Ca^^ storage capacity or that the effect of caffeine application on SR Ca^ "^  
release is greater in these myocytes. As the transmural trends in peak systolic [Cs?'^ ]\ 
are similar for electrically stimulated and caffeine induced transients, this implies 
that the larger Ca^^ transients elicited by sham Epi and LVD endocardial myocytes
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occur due to a higher SR Ca^ "^  content rather than these myocytes being differentially 
affected by caffeine application.
4.5.4. Comparisons between sham and LVD caffeine induced Ca^  ^
transients
Caffeine-induced peak systolic [Ca^ '^ Ji in endocardial myocytes are virtually 
the same in sham and LVD (figure 4.7) and these results are similar to those 
observed in the electrically elicited Ca^ "*" transient data (figure 4.4,A). In contrast, 
there was a significant decrease in LVD epicardial peak systolic at all
stimulation frequencies in comparison to the sham data (figure 4.7,B). Again, these 
sham/LVD differences were present in the electrically elicited peak systolic [Ca^ '*'], 
transient data (figure 4.4,B).
Comparisons between sham and LVD peak systolic [Ca^^ji induced by 
caffeine application showed almost identical trends in peak systolic [Ca^^]i as those 
elicited by electrical stimulation. As these results are similar it suggests that the 
significant differences observed between sham and LVD epicardial myocytes are a 
function of the myocytes themselves rather than the affect of caffeine application. As 
discussed earlier, the most likely explanation is that heterogeneous changes in Ca^ "^  
handling mechanisms have occurred in LVD, and that these changes are greater in 
LVD epicardial myocytes.
4.6. Summary
In summary, a small transmural difference in diastolic and peak systolic 
[Ca^‘*‘]i exists in sham myocytes, where [Ca^ '*']i was slightly higher in epicardial in 
comparison to endocardial myocytes. This difference was reversed in LVD myocytes 
(endocardial higher than epicardial). Comparisons between sham and LVD showed 
overall lower diastolic and peak systolic [Ca^^]i at all stimulation frequencies in the 
LVD data, reaching statistical significance in the epicardial data set. Both sham and 
LVD endocardial myocytes have similar diastolic and systolic [Ca^ '*']i although there 
is a tendency for lower values in the LVD data. In contrast, LVD epicardial 
myocytes have a significantly lower diastolic and systolic [Ca^ '*’]i in comparison to 
sham. This may reflect greater alterations in intracellular Ca^ "^  handling mechanisms 
in epicardial in comparison to endocardial LVD myocytes.
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Caffeine-induced calcium transients showed the same trend as electrically 
induced calcium transients, i.e. increasing peak systolic [Ca^ '*']i as stimulation 
frequency increased. Similar to the electrically induced Ca^ '*' transients, the LVD data 
showed overall lower peak systolic [Ca^^Ji in comparison to the sham data. LVD 
endocardial peak systolic [Ca^‘']i induced by caffeine was similar to sham whereas 
epicardial values were significantly lower.
Caffeine is used as an indicator of SR Ca^^ content and the data suggest sham 
and LVD endocardial SR Ca^ '*' content was similar whereas LVD epicardial content 
was significantly lower than sham.
Ratiometric differences between electrical and caffeine induced peak systolic 
(PS) [Ca^”^] (table 4.2) revealed no significant differences between endocardial and 
epicardial myocytes within experimental groups and between sham:LVD data sets. 
This data indicates that fractional release of SR Ca^ **" is similar irrespective of the 
mode of release (electrical or caffeine).
E SP SC a/C affP SC a Number of myocytes
Sham Endo 0.99 ± 0.02 17
Sham Epi 0.94 ± 0.02 14
LVD Endo 0.99 ± 0.02 26
LVD Epi 0.97 ± 0.02 20
Table 4.2. Ratio of electrically stimulated peak systolic Ca^^ (ES PS Ca) to 
caffeine induced peak systolic Ca^^ (Caff PS CA) In Sham and LVD 
endocardial and epicardial myocytes at 1 Hz. ANOVA analysis revealed no 
statistical differences between any of the data sets (p>0.05).
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Chapter 5 
Assessment of protein retrieval from cardiac homogenates
5.1. Background
This biochemical study was perfoimed to assess protein content and the 
efficiency of protein retrieval from homogenates of rabbit left ventricular 
myocardium and crude sarcoplasmic reticulum (SR) preparations derived from these 
samples. Left ventricular muscle samples were obtained from control (sham 
operated) hearts and those with left ventricular dysfunction (LVD). This study was 
also performed to compare homogenate and SR protein content between sham and 
LVD ventricular samples.
5.2. Methods
Initially, samples for protein assessment were prepared as desciibed in the 
general methods section (2.3.1) and stored in ice cold Ringer solution until use. Total 
protein content (mg ml"^) was assayed for homogenate and SR samples using the 
method described in 2.3.2 (chapter 2). Coomassie staining methods are described in 
section 2.3.4.1 (chapter 2).
5.2.1. Homogenate tissue samples for protein retrieval assessment
Transmural tissue sections of various weights (60, 125, 250, 500, lOOOmg) 
were dissected from the left ventricular free wall, blotted to remove excess Ringer 
solution (prevents overestimation of actual wet tissue weight) and resuspended in 10 
volumes of ice cold homogenisation buffer (see methods). Tissue samples were 
finely chopped with scissors and then homogenised for approximately 1 minute or 
until no tissue pieces were visible using either the Kimematica homogeniser for the 
large samples or the ultra-turrax Tg (IKA Labortechnik) for the smaller samples. 
From each of these homogenate suspensions, lOOpl was removed and frozen for 
future total protein analysis (total protein homogenate). Homogenate samples did not 
undergo any centrifugation therefore contained all ventricular proteins.
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5.2.2. Crude SR vesicles for protein retrieval assessment
Crude SR vesicles were prepared from homogenate samples (1000, 500, 250 
and 125mg). The protocol detailed in figure 5.1 is based upon the isolation technique 
by Chamberlain et a l (1983). All crude SR vesicle samples were used to calculate 
total SR protein content derived from wet weight homogenate samples of 1000, 500, 
250 and 125 mg.
The following solutions were used in the preparation of SR vesicles:
Precipitation buffer contained in mM: 300 Sucrose, 600 KCl, 20 Histidine, 10 
Imidazole, 1 DTT, and protease inhibitors; Leupeptin 5mg m l'\ Aprotinin lOmg ml ' 
at pH 7.2
Assay buffer contained in mM: 50 Tris base, 15 MgCl%, 0.1 EGTA (Ethylene 
glycolbis (P-aminoethyl ether) N,N,N,N’- tetraacetic acid, 1 DTT and protease 
inhibitors; Leupeptin 5mg m l'\ Aprotinin lOmg ml"' at pH 7.4
5.2.3. Statistical analysis
All data are expressed as mean ± SEM. Statistical analysis was performed 
using student t test and linear regression analysis. Results were considered significant 
at p<0.05.
5.2.4. In vivo left ventricular echocardiographic parameters
Mean ejection fractions were 51.4 ± 1.61 and 40.9 ± 0.41% for moderate 
(n=13) and severe (n=9) LVD groups respectively with a combined mean of 47.1 ± 
1.5% for the LVD group. Mean sham ejection fraction was 72.7 ± 1.9% (n=10). 
Mean LVEDD values were 21 ± 0.39 and 21.9 ± 0.33mm for moderate and severe 
LVD groups. The combined LVD group LVEDD was 21. 4 ± 0.3 and sham values 
were 17.7 ± 0.3mm.The above values were not statistically different from the mean 
EF and LVEDD values calculated for this whole study (table 2.1).
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Isolation of crude SR vesicles 
The SR preparation protocol is shown diagrammatically below (figure 5.1).
Homogenised LV tissue (10 volumes o f Homogenisation buffer (HB))
^  Removes;
Low speed spin - 8888 g for 20 min @4° C
Discard pellet, remove supernatant and repeat centrifuge ___
cellular debris. 
Connective tissue, 
nuclei
Rem ove supernatant and resuspend in HB
High speed spin -  49,654 g for 60 min @ 4^C mitochondria
Discard supernatant and resuspend pellet in 1ml o f precipitation buffer (PB)
Leave on ice for 15 min
I
Low speed spin -  2222 g for 15 min @ 4°C
actin and myosin
R em ove supernatant and resuspend in PB
High speed spin -  49 ,654 g for 60 min @ 4°C
Discard supernatant and resuspend pellet in Assay buffer (AB) 
(AB volume can vary depending on protein concentration desired)
i
Crude SR vesicle sample
Figure 5.1. Flow diagram of SR vesicle preparation protocol
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5.3, Homogenate verses SR total protein content
To assess the differences in protein content between homogenate and SR 
preparations, samples were subjected to gel electrophoresis and subsequent 
Coomassie staining. See general methods for protocol (chapter 2). A typical example 
of a Coomassie stained gel (figure 5.2) shows that overall, homogenate samples 
cover a large molecular weight range (25 to 200kDa) and have an abundance of 
proteins. In comparison, SR vesicle preparations possess fewer proteins overall and 
protein bands specific for SR proteins are more clearly defined. A lower protein 
density would be expected in SR preparations as these samples have undergone 
several centrifugal steps in order to remove excess cellular proteins such as 
connective tissue, actin and myosin and organelles such as mitochondria (figure 5.1).
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8Homogenate
I#
SR
I
markers
Molecular 
weight (kDa)
—  188 kDa
—  98 kDa
—  62 kDa
—  49 kDa
—  38 kDa
28 kDa
2.5 5 10 20 2.5 5 10 20 ng protein load
Figure 5.2. Typical example of a Coomassie stained Tris-glycine gel 
showing increasing protein loads (2.5 -  20 jag) of homogenate and SR 
samples. Molecular weight markers (kDa) are indicated with solid lines on 
the right hand side of the gel.
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5.4, Homogenate protein retrieval and quantiHcation
Left ventricular tissue samples weighing 60, 125, 250, 500 and lOOOmg were 
isolated and analysed to determine whether homogenate protein retrieval was 
comparable when calculated from a range of tissue wet weights. In all experimental 
groups a linear increase in absolute protein homogenate retrieval (mg) was observed 
as tissue sample size increased from 60 to lOOOmg (figure 5.3). This relationship was 
confirmed statistically by linear regression analysis and produced slopes of 0.10 ± 
6.4xlO"\ 0.10 ± 7.43xlO '\ and 0.09 ± 0.002, for sham, moderate LVD and severe 
LVD groups respectively (values are mean ± SEM). Analysis showed that no 
statistically significant difference in protein retrieval throughout the range of tissue 
weights (60 to lOOOmg) and between the three experimental groups (sham, moderate 
and severe LVD) was present. As no significant difference in protein retrieval was 
apparent between moderate and severe LVD samples (figure 5.3), data from these 
two groups were pooled and hereafter classed together as the LVD group.
Protein retrieval was also expressed per total homogenate protein (mg/g) and 
throughout the weight ranges and between groups no statistical differences were 
apparent (table 5.1). Total protein values in table 5.1 have been standardised to mg of 
protein retrieved per Ig of wet tissue weight.
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a .
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4 0
100060 125 250 500
LV tissue wet weight (mg)
Figure 5.3. Absolute homogenate protein (mg) retrieved from various left 
ventricular tissue weights (mg) isolated from 3 experimental groups; sham, 
moderate and severe LVD. Slope data are expressed as mean ± SEM. 
Statistical analysis produced r values of 0.9, 0.99 and 0.99 for sham, 
moderate and severe LVD groups respectively and p values of <0.001 (all 3 
experimental groups), n numbers as per table 5.1.
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Left ventricular wet weight (mg)
60 125 250 500 1000
Sham 103.2 + 13 91.2 + 19 100.7± 15102.5 ± 38 100.5±19
Total
Homogenate (n =4) (n =8) (n =8) (n =8) (n =11)
protein 
(mg/g)
LVD 102.8 ±23 87.2 ± 23 92.3 + 24 98.9 + 21 97.6 ± 26 
(n = 12) (n = 11) (n =14) (n = 19) (n = 19)
Table 5.1. Total homogenate protein retrieved (mg/g) per left ventricular 
wet weight sample (mg) in sham operated and LVD rabbit hearts. Data are 
expressed as mean + SD. n =indicates number of hearts.
These data suggest that homogenate protein retrieval via this protocol is reproducible 
even when using a broad range of tissue weights and that there were no significant 
differences in protein retrieval between sham and LVD preparations.
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5.5. SR protein retrieval and quantifîcation
All crude SR vesicles were isolated from homogenate samples of 125, 250, 
500 and lOOOmg as described in figure 5.1. Absolute SR protein retrieval showed a 
linear increase as tissue wet weight was increased from 125 to lOOOmg (figure 5.4). 
This relationship was confirmed by linear regression analysis which produced slopes 
of 6.8 ± 0.2 xlO'" ,^ 8.6 ± 0.4x10"" ,^ and 7.2 ± 0 .3x l0 '\ for sham, moderate LVD and 
severe LVD groups respectively (data are mean ± SEM). Again, no statistical 
differences in protein retrieval were observed between moderate and severe LVD 
preparations therefore the data were pooled and classed hereafter as the LVD group. 
The linear regression lines were fixed through zero, and it can be seen that the 
absolute protein content at 125 mg (all experimental groups) was less than the 
predicted value (figure 5.4).
Expressing SR protein retrieval in mg/g, showed no significant differences in the 
efficiency of protein retrieval in SR preparations isolated from samples weighing 
250, 500, and lOOOmg in both sham and LVD preparations. However, as seen in 
Table 5.2 and figure 5.4, SR protein retrieval from 125mg of both sham and LVD 
tissue samples was noticeably lower in comparison to the larger tissue samples 
although these values did not reach statistical significance.
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o Mod LVD 
□ Sev LVD
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E
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2
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125 250 500 1000
LV tissue wet weight (mg)
Figure 5.4. Absolute SR protein retrieved (mg) from various left ventricular 
tissue weights (mg) isolated from 3 experimental groups (sham, moderate 
and severe LVD). Statistical analysis produced r values of 0.99 for all 3 
experimental groups and p <0.001 (0.002, 0.0008 and 0.0005 for sham, 
moderate and severe LVD respectively), n numbers as per table 5.2.
I l l
Left ventricular wet weight (mg)
125 250 500 1000
Total SR Sham 0.42 ±0.21 0.65 ± 0.36 0.65 + 0.25 0.69 ± 0.26
Protein (n =8) (n =8) (n =8) (n =8)
(mg/g)
LVD 0.44 + 0.18 0.75 ± 0.27 0.77 ±0.31 0.83 ± 0.22
(n =10) (n =14) (n =16) (n =16)
Table 5.2. Protein content of SR fraction per gram wet weight of ventricle 
isolated from sham operated and LVD rabbit hearts. Values are means ± 
SD. n = indicates number of hearts.
Due to reduced SR protein retrieval efficiency below 250mg in both experimental 
groups, samples smaller than 250mg were deemed quantitatively unsuitable for SR 
vesicle preparations and further experimental purposes involving SR preparations.
Although linear increases in absolute homogenate and SR protein retrieval 
was associated with increasing tissue weight, SR protein content was some 100 fold 
smaller than that of the homogenate. This suggests that total SR protein is 
approximately 1% of total myocardial protein content in both normal and failing 
hearts. This value is comparable to that found in other studies (table 5.3). 
Quantification of homogenate and SR protein retrieval was performed by other 
research groups and has yielded similar results to those observed in this study (table 
5.3). Interestingly, Schwinger et a l 1995 and Frank et a l 2002 also found an 
increase in the amount of protein retrieved from SR failing preparations as opposed 
to non-failing, although no additional comments regarding this finding were 
mentioned.
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5.6. Homogenate protein variation
Examination of the data revealed a moderate amount of variation between 
tissue weights isolated from multiple samples in single hearts and those isolated from 
different hearts. Intracai'diac samples are defined as tissue samples isolated from 
within the same heart whereas intercardiac samples are preparations that have been 
isolated from different hearts.
Combining intra and intercardiac samples (sham & LVD) to calculate protein 
retrieval per gram wet weight produced a normal distribution curve (bell shaped) 
with a mean value of 95.68 ± 21.93 (SD) suggesting a mean protein retrieval of 
approximately lOOmg/g (figure 5.5, panel A). Differences between intracardiac and 
the combined intra/intercardiac data are representative of the intercardiac variation 
i.e. variation in protein retrieval between hearts. The mean relative intracardiac 
protein retrieval data produced a normal distribution curve with a mean value of 0.99 
± 0.19 (SD) (figure 5.5, panel.B). All tissue samples (60 to lOOOmg) were 
normalised to the protein retrieved from 1 gram wet weight. The combined 
intra/intercardiac data showed slightly more variation in protein retrieval in 
comparison to the intracardiac data although these differences were not statistically 
significant.
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A0  20  40  60  80  100 120 140 160 180 2 0 0
protein retrieved (mg) / gram wet weight
B
0.0  0 .2  0 .4  0 .6  0 .8  1.0 1.2 1.4 1.6 1.8 2 .0
Relative protein retrieval (intracardiac)
Figure 5.5. Protein retrieved (mg) per gram wet tissue weight (A) pooling both 
intracardiac and intercardiac samples (Mean 95.68 ± 21.93) and (B) relative 
intracardiac protein retrieval (Mean 0.99 ± 0.19). Intracardiac data are 
normalised to protein retrieved from 1 gram samples. Data are from all three 
experimental groups and are expressed as mean ± SD. A normal distribution 
curve is superimposed onto both histograms, confirming the normal 
distribution of the data.
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5.7. SR protein variation
Figure 5.6. shows SR protein retrieved (mg) per gram tissue wet weight for 
sham and LVD samples respectively. Both data sets consist of pooled results for 250, 
500 and lOOOmg samples. Each set shows a normal distribution pattern with a mean 
value 0.66 ± 0.28 and 0.76 ± 0.25 for sham and LVD data respectively. T-test 
analysis on the two data sets produced a p value of 0.075. Calculating SR protein 
retrieval directly from tissue wet weight is likely to introduce vaiiation into the data 
as there are many steps between the initial wet weight tissue sample and the final SR 
sample (figure 5.1). Therefore, variation in SR protein retrieval was conected for by 
calculating the SR protein retrieval directly from the absolute protein homogenate 
values (figure 5.7). Mean values were 0.61 ± 0.29 for sham and 0.81 ± 0.21 for LVD, 
p = 0.01. This analysis suggests that SR protein retrieval from LVD samples is 
significantly greater than that retrieved from sham samples.
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SR protein retrieval mg/g wet weight
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SR protein retrieval mg/g wet weight
P = 0.075
Figure 5.6. SR protein retrieved (mg) per gram tissue wet weight isolated 
from (A) sham and (B) LVD tissue samples. Data combines all SR protein 
retrieved from 250, 500 and lOOOmg (n=24). Data are mean ± SD. Number 
of animals: N=24 and 46 for sham and LVD samples respectively. Mean 
values were 0.64 ± 0.28 (sham) and (LVD) 0.76 ± 0.25, p =0.075. A normal 
distribution curve is superimposed onto both histograms (solid line).
117
LVD
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2,0 o.O 0.2 0.4 0,6 0.8 1.0 1,2 1.4 1.6 1.8 2.0
SR protein retrieval {mg/1 OOmg) SR protein retrieval (mg/1 OOmg)
P = 0.01
Figure 5.7. SR protein retrieved (mg) per 100mg sham (A) and LVD (B) 
homogenate. Data combines all SR protein retrieved from 250, 500 and 
lOOOmg samples Sham. Data are represented as mean ± SD. Mean values 
were 0.61 ± 0.29 (sham) and 0.81 ± 0.21 (LVD), p = 0.01. A normal 
distribution curve is superimposed onto both histograms (solid line).
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5.8. Discussion
5.8.1. Homogenate retrieval variation
The aim of this study was to assess the efficiency of protein retrieval in 
homogenate and SR samples produced from different tissue wet weights. The 
homogenate retrieval data suggests that it is possible to retrieve reproducible protein 
amounts (mg/g) from a large range of tissue weights (60 to lOOOmg). This 
reproducibility was present in both sham and LVD tissue samples (table 5.1 and 
figure 5.3).
The results show that there is a moderate, yet similar amount of both intra and 
intercardiac variation in total protein homogenate content (figure 5.5). Such variation 
may arise from either differences in connective tissue content or in the 
homogenisation technique. Differences in connective tissue content seem unlikely as 
the amount of connective tissue throughout an individual heart should be uniform 
and would therefore not influence protein content. Therefore the most likely reason 
for the intracardiac variation is via differences in homogenisation technique. 
Potential vaiiables in the homogenising technique were temperature, speed, 
resuspended volume, and homogenisation time. All of these variables were constant 
for each sample except for the homogenisation time. Homogenisation times varied 
slightly depending on how well the chunks of tissue were broken up, i.e. a longer 
time would be necessary if non muscle tissue (connective tissue) prevented adequate 
homogenisation of muscle tissue. Furtheimore, differences in homogenisation time 
could alter sample viscosity, i.e. increased viscosity of sample if homogenisation 
time was inadequate. The more viscous a sample is the greater is the potential for 
pipetting errors, i.e. a reduced volume of sample being drawn up. Such pipetting 
error may be sufficient to produce quantifiable differences in calculated protein 
content. Excessive connective/adipose tissue was removed from the epicardial 
surface of all hearts to minimise variation in the homogenisation time required.
In addition, inaccuracies in the protein assay itself may influence protein 
content values. Protein concentration is deteimined using a calibration curve 
produced by BSA standards (general methods, 2.3.3). To minimise intracardiac 
variation, samples from the same heart were assayed on the same plate using one 
particular standard curve. Variation within individual plates would influence all of
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the samples on each plate and could not explain the observed intracardiac variation. 
As calibration curves vary between plates variation in protein determination is 
inevitable, this may account for some of the observed intercardiac variation. 
Furthermore, additional errors may be introduced to both intracardiac and 
intercardiac samples as the mean of 3 optical density readings were calculated per 
sample, plus the mean of up to 3 optical density readings were calculated for various 
sample dilutions to produce the final protein concentration. Variation within any or 
all of these triplicate samples is likely to influence the final protein concentration 
reading, and hereafter any analysis performed on the data, i.e. calculating means.
In summary, the observed intracai’diac variation is most likely due to 
variation in the homogenisation technique i.e. homogenisation time, combined with 
the variation produced when the mean of the optical density measurements are 
calculated. Intercardiac variation is most likely due to variations present within 
calibration curves and when calculating the mean of the optical density 
measurements. Figure 5.5. suggests that there are no significant differences in the 
amount of protein retrieved from different samples within one heart, than that which 
can be retrieved from samples from many different hearts. This suggests that protein 
content between hearts iiTespective of experimental type i.e. sham or LVD is similar. 
In addition, protein retrieval from a range of tissue weights yields comparable protein 
levels.
5.8.2. SR retrieval variation
SR protein retrieved from both sham and LVD tissue samples was 
comparable throughout tissue weights between 250 and lOOOmg although a tendency 
for higher LVD SR protein retrieval was observed. SR protein retrieval was slightly 
lower in 125mgs samples (table 5.2 & figure 5.4). This reduction in SR protein 
retrieval suggests that a moderate amount of error is introduced in the efficiency of 
protein retrieval when samples weighing less than 250mg are used. All tissue 
samples irrespective of weight were resuspended in xlO volumes of homogenisation 
buffer, therefore it follows that, the smaller the original tissue sample the smaller the 
volume of buffer it is resuspended in. The SR isolation protocol involved many steps 
and any loss of the resuspended sample (via pipetting or sticking of sample to the 
side of centrifuge tubes) would disproportionately affect the protein content retrieved
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in smaller rather than larger volume samples. This may account for the decreased 
protein retrieval observed from 125mg samples. An additional factor may be the 
introduction of error when calculating protein content via the actual protein assay, as 
discussed earlier (homogenate retrieval variation). However, this error is likely to 
occur throughout all samples and is unlikely to be totally responsible for the 
decreased protein observed only in 125mg samples. For that reason, it was concluded 
that reduced SR protein retrieval at 125mg most likely arises from errors produced 
whilst dealing with small volume samples, rather than small variations introduced by 
assay and calculation techniques. Taking this into account, tissue samples less than 
250mg were deemed unsuitable for experimental purposes involving SR preparations 
due to the inaccuracy of calculating actual protein content, e.g. quantitative 
assessment of SR proteins.
5.8.3. LVD vs sham SR retrieval
Overall SR protein retrieval was greater in LVD samples than in sham 
samples although these values are not statistically significant when calculated in 
mg/g wet weight (table 5.2 & figure 5.6). As all samples underwent the same 
preparation technique, and these results were the mean value of 16 samples it seems 
unlikely that the retrieval differences could arise from minor technical differences. 
Due to the multiple steps required to produce SR vesicles from tissue homogenates, 
SR protein retrieval was calculated directly from absolute homogenate values 
therefore reducing variation introduced by multiple preparation steps (figure 5.7). 
Statistical analysis comparing these results showed that SR protein retrieval from 
LVD samples was significantly greater (p<0.05) than from sham samples. Such a 
significant difference could not be accounted for simply by the observed small 
technical variation.
The question that now arises is: Why is SR protein retrieval greater in LVD samples 
in comparison to sham samples?
One possibility is that LVD tissue samples may in fact possess a higher SR 
protein amount per weight of tissue than sham samples. As LVD myocytes are 
known to hypertrophy during the compensatory phase of heart failure (Gerdes et al. 
1992; Bryant et a l  1997; McIntosh et a l 1999 & 2000) it is possible that the size of 
their intracellular organelles would increase to compensate for such enlargement.
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Therefore, the proportion of SR protein would remain constant per weight of tissue. 
Alternatively, the amount of SR protein in LVD samples may in fact be 
disproportionately smaller in comparison to sham samples as connective tissue 
content may be increased in LVD due to compensatory mechanisms (Schaper & 
Schaper, 1986; Olivetti et al. 1994). Ultracentrifugation steps during the SR vesicle 
isolation protocol (figure 5.1) removes excess intracellular organelles and connective 
tissue, therefore in LVD samples more protein, in the form of connective tissue 
would be removed leaving a reduced SR protein retrieval for any given wet weight. 
As this is not observed, it appears that greater SR protein is present in LVD tissue 
samples despite a potential increase in connective tissue protein content. To further 
explain these results additional biochemical investigations would be required.
In conclusion, homogenate protein retrieval from a variety of tissue weights 
(60 to lOOOmg) and hearts (sham and LVD) yielded comparable protein amounts. No 
significant differences in protein retrieval were observed within or between heart 
samples in both sham and LVD samples. The minor differences in protein retrieval 
within samples was most likely caused by variations in the homogenisation technique 
and/or the accuracy of the protein assay, rather than actual differences in tissue 
protein content.
SR protein retrieval (mg/g) throughout a range of tissue weights (250 to lOOOmg) 
was greater in LVD samples in comparison to sham. These values were significantly 
higher when SR protein retrieval was calculated directly per lOOmg protein retrieved. 
Furthermore, SR preparations below 250 mg produced less than predicted amounts 
of protein retrieval due to inaccuracies when dealing with such small sample 
volumes.
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Chapter 6 
Quantification of protein expression using Western Blotting
As with many experimental techniques variability is introduced into the data 
by the technique itself. Western blotting is no exception. This chapter highlights the 
major sources of variation observed within this technique and details the 
experimental approach taken in order to minimise this variation hereafter optimising 
the technique and subsequent quantification. A variety of internal nonnalisation 
sources were also investigated.
6.1. Methods
The protocol for Western Blot technique and Commassie stained gels are 
described in the general methods (2.3.4).
6.1.1. Reproducibility of Western Blots
6.1.1.1. Assessment o f experimental variation
SDS“polyacrylamide gel electrophoresis was performed on the same protein 
sample loaded in duplicate, i.e.lpg protein load across one gel. Normal transfer and 
subsequent probing for SERCA and calsequestrin proteins were earned out to assess 
the homogeneity of protein loading, transfer and antibody binding across the gel. 
This protocol was performed on two separate homogenate samples.
Assaying identical samples (complete western blotting procedure) i.e. 2 gels 
loaded with identical samples, assesses the amount of variation produced within one 
experiment (intra variation). All solutions, running, and transfer times were identical 
therefore nanowing any final variation in the blots to either pipetting, protein transfer 
or antibody binding. The same samples were also electrophoresed on different days 
to assess daily variation (inter variation).
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6.1.2. Sources of normalisation
PAGE was performed on 2 identical gels run in parallel followed by 
Coomassie staining of one gel (untransfened) and normal Western blotting of the 
other. Individual protein content (SERCA/NCX/CSQ) and total lane protein content 
were calculated using optical density measurements as described in section 2.3.5. 
Total lane protein as a normalisation source for individual proteins was also assessed.
6.1.3. Statistical Analysis
All data are expressed as Mean ± SEM unless stated otherwise. Paired 
students /-tests were used to compare two groups and ANOVA multi variant analysis 
(parametric) was used to compare multiple groups. A value of p<0.05 was 
considered statistically significant.
124
6.2. Sources of experimental variation
Accurate quantification of individual proteins within tissue homogenates is a 
difficult task and variation may be introduced at several different stages.
These include:
• Homogenisation of tissue sample
• Assay for total protein content
• Sample preparation for electrophoresis
• Sample loading into gels
• Electroblotting of proteins from gel to nitrocellulose membranes (protein
transfer)
• Primary and secondary antibody binding
• Optical density measurements
Repetitive loading of a tissue homogenate sample (Ipg protein load) across a
gel was performed to assess variation in sample loading, protein transfer and
antibody binding (figure 6.1). Two separate tissue samples (1& 2) were run on two 
separate gels. Figure 6.1 shows the results of both gels. Panel A in figure 6.1 shows 
the variation in optical density of a largely untransfened protein (~200kDa molecular 
weight) observed in a Coomassie stained gel (stained after protein transfer). This 
graph shows minimal variation in optical density across the 15 well gel suggesting 
that sample loading was both accurate and reproducible. The Coefficient of variation 
(CV) (S.D./Mean) of the optical density was used to assess the degree of variation 
within each data set. CV of 0.09 and 0.05 were calculated for samples 1 and 2 
respectively. The small variation present may be due to either loading enor or 
inhomogeneity of the Coomassie staining. Additional evidence verifying accurate 
sample loading is shown in figure 6.2. In this example, a linear relationship exists 
between optical density and protein load, i.e., doubling the protein load doubles the 
optical density.
Panels B and C in figure 6.1 show the variation in optical density of 2 homogenate 
samples probed with SERCA and calsequestrin antibodies. Optical density variation 
was random for both experimental samples (1& 2) and protein detection across the 
gel suggesting that protein transfer and antibody binding does not depend on the
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region of the gel. Antibody binding affinity is similar irrespective of antibody type 
and all areas of the nitrocellulose membrane appear equally exposed to the antibody 
solution. CV ranged between 0.25 and 0.11 for calsequestrin (sample 1& 2) and 
between 0.24 and 0.18 for SERCA (sample 1& 2). Since minimal variation is 
observed when loading reproducibility alone is assessed (0.05 -0.09), and the 
variation in optical density measurements increases considerably (almost doubles) 
after protein transfer and antibody incubation, these results suggest that the majority 
of variation found within this technique is introduced during protein transfer and 
antibody binding stages.
In a limited number of experiments, identical samples were assayed 
(complete western blotting procedure) on the same and different days to investigate 
the intra experimental variation (2 gels (same sample), same day) and inter 
experimental variation (same samples, different days) of this technique. CV in 
optical density readings from gels run on the same day and those run on different 
days were comparable. Inter-CV values ranged from 0.4 to 0.56. As CV did not 
differ markedly between daily experiments (inter) this again suggests that the largest 
amount of variation arises from the assay technique itself. An additional source of 
variation may be introduced from incomplete homogenisation of the tissue sample. 
Microscopic pieces of non-homogenised tissue within the sample solution may lead 
to inaccuracies in volume loading (see chapter 5).
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Figure 6.1. Repetitive loading of a 1|ig protein sample across one gel. Two 
separate samples (1 & 2) were loaded and run on separate gels. Panel A is 
the resulting Coomassie stained gel after protein transfer. Nitrocellulose 
membranes were probed with Calsequestrin (B) and SERCA (C) antibodies. 
Co-efficient of variation (SD/mean): Coomassie variation; 0.09 and 0.05; 
calsequestrin variation; 0.25 and 0.11; SERCA variation; 0.24 and 0.18 for 
samples 1 and 2 respectively.
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Figure 6.2. Linear relationship between optical density and protein load (|ig). 
Data shown is from Sham; endocardial and epicardial and LVD endocardial 
and epicardial samples.
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6.3. Normalisation of optical density measurements
At the beginning of this study it was the intention to normalise all protein 
expression data (sham endocardial /epicardial and LVD endocardial /epicardial) to 
the calsequestrin values of one sample within each gel. This normalisation was 
considered suitable as it is generally accepted in the literature that calsequestrin 
expression is unchanged in heart failure or left ventricular dysfunction (Movesian et 
al. 1994; Meyer et al. 1995; Schwinger et al. 1999). However, it has come to light in 
this study that this rabbit model of LVD was associated with a marked increase in 
calsequestrin protein expression. Furthermore, small transmural differences in 
calsequestrin expression were also observed in both sham and LVD samples (chapter 
7). In agreement with this study, a recent paper by Naqvi et al. (2001) observed 
increased calsequestrin expression in their rabbit aortic banding model of 
hypertrophy. In contrast, Prestle et al. (1999) observed no changes in CSQ 
expression between either endocardial and epicardial myocardium or between non 
failing and failing human heart samples.
As calsequestrin appears to change across the ventricle wall (endocardial to 
epicardial) and between experimental groups it was considered unsuitable as a 
normalisation standard. Unfortunately, the unsuitability of calsequestrin as a standard 
was only discovered in the latter stages of this study when sufficient experiments had 
been performed to observe the changes in calsequestrin expression. As a result, 
alternative normalisation sources were investigated only towards the end of the 
study.
The following normalisation options were investigated;
6.3.1. Normalisation using a nominal protein load
Normalisation of protein optical density to the nominal protein load is a 
commonly used way of normalising data. In this study, nominal protein loads of 
0.5,1 and 2 pg were used. Sample protein content was calculated using the Bradford 
method and BSA as standard (2.3.3).
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6.3.2. Normalisation using relative lane protein
Another alternative was to run 2 identical gels in parallel, protein transfer was 
performed on one gel only whilst the other was stained with Coomassie stain. 
Staining an untransfened gel allows quantification of the total protein content found 
within each lane. It was thought that the total lane protein could be used to normalise 
the optical density of the protein bands, which were developed from the parallel 
transferred gel. These stained gels were also used to assess the accuracy of protein 
loading. As figure 6.2 shows, a linear relationship exists between protein content and 
optical density.
It is worth noting at this point that absolute protein content in each sample 
loaded may differ slightly from the total protein content calculated per lane due to 
the running conditions of the gel. Differences in gel running conditions determine 
how far the dye front migrates down the gel and how much sample enters the gel 
from the wells. In short, some lower molecular weight proteins may migrate off the 
gel and higher moleculai* weight proteins remain unresolved at the top end of the gel. 
Therefore, the estimate of total protein per lane is based on the running conditions of 
the particular gel and not solely on how much protein is actually loaded.
6.3.3. Normalisation using a non transferred protein band
Gels were stained after protein transfer and it was observed that consistently a 
200 kDa protein remained on the gel. This largely nontransferred protein was 
subsequently investigated as a normalisation standard.
6.3.4. Comparisons between normalisation sources
In this study, protein loads ranged by a factor of 4; 0.5 to 2pg. A range of 
protein amounts was assessed prior to beginning experiments to find the optimum 
signal achieved under our standard immunoblot conditions. In order to allow 
multiple sample comparisons to be made across an individual gel only 3 different 
protein loads were used; 0.5, 1 and 2 pg.
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The importance of using a suitable normalisation source is highlighted in 
figure 6,3, This figure shows the results of nitrocellulose membranes probed with a 
monoclonal antibody against SERCA. Panel A shows the optical density plotted 
against the nominal protein loads (0.5, 1,2 pg). This graph suggests that for the sham 
2pg protein load, SERCA optical density is higher in epicardial than endocardial 
samples. Normalising this same data to total lane protein from the parallel stained gel 
is shown in panel B. This graph suggests that the higher optical density reading in the 
epicardial data was due to a larger amount of SERCA present in this sample. This 
high content was present despite an apparent lower total protein load in epicardial 
compared to endocardial sample; 12 as opposed to 18 optical density units. This 
result itself is feasible, however if you then compare SERCA optical density against 
the stained 200 kDa band from the same gel then the results appear quite different. 
Normalising SERCA optical density to the optical density of the 200 kDa band from 
the same gel suggests that the optical density of the epicardial sample is higher than 
endocardial because the actual protein loaded into the gel was greater. This is 
expressed as a higher optical density reading; 0.15 compared to 0.13. It appears that a 
small amount of variation is present between the 2 apparently identical gels. 
Furtheimore, when comparisons of the 200 kDa protein bands were made between 
the transfeiTed and the untransferred gels differences in optical density were present. 
It is the generally accepted view that optimum protein transfer occurs within the 
middle area of the gel (top to bottom). Under these running conditions minimal 
transfer occurs at the 200 kDa level therefore minimal differences in optical density 
should exist between the transferred and non transfened 200 kDa protein band. As 
small differences in optical density were observed this confinns along with the 
different normalisation results (figure 6.3) that variation in the loading between gels 
had occuned. This variation is most likely due to errors in micropipetting and or 
microscopic tissue pieces affecting the final loading volume. These results indicate 
that normalisation to total lane protein from a separate gel albeit a supposed 
“identical” gel is not accurate.
Clearly, very different conclusions can be drawn regarding protein expression 
depending on the normalisation source. Ideally, normalising to a protein within the 
same lane on the same gel is the most accurate as this corrects for non-uniformity in 
protein loading between different lanes and gels.
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Due to the problems of finding a suitable normalisation standard in this study, 
protein optical densities were normalised to the nominal protein load. Nominal 
protein load is commonly used in the literature as a standard and the variation was 
not too dissimilar to the 200 kDa therefore it was chosen as the normalisation 
standard for this study. The slopes of the linear regression lines fitted to the data at
0.5, 1 and 2 |Lig determined the relative protein content of each sample.
Some non-linearity was observed in the optical density readings when the 
sample loads were doubled (figure 6.3). Such non-linearity was observed in many of 
the samples analysed. This non-linearity may be due to several factors. Pipetting 
errors should be minimal, as each volume added is simply double that of the previous 
sample. However, microscopic pieces of unhomogenised tissue may affect the actual 
volume drawn up giving rise to some variation. Homogenisation efficiency varies 
depending on technique. In addition, low optical density readings have a greater 
signal to noise ratio and high optical density readings may saturate the analysis 
system producing variability in these readings. Therefore, the inability of the 
densitometer to resolve small differences in optical density values at high and low 
readings may also add to the variation observed in the data.
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6.4. Future technical improvements
Taking into account the sources of variation found within this Western 
Blotting technique current and future experiments have been modified to minimise 
where possible these sources.
Some of the most important modifications regarding protein normalisation will now 
be discussed. As detailed in the last section, protein normalisation is best achieved by 
normalisation to a specific protein/s within the same lane and/or gel as the 
experimental samples. This is the most accurate method as it corrects for non­
uniformity in protein loading within different gels.
6.4.1. Single protein normalisation
A known amount of a purified protein run along with experimental samples 
(same gel) can be used as a normalisation standard. Purified proteins can be acquired 
from collaborators in other labs or bought commercially, although choice may be 
limited. It is also possible to make ones own purified proteins, however this depends 
on technical expertise and resources within the lab. As an alternative, nomialisation 
to other proteins found in the tissue type being studied can be used. Proteins such as 
myosin, actin and GAPDH are commonly used as normalisation proteins. 
Normalisation proteins must be in a similar molecular weight range to the proteins 
that are being probed for in order that they can be run under the same gel conditions. 
However, their molecular weight must be sufficiently different to the proteins being 
investigated to allow adequate resolution of individual protein bands. Ensuring 
adequate band resolution avoids the additional problems associated with having to 
strip the nitrocellulose membrane of one antibody prior to incubation with another in 
order to determine protein expression. Unchanged protein density must be confirmed 
within the tissue sample or region of interest before any protein can be used as 
normalisation protein.
Alternatively, samples within each lane may be “spiked”, i.e. a known 
amount of a specific protein (labelled or unlabelled) can be added into each lane 
along with the experimental sample and subsequently used as a normalisation source.
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6.4.2. Total lane protein normalisation
Commercial stains such as Amido black (Biorad) are also available which can 
be used to stain the nitrocellulose membrane after probing with protein antibodies. 
This solution stains all proteins on the nitrocellulose membrane and allows 
quantification of total lane protein content. Normalisation to total protein on a lane to 
lane basis can then be performed. Recently, a new stain called RedAlert (Novagen) 
has become commercially available. In this case the nitrocellulose membrane is 
stained and total lane protein quantified prior to probing with antibodies. The 
advantage of both these methods is that normalisation is performed on the same 
nitrocellulose membrane from which the protein optical density readings are 
calculated. The suitability of both these stains would have to be assessed prior to use.
6.4.3. Use of Radiolabelled isotopes
An alternative experimental approach to quantifying individual protein 
expression is via the use of radiolabelled antibodies. The whole Western Blot 
procedure up to and including primary antibody incubated is the same as the 
Immunoblot technique. However the secondary antibody is conjugated with a 
radioactive isotope as opposed to Horseradish peroxidase used in the immunoblot 
technique. Radioactive decay is measured using a phosphoimager and is used as an 
indicator of protein expression. Again, the advantages and disadvantages of this 
technique would have to be investigated prior to use.
6.4.4. Linear protein detection range
To assess the linearity of the optical density/protein load relationship a large 
range of protein amounts (pg) can be loaded across one gel from a single sample. 
The complete Western Blotting procedure is performed and the data analysed. This 
establishes the linear range of protein detection. Optimum protein loading can be 
calculated by this method. The optimum protein load would have to be detennined 
for every individual protein that was to be studied. It may also verify if particularly 
low or high optical density are disproportionately influenced by resolution 
limitations and/or high signal to noise ratios.
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6.4.5. Additional points
As highlighted in Chapter 5 the homogenisation procedure used in this study 
was not ideal for the tissue type under investigation. Currently, a new 
homogenisation technique using a Mixermill (Qiagen) is being tested. Preliminary 
evidence suggests that this technique fully homogenises ventricular tissue samples, 
thereby minimising residual pieces of tissue within the solution.
Electroblotting of proteins from the gel to nitrocellulose membranes was 
optimised by using two blot modules instead of one. Earlier experiments had 
observed an inconsistency in protein transfer between the gels depending on their 
position in the blot module.
Variation caused by the transfer process and antibody binding appear to 
introduce the largest sources of variation. The wet transfer system used in this study 
produced a more homogeneous transfer than the alternative semi dry system, 
therefore is more accurate and was used in this study.
In this study the mean Coefficient of variation (SD/Mean) in the protein 
expression data was 0.76. Using statistical power calculations (Instat statistical 
program, assumes mean of 1) it was estimated that in order to detect a 40% 
difference in protein expression at the 5% significance level n =29 would be 
required. To detect a 10% difference at the same significance level (5%) requires n = 
454. For example, no significant difference in endo/epicardial LVD CSQ expression 
was detected even though the increase in expression was 35 -  43% higher than sham. 
Power calculations estimated n = 29 would be required to detect this difference. 
Endocardial/epicardial CSQ data was n =18 and 15 (respectively), consequently, 
with the observed error present in the data this number was insufficient to detect a 
40% difference in expression. Sample numbers would approximately have to be 
doubled in order to detect a 40% difference.
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6.5. Summary
Sources of variation within this Western Blotting technique include; protein 
assay, sample preparation and loading, electroblotting of proteins, antibody binding 
and optical density measurements.
It was concluded from this study that the major sources of variation arise 
from the electroblotting and antibody binding stages of the Western blotting 
technique.
Some sources of variation can be minimised by:
• Adequate homogenisation of tissue sample.
• Ensuring that protein sample readings are taken on the straight line section of the 
protein calibration curve and not at the highly non-linear sections of the curve.
• General consistency and accuracy in solution making, sample preparation, 
pipetting, running/transfer buffer solution levels, antibody dilutions, and adequate 
submerging and mixing of nitrocellulose membranes within antibody solutions.
• Ensuring optical density measurements are on the linear section of the optical 
density /protein concentration curve.
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Chapter 7
Quantification of cardiac Ca^  ^handling proteins
7.1. Background
Precise regulation of intracellular [Ca^^] is critical for normal cardiac 
contractile function. There are several key proteins involved in the regulation of 
intracellular [Ca^ '*'] within cai'diac myocytes. This study aimed to quantify protein 
expression of three of these proteins, calsequestrin (CSQ), SR Ca^^-ATPase pump 
(SERCA2) and the sarcolemmal sodium-calcium exchanger (NCX). Expression of 
these three proteins was compared between endocardial and epicardial regions within 
each experimental group (sham & LVD) and between sham and LVD tissue samples.
The most commonly used and simplest method of quantify protein expression within 
tissue samples and the technique used in this study is via the Western blotting 
technique (general methods, 2.3.4,),
Calsequestrin (CSQ)
CSQ is a small protein with a molecular weight of 53kDa. CSQ is a relatively 
easy protein to quantify as it is stable, i.e. not particularly susceptible to proteolysis 
and the antibodies currently available against CSQ are fairly specific (i.e. minimal 
non-specific binding occurs). Using Western blotting, most current literature reports 
that CSQ protein expression is unchanged in human heart failure and left ventricular 
dysfunction (Takahashi et al. 1992; Meyer et al. 1995; Schwinger et al. 1999; Prestle 
et al. 1999). However, the results of animal studies are less well defined. In a rat 
animal model of cardiac hypertrophy CSQ mRNA levels were found to be 
unchanged over a range of severity of cardiac hypertrophy (Arai et al. 1996). In 
contrast, a recent study by Naqvi et al. (2001) observed a 65% increase in CSQ 
protein expression in their rabbit model of cardiac hypertrophy. In a separate rabbit 
cardiac hypertrophy study, Matsui et al. (1995) observed a decrease in mRNA for 
CSQ.
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SR calcium-ATPase pump (SERCA)
SERCA is classed as a medium sized protein with a molecular weight of 
1 lOkDa. Similar to CSQ, SERCA is a reasonably stable protein, and the monoclonal 
antibodies currently available against SERCA are specific. Generally SERCA 
expression in human heart failure and animal models of failure and LV dysfunction 
shows a decrease in both protein and mRNA expression (Hasenfuss, 1998 and 
Ravens, 2000, for reviews). Again animal model results are less defined, decreases in 
SERCA protein expression (O’Rourke et al. 1999) and SERCA mRNA expression 
(Matsui et al. 1995) have been observed. In contrast, Pogwizd et al. (1999) observed 
no change in SERCA protein or mRNA in their pressure overloaded rabbit model of 
heart failure.
Sodium-calcium exchanger (NCX)
NCX protein expression has been difficult to quantify in general as it is not 
abundant and is relatively unstable during sample preparation i.e. proteolysis 
commonly occurs. A wide range of protease inhibitors was used during sample 
preparation in an attempt to minimise proteolysis, however this does not completely 
overcome the problem (see general methods). Throughout the literature several 
protein bands are reported to be associated with the NCX protein when heart 
preparations are assayed and even today the exact nature and function of the 
individual protein bands remains controversial. Gel electrophoresis reveals several 
major protein bands running at 70, 120 and 160 kDa (Philipson et al. 1988; and Iwata 
et al. 1995; Shigekawa & Iwamoto, 2001). The exact origin of the 120 and 160 kDa 
protein bands remains unknown. It is possible that they represent two different 
confoiTnational states of the one protein although it remains unclear which is the 
native protein. The 160 kDa may represent an altered confonnational state of the 120 
kDa protein due to sample preparation for SDS-PAGE, this changed conformational 
state leads to an alteration in protein migration rate (Durkin et al. 1991). The 160 
kDa protein appears under reduced (Durkin et al. 1991, Iwata et al. 1995) and non­
reduced conditions (Philipson et al. 1988) and its origin has been proposed to be 
either a combination of 70 and 120 kDa protein dimers (Philipson et al. 1988) or may 
reflect glycosylation of the 120 kDa protein (Nicoll et a l 1990; Iwata et a l 1995). 
Evidence suggests that the 70 kDa protein is an active proteolytic fragment, most 
likely from the 120 band (Philipson et a l 1988, Saba, Bollen & Herchuelz 1999).
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It is thought that either of the 120 and the 70 kDa proteins represents the main 
functional units of the NCX. Commonly quantification of immunoblots from both 
protein bands are combined and reflect NCX protein expression. Throughout this 
study, NCX protein expression combined optical density measurements calculated 
from both the 120 and the 70 kDa protein bands. In this study a polyclonal antibody 
was used as the currently available monoclonal does not pick up the 70kDa band.
NCX protein expression in heart failure (human & various animal models) remains 
controversial as studies have either observed no change (Schwinger et al. 1999; 
mRNA; Prestle et al. 1999) or an increase in protein (Reinecke et at. 1995; O’Rourke 
et al .1999; Pogwizd et al. 1999) and mRNA expression (Studer et al. 1994; Pogwizd 
et al. 1999).
7.2. Experimental approach
Tissue preparations and solutions used in the experiments described in this 
chapter are detailed in the general methods (chapter 2).
Throughout this study, 15 well gels were used to allow multiple sample 
comparisons to be made across an individual gel. For all 4 experimental samples 
(sham; endo/epi; LVD endo/epi) protein amounts of 0.5, 1 and 2|Lig were loaded into 
the gels. These protein loads were used as they produced readings within the 
optimum optical density range. Typical examples of some developed 
autoradiographs showing the gel set up are shown in figure 7.1. Gradient values were 
calculated for all experimental samples using these three protein loads. Examples of 
gradients calculated from these protein loads (0.5, 1 & 2pg) are shown in figure 7.2. 
Gradients were calculated for CSQ, SERCA and NCX proteins using sham 
endocardial and epicardial homo gen ate samples. In order to maximise the accuracy 
of the Western measurements (see chapter 6) protein results were expressed relative 
to either another sample within the gel (eg. endo: epi) or to another protein developed 
from the same gel (NCX:SERCA). Subsequent analysis directly compared sham and 
LVD transmural (endo/epi) and Sham/LVD (endo & epi) gradient differences. These 
ratios values reflect the relative protein expression of CSQ, SERCA and NCX.
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7.2.1. Statistical analysis
All data aie expressed as mean ± SEM. Statistical analysis was performed 
using either students t tests or ANOVA (repeated measures, parametric). p<0.05 was 
considered statistically significant.
7.2.2. In vivo left ventricular echocardiographic parameters
Mean ejection fractions were 72.2 ±1.8 and 44.0 ± 1.6% with LVEDD values
of 17.3 ± 0.3 and 21.4 ± 0.3mm for sham (n=10) and LVD hearts (n=20) 
respectively. These values were not significantly different from the mean ejection 
fraction and LVEDD values calculated for this whole study (table 2.1).
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7.3. Protein expression results
A  CSQ gradients; endo & epi
0.10-1
■ Endo 
□ Epi
0 .0 8 -
ë '  0 .0 5 -
0 .0 3 -
0 .0 0 -
-0.03
1.5 2,00.0 1.0 2.5- 0.5 0.5
Nominai protein load (pg) 
B SERCA gradients: endo & epi
0 .20-1
■ Endo
t  0.10- 
Ii
—  0 ,0 5 -
o
0 .0 0 -
1.5 2.0- 0.5 0.0 1.0 2,50.5
Nominal protein load (pg) 
C NCX gradients: endo & epi
0 ,4-1
■ Endo
0 .3 -
I 0.1 -
0 .0 -
- 0.1
2.00.0 0.5 1.0 1.5 2,5-0.5
Nominal protein load (pg)
Figure 7.2. Typical examples of gradient values calculated from three protein 
loads for CSQ, SERCA & NCX. The examples shown are sham endocardial 
and epicardial samples.
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7.3.1. Calsequestrin protein expression
Transmural or epi/endo ratios for CSQ protein expression are shown in panel 
A of figure 7.3. As reference, a ratio value of 1.0 shown as the dotted line represents 
equal epicardial CSQ expression. It follows that, a ratio value of less than 1.0 
indicates lower epicardial protein expression whereas a ratio value more than 1.0 
indicates higher epicardial protein expression. Panel A shows that both sham and 
LVD epicardial CSQ expression is lower than endocardial by approximately 9 ± 8 % 
(sham) and 1 ± 1  % (LVD). Comparisons between sham and LVD CSQ expression 
are shown in panel B. Both LVD endocardial and epicardial data showed a large 
increase in CSQ expression of 43 ± 19% (endocardial) and 35 ± 18% (epicardial). 
This increased expression although marked was not statistically significantly using 
ANOVA analysis. As no significant transmural difference in CSQ expression was 
observed endocardial and epicardial data could be treated as one homogeneous 
population (i.e. could be combined as one data set). The combined LVD data showed 
a significance increase in CSQ expression of 39 ± 13% (p< 0.001) in comparison to 
sham.
It is worth noting at this point that combining endocardial and epicardial data 
does not necessarily reflect the results that assaying CSQ expression from whole 
transmural left ventricular samples would yield. This is because the combined 
endocardial and epicardial data represents only a small portion of left ventricular 
mass and does not contain mid myocardial sample data which makes up the majority 
of the left ventricle. It is possible that assaying CSQ expression in ventricular 
homogenate samples from the whole left ventricle may show different results. To 
date this assay has not been perfoi*med on this rabbit LVD model.
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7.3.2. SERCA protein expression
Transmural (epi/endo ratio) SERCA protein expression showed no difference 
in both sham and LVD data, i.e. all ratio values are approximately one. Comparisons 
between sham and LVD data revealed a small decrease in SERCA expression in both 
LVD endocardial (8 ±11%) and epicardial data (8 ±10%). This was not statistically 
significant (ANOVA). Again, treating endocardial and epicardial data as one 
homogeneous population revealed a significant decrease in LVD SERCA expression 
of 8 ± 7% (p< 0.05) (figure 7.4).
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EPI/ENDO ratio for CSQ
O 0.8
Q.
LU 0.2
(n=20)
SHAM
(n=20)
LVD/Sham ratio for CSQ
1.0 -
0 .8 -
E
CO
0.6  -œ
§  0 .4 -
(n=15)
ENDO 
(n=18)
Figure 7.3. Transmural (epi/endo) and LVD/Sham ratios for calsequestrin
expression are shown in panels A and B respectively, n denotes number of
hearts.
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EPI/ENDO ratio for SERCA
m  0.8
LU 0.2
n=18
SHAM
(n=19)
B LVD/Sham ratio for SERCA
CC 0 . 4
(n=17)
ENDO
(n=17)
Figure 7.4. Transmural (epi/endo) and LVD/Sham ratios for SERCA
expression are shown in panels A and B respectively, n denotes number of
hearts.
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7.3.3. Sodium-Calcium exchanger protein expression (NCX)
Transmural (epi/endo) NCX expression showed a small decrease in sham 
epicardial NCX expression of 14 ± 10% in comparison to sham endocardial data. 
This transmural difference is not as marked in the LVD data which showed minimal 
decrease in expression 3 ± 12 % (panel A, figure 7.5)
Comparisons between sham and LVD NCX expression are shown in panel B, where 
an increase in NCX protein expression was observed in both endocardial and 
epicardial LVD data sets. NCX expression in the LVD endocardial data was 11 ± 
15% higher than sham whereas LVD epicardial NCX expression was 29 ± 18% 
higher. Statistical analysis (ANOVA) revealed no significant differences between the 
data sets. Again statistical analysis on the combined endocardial and epicardial data 
sets for sham and LVD revealed a significant increase in LVD NCX expression of 21 
± 1 2 %  (p <0.05).
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Figure 7.5. Transmural (epi/endo) and LVD/Sham ratios for NCX expression
are shown in panels A and B respectively, n denotes number of hearts.
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7.3.4. Sodium-calcium exchanger/SERCA ratio
As discussed in chapter 6, an alternative method to maximise accuracy 
(minimise variation) of the Western technique and to confinn changes in protein 
expression is to normalise one protein to another developed from the same gel. The 
NCX/SERCA and SERCA/CSQ ratios were calculated in transmural (endoiepi) and 
Sham/LVD samples to confirm the changes in NCX, SERCA and CSQ protein 
expression observed when the data was normalised to other samples within the gel,
i.e., epi:endo, and LVD:sham. NCX and SERCA are the two major proteins 
responsible for reducing cytosolic Ca^^ levels back to resting values during diastole. 
In rabbit, approximately 28% of cytosolic Ca^ "^  is extruded from the cell by NCX, 
70% is resequestered into the SR by SERCA mediated Ca^ "^  uptake and the 
remaining 2% is taken up by mitochondria or extruded from the cell by the 
sarcolemmal Ca^^-ATPase pump (Bassani et al. 1994). Assessment of the 
NCX/SERCA ratio gives some indication of changes in the ratio of the two major 
proteins responsible for removal of cytoplasmic Ca^ "^  during diastole. A small 
transmural difference in NCX/SERCA ratio was present in sham but not in the LVD 
data. Sham epicardial NCX/SERCA ratio was 15 ± 9% lower than endocardial 
whereas the NCX/SERCA ratio in LVD was only 4 ± 14% lower (figure 7.6; panel 
A). LVD and sham comparisons of NCX/SERCA ratio revealed an 18 ±16% and a 
34 ± 14% increase in endocardial and epicardial samples respectively (figure 7.6, 
panel B). The combined LVD endocardial and epicardial data revealed a 26 ± 11% 
increase in NCX /SERCA expression ratio (p < 0.05).
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7.3.5. SERCA/CSQ ratio
As it is commonly observed that CSQ protein expression is unchanged in 
heart failure or LVD it is often used as a normalisation source when quantifying 
other proteins. As this study observed changes in CSQ protein expression in LVD 
CSQ was not used as a normalisation source.
A nomial transmural difference (sham) in SERCA/CSQ was observed with a 
34 ± 15% higher epicardial SERCA/CSQ ratio. LVD data showed minimal 
transmural differences (epicardial 4 ± 10% higher than endocardial). These data 
suggest that a small normal transmural difference in SERCA/CSQ exists but it is lost 
in LVD (figure?.7; panel A). Both endocardial and epicardial LVD samples showed 
a decrease in the SERCA/CSQ ratio in comparison to sham (endo; 9 ± 17% & 28 ± 
13%). This decreased ratio was more pronounced in LVD epicardium (figure 7.7; 
panel B). The combined LVD endocardial and epicardial data revealed a 19 ± 11% 
decrease in SERCA/CSQ expression ratio (p <0.05).
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EPI/ENDO difference in NCX/SERCA ratio
O  1.0
(n=17
SHAM
(n=18)
B LVD/SHAM differences in NCX/SERCA ratio
(n=17)
ENDO 
(n=18)
Figure 7.6. Transmural (epi/endo) and LVD/Sham ratios for NCX/SERCA 
expression are shown in panels A and B respectively, n denotes number of 
experimental samples.
152
EPI/ENDO difference in SERCA/CSQ ratio
(n=20
SHAM
(n=19)
B LVD/SHAM differences in SERCA/CSQ ratio
w 0.6
2  0.4
2  0.2
ENDO
(n=19)
Figure 7.7. Transmural (epi/endo) and LVD/Sham ratios for SERCA/CSQ 
expression are shown in panels A and B respectively, n denotes number of 
experimental samples.
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7.4. Discussion
The purpose of the experiments described in this chapter was to quantify Ca^  ^
handling protein expression between endocardial and epicardial regions and between 
sham and LVD experimental groups in the model of LVD featured in this study. 
Previous studies have reported alterations in protein expression of Ca^”^ handling 
proteins linked to disruption in diastolic and systolic Ca^ "^  regulation and contractile 
dysfunction. However, prior to this study, no work has featured this particular rabbit 
model of LVD.
7.4.1. Transmural protein expression
Most studies investigating transmural differences in heart have concentrated 
on functional and eiectrophysiological changes and minimal work has been 
published on protein expression. This study observed only minor differences in 
transmural protein expression in all three proteins studied. The data suggest that there 
is a trend towards lower CSQ in epicardial tissue samples (sham and LVD), no 
transmural difference in SERCA expression (sham and LVD) and that NCX 
expression was slightly lower in sham epicardial samples but this trend was not 
present in LVD epicardial samples. With such small differences in transmural protein 
expression for all three proteins, it is unclear whether any normal transmural 
difference in expression actually exists. To verify any transmural differences a 
significantly larger sample size would be required. A study by Prestle et a l (1999) 
investigated transmural protein expression in failing human hearts. In agreement with 
the results in this study they observed a slight increase in endocardial CSQ 
expression in non-failing and failing hearts in comparison to epicardial although this 
was not significant. In contrast, they observed lower SERCA expression in 
endocardial in comparison to epicardial in both failing and non-failing hearts. This 
difference was statistically significantly in the failing group. Northern blot analysis 
quantified SERCA mRNA expression and observed a similar trend to that of protein 
expression. No assessment of NCX protein expression was performed in the Prestle 
study although quantification of mRNA revealed no transmural differences in mRNA 
expression in failing or non-failing hearts. The difference in results between these 
two studies may be due to a species difference (human vs rabbit), the degree of 
severity of failure/dysfunction and/or a difference in the aetiology of the underlying
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disease. Although, direct extrapolation between mRNA and protein expression 
cannot be made due to possible post translational modifications it may give some 
indication of the trend in protein expression. Igarashi-Saito et al. (1999) investigated 
transmural gene expression in canine myocardium and observed a significant 
reduction in SERCA mRNA in endocardium in comparison to epicardium, but 
observed no change in CSQ mRNA. In failing canine myocardium they observed the 
same trend to lower SERCA mRNA in endocardium, but the endo:epi ratio was the 
same in control as heart failure. CSQ mRNA in heart failure showed no transmural 
differences. However, overall SERCA mRNA expression was lower in heart failure, 
and CSQ mRNA was slightly higher in heart failure.
The NCX/SERCA ratio in the sham epicardial data is lower than endocardial 
suggesting epicardial samples normally have either higher SERCA or lower NCX 
expression. As no sham transmural differences were observed in SERCA expression 
(figure 7.4, A) and NCX was slightly lower in epicardial samples (figure 7.5, B) it is 
likely that the lower NCX expression is responsible for the transmural differences in 
ratio values. The small transmural differences observed in the sham NCX/SERCA 
ratio was not present in the LVD data due to higher NCX expression in LVD 
epicardial samples.
The sham epicardial SERCA/CSQ ratio is higher than endocardial suggesting 
either a decrease in epicardial CSQ or an increase in SERCA expression. Epicardial 
CSQ is very slightly lower than endocardial and SERCA is unchanged. The 
decreased epicardial CSQ expression may be responsible for the ratio difference 
although the changes in CSQ expression (<10%) are not directly proportional to the 
changes in SERCA/CSQ ratio (34%). The SERCA/CSQ ratio in LVD endocardial 
and epicardial samples is similar as may be expected by minimal 
endocardial/epicardial differences in both SERCA and CSQ protein expression.
7.4.2. Comparisons between Sham and LVD protein expression
The most striking result in this study was the large increase in CSQ 
expression observed in LVD endocardial and epicardial samples. To date most 
studies have concentrated on whole ventriculai' samples and have observed no 
change in CSQ expression from failing or hypertrophied hearts (Takahashi et at.
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1992; Meyer et al. 1995; Schwinger et al. 1999; Prestle et al. 1999;). The combined 
endocardial and epicardial samples showed a 35-40% increase in CSQ expression.
It should be noted that the combined data do not contain cells from the mid 
myocardium therefore do not necessarily reflect the results that would be produced 
from a whole ventricular sample. However, in agreement with these results, a recent 
study by Naqvi et al (2001) observed a 65% increase in CSQ expression in their 
rabbit aortic banding model of hypertrophy.
The small decrease in LVD SERCA protein expression (-10%) in this model 
is consistent with the general literature view in which a small decrease in SERCA 
expression is observed (Hasenfuss, 1998 and Ravens, 2000, for reviews). Previous 
investigations using the same rabbit model of LVD observed a significant decrease in 
SERCA expression (by 53 ± 9%) (Currie & Smith 1999). The reason for the more 
profound reduction in SERCA expression is not known. In vivo echocardiography 
revealed similar average ejection fractions for both studies, suggesting no gross 
differences in the degree of LVD in both groups. One possible explanation for the 
differences in SERCA expression may be that in this cuiTent study, tissue samples 
were only dissected from basal regions of sham and LVD hearts whereas samples in 
the Currie & Smith study (1999) where dissected from both apical and basal regions. 
Furthermore, whole ventricular samples were assayed by Cunie & Smith (1999) 
whereas the results presented here are a combination of only endocardial and 
epicardial samples (no mid-myocardium).
NCX expression is slightly higher in LVD (endo & epi) than sham which is 
in line with literature results. Pogwizd et al. (1999) in a pressure over load rabbit 
model observed no change in SERCA protein expression and a large increase in 
NCX protein expression (93%). The differences in changes in protein expression 
between this study and Pogwizd’s may be due to differences in the type or duration 
of animal model, i.e. volume vs pressure overload. Overall there is more uncertainty 
regarding the direction of change in NCX protein expression in heart failure and/or 
hypertrophy, as it appears to vary depending on species, severity, duration and 
aetiology of the underlying disease. Either no change in protein expression 
(Schwinger et al. 1999; mRNA; Prestle et al. 1999) or an increase in protein 
expression (Reinecke et al. 1995; O’Rourke et al. 1999; Pogwizd et al. 1999) has 
been observed.
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Alterations from the normal transmural NCX/SERCA protein ratio will 
disrupt normal diastolic and systolic Ca^ '*' homeostasis. The NCX/SERCA ratio is 
higher in both endocardial and epicardial LVD samples suggesting either a lower 
SERCA expression and/or a higher NCX expression or both. In fact, both of these 
changes occurred in the LVD data samples and are likely to be responsible for the 
increased ratio. This ratio represents protein expression only and does not take into 
account the functional activity of the proteins. These results are in agreement with 
Hasenfuss et a l  (1999) who also observed an increase in NCX/SERCA ratio in 
failing human myocardium. Interestingly no change in CSQ expression was observed 
in their study. Hasenfuss et a l (1999) identified different phenotypes according to 
diastolic function which were determined by various combinations of changes in 
protein expression. Disturbed diastolic function occurred in hearts with decreased 
SERCA and unchanged NCX expression. In contrast, diastolic function was 
preserved in hearts where NCX was increased and SERCA expression was 
unchanged. They concluded that increased NCX expression serves to preserve 
diastolic function in failing human myocardium and suggested that regulation of 
expression of both proteins occurred by different independent signals. Verifying this, 
Prestle et a l (1999) showed that transmural differences in SERCA but not NCX 
expression exist across failing and non-failing human hearts.
A marked decrease in SERCA/CSQ ratio is observed in both endocardial and 
epicardial LVD data sets. A decreased ratio suggests either increases in CSQ or 
decreases in SERCA protein expression. As both an increase in CSQ (figure 7.3) and 
a decrease in SERCA (figure 7.4) are observed in both LVD endocardial and 
epicardial data sets it appears that these changes are directly responsible for the 
changes in SERCA/CSQ ratio. Therefore, both the NCX/SERCA and the 
SERCA/CSQ ratio results confirm the protein expression changes observed in the 
averaged transmural and LVD/Sham data sets (figures 7.3.; 4 & 5).
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7.4.3. Implications of altered Ca^  ^handling protein expression
As discussed in chapter 1, CSQ distribution is mainly concentrated around 
the Ryanodine receptor (RyR) in the junctional SR where it is increasingly believed 
to have some regulatory influence on RyR activity either directly or indirectly 
(Szegedi et a l 1999). Given the high buffering capacity of CSQ, the overall affect of 
increased CSQ protein expression will be to increase SR Ca^^ content, i.e. increased 
CSQ expression would be expected to provide more Ca^ "*" buffering within the SR. 
This reduces free [Ca^’*']i and subsequently stimulates SERCA pump activity, leading 
to a rise in SR Ca^”^ content. However, as NCX expression is higher and SERCA 
expression is lower in this model of LVD this will counteract to a certain extent the 
affect of increased CSQ expression. Increased expression of NCX would partially 
counter the effect of increased CSQ assuming that the NCX is working in forward 
mode (Na^in/Ca^'^out). However, if NCX was working in reverse mode 
(Na'^out/Ca^'^in) then it would increase [Ca^ "^ ]i and may promote Ca^ "^  loading into the 
SR. Furthermore, SERCA is influenced by the amount of and the phosphorylation 
status of the regulatory protein phospholamban (PLB). PLB expression and 
phosphorylation state may either counteract a decrease in SERCA expression or 
partially alleviate it. To date, transmural expression of PLB has not been studied in 
this model.
Clearly, it is difficult to estimate what the net effect on SR Ca^ "^  content 
would be following such changes in Ca^ "^  handling protein expression. Quantification 
of protein expression reflects only the amount of protein present within a tissue and 
does not take into account the functional activity of the protein. SR functional 
measurements would be required to accurately quantify SR Ca^^ content.
The use of transgenic animal models is becoming an important method in 
which researchers can study the affects of specific protein knockout or 
overexpression. Mouse models specifically overexpressing CSQ have also observed 
additional changes in the expression of other proteins. Transgenic mice 
overexpressing CSQ by 10 fold showed a decrease in protein expression of the 
ryanodine receptor, junctin, triadin and demonstrated minimal change or a small 
increase in SERCA and phospholamban expression (Tones et a l 1998). In another 
CSQ over expressing mouse study, a 20-fold increase in CSQ was produced (Sato et
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al. 1998). In contrast, the Sato study observed an increase in SERCA and 
phospholamban expression, without alterations in ryanodine receptor, junctin and 
triadin expression. These studies suggested that CSQ overexpression might be 
directly responsible for alterations in the expression of other proteins. Alternatively, 
as CSQ is closely associated with the RyR, increased CSQ may disrupt the functional 
properties of the ryanodine receptor complex which may produce alterations in the 
expression of other Ca^^ handling proteins. Whichever mechanism is responsible, 
such alterations in expression probably constitute a compensatory mechanism, the 
degree of which is dependent on the extent of CSQ overexpression. Interestingly, 
transgenic animals overexpressing CSQ show signs of cardiac hypertrophy (Jones et 
al. 1998; Sato et al. 1998; Schmidt et al. 2000).
Studies overexpressing SERCA (Baker et al. 1998) observed no changes in 
phospholamban protein expression and He et al. (1997) observed no changes in the 
ryanodine receptor, CSQ, phospholamban or NCX protein expression, although the 
mRNA expression for phospholamban and NCX were increased 1.4 and 1.8 fold 
respectively. Transgenic animal models overexpressing NCX demonstrated no 
changes in the protein expression of CSQ, SERCA and phospholamban (Terracciano 
et al. 1998; Kiriazis & Kianias, 2000). It appears from transgenic animal studies that 
CSQ expression has a strong influence on cellular form and function and may play a 
regulatory role in the expression of other proteins. In contrast, overexpressing NCX 
and SERCA proteins does not appear to exert such influence on the expression of 
other intracellular proteins.
Finally, it is not possible to determine from this study whether the alterations 
in SERCA and NCX expression observed in this model are triggered by cellular 
changes activated as a compensatory mechanism due to LVD or are a secondary 
affect induced by alterations in CSQ protein expression.
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7.4.4. Summary
In summary, the three proteins quantified in this study CSQ, SERCA and 
NCX , showed minimal transmural differences in protein expression in both sham 
and LVD samples. The most interesting and unexpected finding from these 
experiments was the significant increase (-  40%) in CSQ protein expression 
observed in LVD. This finding is unusual, as most studies have reported unchanged 
CSQ protein expression in heart failure or LVD. The increase in CSQ protein 
expression may be specific to this particular animal model (severity, duration and 
aetiology). SERCA protein expression was slightly lower (-10%) and NCX protein 
expression was higher (15%) in LVD than sham. These findings are consistent with 
most literature observations.
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Chapter 8 
General discussion
8.1. Relationship between myocyte contractility and intracellular 
[Ca"+].
The aim of this study was to characterise and interrelate transmural 
differences in normal myocyte contractility with intracellular [Ca^‘*‘] and Ca^ '*' 
handling protein expression. Furthermore, the effects of chronic myocardial 
infarction on the above parameters were investigated and compared to normal (sham) 
myocytes. Table 8.1 below summarises the changes reported in earlier chapters (3 & 
4).
Sham
Epi/Endo
ratio
LVD
Epi/Endo
ratio
Endo
LVD/Sham
ratio
Epi
LVD/Sham
ratio
Diastolic L. A = 1 = 1 < 1 < 1
Diastolic Ca > 1 < 1 < 1 < 1
Fractional
shortening
< 1 < 1 < 1 4#
Peak systolic > 1 < 1 = 1 < 1
Table 8.1. Summary changes in Epi/Endo and LVD/Sham ratios of diastolic 
length change, fractional shortening and associated changes in diastolic and 
peak systolic [Ca^^j . The ratios are indicated by < 1 and > 1, =1 indicates 
no change. Equal ratios with a trend to lower or higher ratios are indicated by 
< 1 and > respectively.
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8.1.1. Transmural comparisons
Relating changes in myocyte length to [Ca^’^ ji can give some indication of 
myocyte myofilament Ca^ '*' sensitivity. Frequency-dependent changes in diastolic 
length were of a similar magnitude between endocardial and epicardial sham 
myocytes, yet sham epicardial diastolic [Ca^ '^ Ji was slightly higher than endocardial. 
These results may indicate a transmural difference in myofilament Ca^ "^  sensitivity, 
with epicardial myofilaments less sensitive to Ca^ '*' than endocardial myofilaments 
(table 8.1). LVD endocardial and epicardial diastolic length changes were also 
similar yet in contrast to the sham data, LVD epicardial diastolic [Ca^^]; was lower 
than endocardial suggesting higher myofilament Ca^ "^  sensitivity in LVD epicardial 
myocytes in comparison to endocardial. These data suggest that the normal 
myofilament Ca^ "^  sensitivity gradient observed in sham myocytes is not maintained 
in LVD.
CoiTelation between fractional shortening and peak systolic [Ca^^]i in the 
sham data indicate a similar transmural myofilament Ca^ '*' sensitivity gradient to that 
observed with the diastolic length/Ca^^ relationship. Fractional shortening was less in 
sham epicardial myocytes in comparison to endocardial yet peak systolic [Ca '^ j^i was 
similar if not greater in epicardial myocytes. These results indicate lower sham 
epicardial myofilament Ca^ '*' sensitivity. Transmural fractional shortening was very 
similar in the LVD data set, yet peak systolic [Ca^ '^ Ji was slightly lower in epicardial 
myocytes, although not significantly. These results are in agreement with the 
diastolic data where LVD epicardial myofilament Ca^ "^  sensitivity appears higher 
than LVD endocardial myofilament Ca^ '*' sensitivity.
8.1.2. Sham/ LVD comparisons
The trend towards less relative diastolic myocyte length changes with 
increasing frequency of stimulation in LVD myocytes (table 8.1) could reflect either 
lower diastolic [Ca^^], or reduced myofilament Ca^ "^  sensitivity in LVD myocytes. 
Endocardial and epicardial LVD myocytes display lower diastolic [Ca^^], than 
coiTesponding shams myocytes suggesting that the increased resting length is due to 
lower diastolic [Ca '^ ]^j rather than altered myofilament Ca^^ sensitivity (table 8.1). 
Comparisons between LVD/Sham relative diastolic length changes suggests a 
slightly higher sensitivity in both LVD endocardial and epicardial myocytes as
162
relative diastolic length changes are small or unchanged, yet LVD diastolic [Ca^^] is 
lower, significantly so in LVD epicardial myocytes.
Fractional shortening is lower in endocardial LVD in comparison to sham 
although not significantly, yet LVD endocardial peak systolic [Ca '^ J^i is unchanged. 
This suggests that myofilament Ca^ '*' sensitivity is lower in LVD endocardial 
myocytes in comparison to sham. In contrast, the opposite occurs in epicardial 
myocytes (table 8.1), where LVD epicardial fractional shortening is unchanged yet 
the peak systolic [Ca^^] is lower. This result suggests that epicardial myofilament 
Ca^’*' sensitivity is higher in LVD than sham. The diastolic data suggest that both 
LVD endocardial and epicardial myofilament Ca^ "^  sensitivity is greater than sham 
whereas in contrast, the fractional shortening data suggests that only LVD epicardial 
sensitivity is higher. The reason for this difference is unknown.
To further investigate myofilament Ca^ '^  sensitivity changes in LVD, the 
correlation between relative diastolic length and [Ca^^ji with increasing stimulation 
frequency was examined. Figure 8.1 compares the relative diastolic length changes 
associated with changing [Ca^ ' J^i (nM) in both sham and LVD myocytes. Although 
this approach may not be the ideal way of measuring myofilament Ca^ "^  sensitivity 
due to dynamic changes in both diastolic length and [Ca^^ji under these conditions it 
may give some indication of myofilament Ca^ '*’ sensitivity changes. Both endocaidial 
and epicardial results were combined for sham and LVD groups. Relative diastolic 
length changes for each group are expressed relative to diastolic length at 0.3Hz of 
each myocyte subtype. The diastolic length -  [Ca^“^] relationship showed a trend 
towards greater length changes (gradient = -11.2 ± 1.29 xlO'^) in LVD myocytes in 
comparison to the sham (gradient = -9.7 ± 1.56 xlO'^) data set, although no 
significant differences were observed. These results suggest that myofilament Ca^ "^  
sensitivity is similar between LVD and sham myocytes.
163
■ Endo1.01 -1
□ LVD Endo 
O LVD Epi
O-D
0 . 9 9 -
%  0 . 9 7 -
5 0 100 150 200 2 5 0 3 0 0 3 5 0 4 0 0
[ C a n  (nM)
Figure 8.1. Relationship between changes in relative diastolic length and 
[Ca^^i. Solid lines represent best linear fits of the data. Slope of linear fit 
were -  9.76 ± 1.56 xIO'^ and -  11.2 ± 1.29 xIO'^ for sham and LVD 
respectively.
To date, published reports of changes in myofilament Ca^ '  ^ sensitivity in 
failing myocardium have been conflicting. Unchanged myofilament Ca^ '*' sensitivity 
in hypertrophic guinea-pig (Naqvi & Macleod, 1994), rabbit trabeculae (Denvir et al. 
1996), dog (Kinugawa et al. 1999), and human muscle strips (Gwathmey & Hajjar, 
1990; Hajjar et al. 2000) have been reported. Decreased sensitivity in failing rat 
myocytes (Li et at. 1997; Wisloff et al. 2002), and trabeculae (Perez et at. (1999) 
have also been reported. In contrast, increased myofilament Ca^ "^  sensitivity has been 
reported in human (Schwinger et al. 1994; Wolff et a/. 1996) and canine myocardium 
(Wolff gf a/. 1995).
An alternative cause of the altered relationship between intracellular [Ca^ **"] 
and length in failing myocytes is a change in the resistance to myocyte shortening. 
Increased passive resistance would result in decreased myocyte shortening in the face 
of constant myofilament force production. Passive resistance within myocytes is 
dependent on the density and distribution of the cytoskeleton. Increased density and 
disorganisation of cytoskeletal proteins (Schaper et al. 1991) and membrane
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associated proteins (Hein et al. 2000) have been observed. Increased cytoskeletal 
density impedes sarcomere motion, increases intracellular loading and produces 
contractile dysfunction. Contractile dysfunction, in the form of reduced extent and 
velocity of sarcomere shortening (Tsutsui et al. 1994) and loss of compliance 
(increased cytoskeletal stiffness) (Tagawa et al. 1997) have been reported in a feline 
pressure overloaded hypertrophic model. The degree of cytoskeletal accumulation 
and disorganisation may be species, severity of failure, load and chamber dependent 
(Hein et al. 2000). Cytoskeletal changes may be an alternative reason for the 
differences in contraction amplitude observed in this study between LVD and Sham 
myocytes. Further, cytoskeleton density and organisation may vary across the left 
ventricle due to differences in transmural myocyte load.
165
8.2. Relationship between handling protein expression and
intracellular [Ca^ ]^.
As mentioned previously, intracellular [Ca^ '*'] homeostasis is governed by SR 
Ca^ '*' release/uptake and sarcolemmal Ca^^ influx and efflux. The major mechanisms 
responsible for intracellular Ca^ *^  movement are the Ca^ "^  handling proteins, most 
importantly SERCA, RyR, and NCX. Alterations in expression of these proteins are 
likely to have adverse affects on intracellular Ca^‘*‘ homeostasis. Table 8.2 below 
summarises the changes in protein expression between endocardial and epicardial 
samples and between sham and LVD groups. Peak systolic [Ca^ "*"]; (electrically 
induced) and caffeine-induced peak systolic [Ca '^ j^i are included in this table to try to 
determine if a correlation between protein expression and peak systolic [Ca^], exists, 
i.e. are the changes in protein expression responsible for changes in peak systolic
Sham
Epi/Endo
ratio
LVD
Epi/Endo
ratio
Endo
LVD/Sham
ratio
Epi
LVD/Sham
ratio
Peak systolic > 1 < 1 =1 < 1
Caffeine peak 
systolic Ca^ ^
> 1 < 1 =1 < 1
CSQ < 1 < 1 > 1 > 1
SERCA =1 =1 < 1 < 1
NCX < 1 =1 > 1 > 1
Table 8.2. Summary of changes in Epi/Endo and LVD/Sham ratio of peak 
systolic Ga^ '*', caffeine-induced peak systolic Ca^^ and protein expression. 
Increases and decreases in the ratios are indicated by < 1 and > 1, =1 
indicates no change. Equal ratios with a trend to lower or higher ratios are 
indicated by < 1 and > 1 respectively.
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8.2.1. Transmural and LVD/Sham comparisons.
As explained in chapter 7, it is difficult to correlate intracellular changes with 
protein expression directly as the net intracellular effect of a change in a given 
amount of protein is unknown unless the functional activity of the protein has been 
determined quantitatively. Furthermore, it is also possible that the expression of more 
than one protein will change in any given situation, therefore directly relating a 
specific intracellular event to a change in expression of one specific protein is almost 
impossible.
The use of transgenic animals to artificially overexpress or knockout specific 
proteins allows researchers to investigate the physiological role played by these 
proteins. Over expression of CSQ in transgenic mice produced a decreased calcium 
transient amplitude even though SR Ca^ "^  content was increased (assayed by caffeine 
application) (Sato et al. 1998; Jones et al. 1998). In these cases, increased CSQ 
expression was associated with increased SR Ca^ "^  capacity but a decreased 
efficiency of Ca^ "^  induced SR Ca^ "^  release, i.e. decreased peak systolic [Ca^’^ ]i.
In this study, a marked increase in CSQ expression was observed in both 
endocardial and epicardial LVD myocytes (table 8.2). A reduced peak systolic 
[Ca^ "^ ]i was observed in epicardial but not in endocardial LVD myocytes and in 
addition no differences in the caffeine-induced peak systolic [Ca^^]i was observed. 
One explanation for the appaient differences between these studies is that the CSQ 
overexpression in the Sato & Jones models was increased 10 and 20 fold whereas, 
the increased CSQ expression in this LVD model was increased by only ~1.5 fold. 
Therefore, the small increase in CSQ expression observed in this study appears to be 
having a negligible affect on SR Ca^^content.
Another study observed doubling of the calcium transient amplitude when 
SERCA was overexpressed -1.5 fold (Baker et al. 1998). Therefore, one may predict 
that decreased SERCA expression would lead to decreased calcium transient 
amplitudes. In agreement, LVD endocardial and epicardial myocytes showed a ~ 
10% decrease in SERCA expression (table 8.2) and a small decrease in calcium and 
caffeine-induce calcium transient amplitude. Studies overexpressing NCX 
(Tenacciano et al. 1998) observed no significant changes in calcium transient 
amplitude, although transgenic myocytes showed a tendency to smaller calcium 
transient amplitudes, yet SR Ca^ "^  content was 69% higher (caffeine application). In
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addition, contraction kinetics were significantly faster in transgenic myocytes in 
comparison to control myocytes. In contrast Schillinger et al. (2000) observed 
smaller caffeine-induced calcium transients in their NCX overexpression model 
(adenoviral upregulation). The tendency for unchanged or smaller calcium transient 
amplitude observed in LVD may reflect increased NCX activity as a result of 
increased NCX expression.
The peak systolic [Ca^’^Ji and protein expression changes reported in this 
study agree with previously published data regarding trends between these two 
factors. Obviously, with the combination of protein expression changes in this LVD 
model it is impossible to specify which if any single protein is solely responsible for 
the changes in peak systolic [Ca^^];. Furthermore, as the activity of these proteins is 
unknown, one cannot assume that there is direct correlation between protein 
expression and activity (Quinn et al. 2001).
It is likely that the effect on SR Ca^^content and subsequent peak systolic 
[Ca^ "^ ]i is the net effect of the combined protein expression changes. In addition, 
intracellular disruption of normal signalling pathways, biochemical changes, such as 
protein phosphorylation may also influence changes in overall cellular and/or protein 
function.
8.3. Future work
In this study, indirect evidence was presented to suggest that a transmural 
gradient in myofilament sensitivity in normal rabbit myocardium exists and that is 
subsequently altered in this model of LVD.
The most obvious set of experiments to be performed in the future on this LVD 
model is the assessment of transmural sham and LVD myofilament Ca^’^ sensitivity. 
Altered myofilament Ca^‘*‘ sensitivity may arise from changes in intracellular 
conditions such as pH, [Mg^ '*'] and [Pi] which act directly on myofilaments to alter 
force production. Therefore it would be useful to establish which intracellular 
conditions changed in this LVD model and how they subsequently affect Ca^ '^  
myofilament sensitivity.
Alternatively, changes in myosin isoform expression may alter the intrinsic 
activity of the myofilaments in hypertrophy (Bugaisky, et al. 1990). Furthermore, 
alterations in troponin quantity (Westfall & Solaro 1992) and phosphorylation state 
(Solaro & Van Eyk, 1996) may also affect myofilament function and Ca^ '*’
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sensitivity. Assessment of myofilament protein biochemistry and cytoskeletal 
expression in this model of dysfunction may help establish causative factors involved 
in cellular dysfunction.
In addition, quantification of RyR protein expression and activity in sham and 
LVD endocardial and epicardial regions may help to explain differences in SR Ca^’*' 
release. RyRs are thought to be modulated by many intracellular proteins, one of 
which is FKBP. Hyperphosphorylation of FKBP has been reported in heart failure 
(Marx et al. 2000), this hyperphoshorylated state results in defective channel 
function and subsequently alters SR Ca^ '*' release. Assessment of FKBP protein 
expression and phosphorylation status in sham and LVD endocardial and epicardial 
regions could be an important determinant of RyR modulation and may help to 
explain the differences in peak systolic [Ca^’*‘]i.
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